
<html lang="en"     class="pb-page"  data-request-id="018e9669-edcf-4499-ae60-99c4c3f7b225"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00210;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-7"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy" /></meta><meta name="dc.Creator" content="William  McCoull" /></meta><meta name="dc.Creator" content="Andrew  Bailey" /></meta><meta name="dc.Creator" content="Peter  Barton" /></meta><meta name="dc.Creator" content="Alan M.  Birch" /></meta><meta name="dc.Creator" content="Alastair J. H.  Brown" /></meta><meta name="dc.Creator" content="Hayley S.  Butler" /></meta><meta name="dc.Creator" content="Scott  Boyd" /></meta><meta name="dc.Creator" content="Roger J.  Butlin" /></meta><meta name="dc.Creator" content="Ben  Chappell" /></meta><meta name="dc.Creator" content="Paul  Clarkson" /></meta><meta name="dc.Creator" content="Shelley  Collins" /></meta><meta name="dc.Creator" content="Robert M. D.  Davies" /></meta><meta name="dc.Creator" content="Anne  Ertan" /></meta><meta name="dc.Creator" content="Clare D.  Hammond" /></meta><meta name="dc.Creator" content="Jane L.  Holmes" /></meta><meta name="dc.Creator" content="Carol  Lenaghan" /></meta><meta name="dc.Creator" content="Anita  Midha" /></meta><meta name="dc.Creator" content="Pablo  Morentin-Gutierrez" /></meta><meta name="dc.Creator" content="Jane E.  Moore" /></meta><meta name="dc.Creator" content="Piotr  Raubo" /></meta><meta name="dc.Creator" content="Graeme  Robb" /></meta><meta name="dc.Description" content="GPR120 agonists have therapeutic potential for the treatment of diabetes, but few selective agonists have been reported. We identified an indazole-6-phenylcyclopropylcarboxylic acid series of GPR12..." /></meta><meta name="Description" content="GPR120 agonists have therapeutic potential for the treatment of diabetes, but few selective agonists have been reported. We identified an indazole-6-phenylcyclopropylcarboxylic acid series of GPR12..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 4, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00210" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00210" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00210" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00210" /></link>
        
    
    

<title>Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00210" /></meta><meta property="og:title" content="Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0013.jpeg" /></meta><meta property="og:description" content="GPR120 agonists have therapeutic potential for the treatment of diabetes, but few selective agonists have been reported. We identified an indazole-6-phenylcyclopropylcarboxylic acid series of GPR120 agonists and conducted SAR studies to optimize GPR120 potency. Furthermore, we identified a (S,S)-cyclopropylcarboxylic acid structural motif which gave selectivity against GPR40. Good oral exposure was obtained with some compounds displaying unexpected high CNS penetration. Increased MDCK efflux was utilized to identify compounds such as 33 with lower CNS penetration, and activity in oral glucose tolerance studies was demonstrated. Differential activity was observed in GPR120 null and wild-type mice indicating that this effect operates through a mechanism involving GPR120 agonism." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00210"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00210">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00210&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00210&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00210&amp;href=/doi/10.1021/acs.jmedchem.7b00210" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3187-3197</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00180" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00274" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William++McCoull">William McCoull</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2977-1744" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Bailey">Andrew Bailey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Barton">Peter Barton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+M.++Birch">Alan M. Birch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alastair+J.+H.++Brown">Alastair J. H. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hayley+S.++Butler">Hayley S. Butler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Boyd">Scott Boyd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roger+J.++Butlin">Roger J. Butlin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Chappell">Ben Chappell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Clarkson">Paul Clarkson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shelley++Collins">Shelley Collins</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+M.+D.++Davies">Robert M. D. Davies</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne++Ertan">Anne Ertan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clare+D.++Hammond">Clare D. Hammond</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+L.++Holmes">Jane L. Holmes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carol++Lenaghan">Carol Lenaghan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anita++Midha">Anita Midha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pablo++Morentin-Gutierrez">Pablo Morentin-Gutierrez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+E.++Moore">Jane E. Moore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Piotr++Raubo">Piotr Raubo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Graeme++Robb">Graeme Robb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">IMED Oncology and Discovery Sciences, AstraZeneca, 310 Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">IMED CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div><div class="corresp-info"><strong>*</strong>Phone: +44(0)1625236807. E-mail: <a href="/cdn-cgi/l/email-protection#d0a7b9bcbcb9b1bdfebdb3b3bfa5bcbc90b1a3a4a2b1aab5beb5b3b1feb3bfbd"><span class="__cf_email__" data-cfemail="3e49575252575f5310535d5d514b52527e5f4d4a4c5f445b505b5d5f105d5153">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00210&amp;href=/doi/10.1021%2Facs.jmedchem.7b00210" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3187–3197</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 4, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 February 2017</li><li><span class="item_label"><b>Published</b> online</span>4 April 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00210" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00210</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3187%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWilliam%2BMcCoull%252C%2BAndrew%2BBailey%252C%2BPeter%2BBarton%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D7%26contentID%3Dacs.jmedchem.7b00210%26title%3DIndazole-6-phenylcyclopropylcarboxylic%2BAcids%2Bas%2BSelective%2BGPR120%2BAgonists%2Bwith%2Bin%2BVivo%2BEfficacy%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3197%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00210"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2031</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00210" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo Efficacy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;McCoull&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Bailey&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Barton&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;M. Birch&quot;},{&quot;first_name&quot;:&quot;Alastair&quot;,&quot;last_name&quot;:&quot;J. H. Brown&quot;},{&quot;first_name&quot;:&quot;Hayley&quot;,&quot;last_name&quot;:&quot;S. Butler&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Boyd&quot;},{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;J. Butlin&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Chappell&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Clarkson&quot;},{&quot;first_name&quot;:&quot;Shelley&quot;,&quot;last_name&quot;:&quot;Collins&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;M. D. Davies&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Ertan&quot;},{&quot;first_name&quot;:&quot;Clare&quot;,&quot;last_name&quot;:&quot;D. Hammond&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;L. Holmes&quot;},{&quot;first_name&quot;:&quot;Carol&quot;,&quot;last_name&quot;:&quot;Lenaghan&quot;},{&quot;first_name&quot;:&quot;Anita&quot;,&quot;last_name&quot;:&quot;Midha&quot;},{&quot;first_name&quot;:&quot;Pablo&quot;,&quot;last_name&quot;:&quot;Morentin-Gutierrez&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;E. Moore&quot;},{&quot;first_name&quot;:&quot;Piotr&quot;,&quot;last_name&quot;:&quot;Raubo&quot;},{&quot;first_name&quot;:&quot;Graeme&quot;,&quot;last_name&quot;:&quot;Robb&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;3187-3197&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00210&quot;},&quot;abstract&quot;:&quot;GPR120 agonists have therapeutic potential for the treatment of diabetes, but few selective agonists have been reported. We identified an indazole-6-phenylcyclopropylcarboxylic acid series of GPR120 agonists and conducted SAR studies to optimize GPR120 potency. Furthermore, we identified a (S,S)-cyclopropylcarboxylic acid structural motif which gave selectivity against GPR40. Good oral exposure was obtained with some compounds displaying unexpected high CNS penetration. Increased MDCK efflux was utilized to identify compounds such as 33 with lower CNS penetration, and activity in oral glucose tolerance studies was demonstrated. Differential activity was observed in GPR120 null and wild-type mice indicating that this effect operates through a mechanism involving GPR120 agonism.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00210&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00210" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00210&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00210" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00210&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00210" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00210&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00210&amp;href=/doi/10.1021/acs.jmedchem.7b00210" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00210" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00210" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00210%26sid%3Dliteratum%253Aachs%26pmid%3D28374589%26genre%3Darticle%26aulast%3DMcCoull%26date%3D2017%26atitle%3DIndazole-6-phenylcyclopropylcarboxylic%2BAcids%2Bas%2BSelective%2BGPR120%2BAgonists%2Bwith%2Bin%2BVivo%2BEfficacy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D7%26spage%3D3187%26epage%3D3197%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/jmcmar.2017.60.issue-7/20170413/jmcmar.2017.60.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">GPR120 agonists have therapeutic potential for the treatment of diabetes, but few selective agonists have been reported. We identified an indazole-6-phenylcyclopropylcarboxylic acid series of GPR120 agonists and conducted SAR studies to optimize GPR120 potency. Furthermore, we identified a (<i>S</i>,<i>S</i>)-cyclopropylcarboxylic acid structural motif which gave selectivity against GPR40. Good oral exposure was obtained with some compounds displaying unexpected high CNS penetration. Increased MDCK efflux was utilized to identify compounds such as <b>33</b> with lower CNS penetration, and activity in oral glucose tolerance studies was demonstrated. Differential activity was observed in GPR120 null and wild-type mice indicating that this effect operates through a mechanism involving GPR120 agonism.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Type 2 diabetes (T2D) is one of the fastest growing diseases worldwide and is estimated to affect 415 million in 2015.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> One of the likely major reasons for this is unhealthy diet and lifestyle choices leading to obesity, insulin resistance, and elevated levels of free fatty acids in plasma.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The G-protein-coupled receptor GPR120, also known as the free fatty acid receptor 4 (FFAR4), has been suggested to act as a lipid sensor in the body, being implicated in a diversity of processes like adipogenesis, inflammation, and regulation of metabolic control. GPR120 is activated by medium and long chain fatty acids.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Dysfunction of GPR120 has been associated with development of obesity, and recently a mutation in the human GPR120 gene, inhibiting GPR120 signaling, was observed in obese subjects.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A GPR120 agonist has been shown to improve insulin resistance in obese mice,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and selective GPR120 agonists have therapeutic potential for the treatment of diabetes.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> There are only a small number of GPR120 agonists reported, and obtaining high selectivity for GPR120 over a related lipid sensing GPCR, GPR40 (also known as FFAR1), has been challenging to achieve.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13 ref14">(8-14)</a> The GPR120 agonist TUG-891 (3-{4-[(4-fluoro-4′-methyl-2-biphenylyl)methoxy]phenyl}propanoic acid) was shown to be selective over GPR40 in human forms of these receptors but exhibits limited selectivity against the murine form,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> indicating that interspecies differences are also a challenge in the delivery of selective in vivo probes.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A pyrazole <b>1</b> from the patent literature<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> known as “Metabolex 36”<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> was identified as an attractive starting point. We postulated that rigidification of the ether side chain by connecting from oxygen to the pyrazole through installation of an indazole ring as in <b>2</b> would present a novel GPR120 chemotype from which SAR exploration would be possible (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). A carboxylic acid is common in most known GPR120 agonists; thus we postulated that a carboxylic acid with an appropriate spacer group A from a phenyl group attached to the 6-position of the indazole as in <b>2</b> would result in desired GPR120 agonism. A 2-pyridyl substitutent was utilized rather than 4-chlorophenyl for the purposes of reducing overall lipophilicity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Scaffold hop strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">GPR120 agonism was measured by looking at DMR (dynamic mass redistribution response) detected using Corning EPIC technology<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> for overexpressed human GPR120 in CHO cells. Since it was important to ultimately obtain selectivity against GPR40 not only in human but also in murine isoforms, then GPR40 agonism was measured by looking at intracellular calcium levels in FLIPR format for overexpressed mouse GPR40 in HEK293s cells. Although acetic acid analogue <b>3</b> was inactive, the propanoic acid <b>4</b> gave GPR120 agonism with EC<sub>50</sub> = 0.64 μM, thus validating the indazole core as a GPR120 scaffold (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). However, GPR40 agonism was also present for <b>4</b>. Further SAR was evident at the para-position, R1. Dimethyl substitution of the propanoic acid in <b>5</b> removed the GPR40 agonism with 6-fold reduction in GPR120 potency, suggesting that optimization for balance of GPR120 potency and selectivity could be achieved by substituted propanoic acid analogues. Butanoic acid <b>6</b> showed improved GPR120 potency but again with significant GPR40 activity. Propanoic acid (<b>7</b>) and ethanoic acid (<b>8</b>) analogues at the meta-position did not exhibit significant GPR120 agonism.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial Indazole Lead and SAR Exploration</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">h GPR120 Epic EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (efficacy)</th><th class="colsep0 rowsep0" align="center">mu GPR40 FLIPR EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (efficacy)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>17 (8)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.64 (107)</td><td class="colsep0 rowsep0" align="left">1.4 (95)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CMe<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4.1 (79)</td><td class="colsep0 rowsep0" align="left">>100 (18)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.26 (128)</td><td class="colsep0 rowsep0" align="left">2.1 (117)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">>17 (28)</td><td class="colsep0 rowsep0" align="left">>100 (0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">>17 (3)</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Mean of at least two independent measurements.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">pIC<sub>50</sub> SEM is <0.14.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">pIC<sub>50</sub> SEM is <0.03.</p></div></div></div><div class="NLM_p">Having achieved both GPR120 and GPR40 agonism with propanoic acid <b>4</b>, we utilized this side chain to explore SAR for both receptors by modifying substitution on the indazole core (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Incorporation of nitrogen at the 5-position of the indazole gave <b>9</b> which modestly reduced GPR120 and GPR40 potency by 4- and 6-fold, respectively. Since this change was accompanied by a large reduction in log <i>D</i><sub>7.4</sub> of 1.2, then it was considered of potential use in combination with other productive SAR elsewhere in the molecule later. A range of substituents was tolerated at the ortho-phenyl R1 position with relatively flat SAR (<b>10</b>–<b>13</b>). Methoxy, fluoro, and chloro gave similar GPR120 potency and selectivity compared to hydrogen. Cyano gave modestly reduced potency against both receptors. Removal of the methyl group at R3 was tolerated in <b>14</b>, and methoxy substitution modestly improved GPR120 potency 2.5-fold in <b>15</b> with increased selectivity against GPR40. Larger benzyloxy compound <b>16</b> was inactive against GPR120, although GPR40 agonism was maintained. Ethyl analogue <b>17</b> had similar GPR120 and GPR40 potency, as the methyl benchmark <b>4</b> and cyano analogue <b>18</b> reduced GPR120 potency 7.5-fold while maintaining GPR40 potency. Since R3 = H was well tolerated in <b>14</b>, substitution was varied at R2 while keeping R3 unsubstituted (<b>19</b>–<b>21</b>). Fluoro substitution at R2 emerged as giving the greatest GPR120 potency with cyano and methyl substitution being 5- and 10-fold lower.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Exploration of 6-Phenylindazole</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center">h GPR120 Epic EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (efficacy)</th><th class="colsep0 rowsep0" align="center">mu GPR40 FLIPR EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (efficacy)</th><th class="colsep0 rowsep0" align="center">log <i>D</i><sub>7.4</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.6 (78)</td><td class="colsep0 rowsep0" align="left">9.2 (86)</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.72 (82)</td><td class="colsep0 rowsep0" align="left">8.2 (62)</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.4 (80)</td><td class="colsep0 rowsep0" align="left">6.1 (47)</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.60 (113)</td><td class="colsep0 rowsep0" align="left">1.5 (105)</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.71 (113)</td><td class="colsep0 rowsep0" align="left">1.2 (102)</td><td class="colsep0 rowsep0" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.99 (114)</td><td class="colsep0 rowsep0" align="left">4.5 (106)</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">0.25 (122)</td><td class="colsep0 rowsep0" align="left">2.6 (96)</td><td class="colsep0 rowsep0" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OBn</td><td class="colsep0 rowsep0" align="left">>17 (2)</td><td class="colsep0 rowsep0" align="left">1.3 (81)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.76 (75)</td><td class="colsep0 rowsep0" align="left">1.1 (93)</td><td class="colsep0 rowsep0" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">4.8 (87)</td><td class="colsep0 rowsep0" align="left">2 (124)</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4.6 (70)</td><td class="colsep0 rowsep0" align="left">2.6 (82)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.47 (100)</td><td class="colsep0 rowsep0" align="left">2.6 (126)</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.0 (78)</td><td class="colsep0 rowsep0" align="left">19 (113)</td><td class="colsep0 rowsep0" align="left">2.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Mean of at least two independent measurements unless otherwise stated.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">pIC<sub>50</sub> SEM is <0.31.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">pIC<sub>50</sub> SEM is <0.19.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last"><i>n</i> = 1.</p></div></div></div><div class="NLM_p">A parallel SAR exploration was conducted to explore substitution on the ethyl linker (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). α-Methylation to the acid of <b>14</b> reduced GPR120 potency 4-fold and (<i>S</i>)-<b>22</b> maintained GPR40 potency while (<i>R</i>)-<b>23</b> was not active against GPR40, indicating that chirality at this position was important. β-Methylation to the acid of <b>9</b> reduced both GPR120 and GPR40 activity in <b>24</b>. This led us to postulate that the smallest possible α,β-disubstituted cyclopropyl analogues<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> were worth investigating. The <i>trans</i>-racemate <b>25</b> maintained GPR120 potency but was inactive against GPR40, while the <i>cis</i>-racemate <b>26</b> was inactive against GPR120 potency and weakly active against GPR40. Consequently, the enantiomers of <i>trans</i>-cyclopropyl were prepared and all GPR120 activity was found to reside with the (<i>S</i>,<i>S</i>)-<b>27</b> enantiomer while the (<i>R</i>,<i>R</i>)-<b>28</b> enantiomer was inactive. A specific cyclopropane configuration has also recently been identified as critical for GPR120 potency and selectivity over GPR40 within a different chemotype.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Exploration of Ethyl Linker</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Mean of at least two independent measurements.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">pIC<sub>50</sub> SEM is <0.07</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">pIC<sub>50</sub> SEM is <0.15.</p></div></div><div></div></div><div class="NLM_p">The next SAR iteration involved combining some of the groups which improved potency of 6-phenylindazoles for GPR120 with the (<i>S</i>,<i>S</i>)-cyclopropanecarboxylic acid. The latter was expected to consistently give selectivity against GPR40, and this was achieved in all analogues (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). For each of R1 and R2 either hydrogen or fluorine was selected, and for R3 either methyl or methoxy was selected. The pyridyl ring on the indazole nitrogen had not been altered throughout the SAR exploration, but other groups were expected to be tolerated; thus pyridyl, 4-methylpyridyl, and tolyl were selected to increase the diversity of structures. In addition, a nitrogen was introduced at the 5-position in <b>29</b> and <b>33</b> to further increase diversity of structure and also ADME properties by reduction of lipophilicity. Gratifyingly, the compounds all exhibited submicromolar potency against GPR120 and 4-fluoro-3-methoxyindazole <b>35</b> gave a significant increase in GPR120 potency at 78 nM. All compounds (<b>29</b>–<b>35</b>) were inactive in a null cell Epic assay and gave similar activity against the mouse isoform of GPR120, as the human isoform thus had potential to be in vivo probes (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Selected Combination Compounds with (<i>S</i>,<i>S</i>) Cyclopropane Acid</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0012.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">A</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center">B</th><th class="colsep0 rowsep0" align="center">R4</th><th class="colsep0 rowsep0" align="center">h/mu GPR120 Epic EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (efficacy)</th><th class="colsep0 rowsep0" align="center">mu GPR40 FLIPR EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (efficacy)</th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><sub>7.4</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.90 (76)/0.64 (99)</td><td class="colsep0 rowsep0" align="left">>100 (12)</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.52 (88)/0.54 (112)</td><td class="colsep0 rowsep0" align="left">>100 (14)</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.51 (93)/0.62 (103)</td><td class="colsep0 rowsep0" align="left">>100 (19)</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.47 (102)/0.41 (99)</td><td class="colsep0 rowsep0" align="left">>100 (1)</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.74 (66)/1.0 (79)</td><td class="colsep0 rowsep0" align="left">>100 (2)</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.36 (100)/0.51 (91)</td><td class="colsep0 rowsep0" align="left">>100 (1)</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.078 (115)/0.017<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (176)</td><td class="colsep0 rowsep0" align="left">>100 (11)</td><td class="colsep0 rowsep0" align="char" char=".">>4.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Mean of at least two independent measurements unless otherwise stated.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">pIC<sub>50</sub> SEM is <0.22</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Synthesis</h3><div class="NLM_p">Synthesis of the (<i>S</i>,<i>S</i>)-indazole-6-phenylcyclopropylcarboxylic acid was conducted as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Starting from the bromoaldehyde (<b>36</b>), the corresponding racemic 4-bromophenylcyclopropylcarboxylic acids (<b>39</b>) were obtained in the three-step sequence of reactions involving Horner–Wadsworth–Emmons olefination of <b>36</b> followed by Corey–Chaykovsky cyclopropanation of α,β-unsaturated ester <b>37</b> and hydrolysis of the ester <b>38</b> to corresponding racemic <i>trans</i>-cyclopropanecarboxylic acids <b>39</b>. Racemic <b>39</b> were converted to corresponding Evans’ <i>N</i>-acyloxazolidinones, and diasteroisomers were separated by flash chromatography. The enantiomerically pure oxazolidinones <b>40</b> were subjected to hydrolysis and subsequently to palladium catalyzed boronylation with bis(pinacolato)diboron to afford corresponding boronic esters <b>42</b>. In the next step, Suzuki–Miyaura cross-coupling reaction of <b>42</b> with corresponding heteroaryl halides <b>43</b> delivered homochiral (<i>S</i>,<i>S</i>)-indazole-6-phenylcyclopropanecarboxylic acids (<b>27</b>, <b>29</b>–<b>35</b>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of (<i>S</i>,<i>S</i>)-Indazole-6-phenylcyclopropylcarboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) RO<sub>2</sub>CCH<sub>2</sub>P(O) (OEt)<sub>2</sub>, NaH, THF, R1 = H, 72%, R1 = F, 95%; (ii) I(OSMe<sub>3</sub>), <sup><i>t</i></sup>BuOK, DMSO, R1 = H, 70%, R1 = F, 61%. (iii) R1 = H, Et ester: LiOH, H<sub>2</sub>O/THF, 93%. R1 = F, <sup><i>t</i></sup>Bu ester: TFA, DCM, 99%. (iv) Oxalyl chloride, NEt<sub>3</sub>, (<i>S</i>)-4-isopropyloxazolidin-2-one, DCM, separate diastereomers, R1 = H, 27%, R1 = F, 34%; (v) LiOH, H<sub>2</sub>O<sub>2</sub>, H<sub>2</sub>O/THF, R1 = H, 66%, R1 = F, 85%; (vi) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bis(1,3,2-dioxaborolane), Pd(dppf)Cl<sub>2</sub>, KOAc, 1,4-dioxane, R1 = H/F, 100%; (vii) Pd-118, K<sub>3</sub>PO<sub>4</sub>, H<sub>2</sub>O/MeCN, 100 °C, microwave, 19–70%.</p></p></figure><div class="NLM_p">In order to determine the absolute stereochemistry of the cyclopropyl group, a single crystal of <b>41</b> (R = H) was obtained and X-ray crystallographic analysis<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> showed (<i>S</i>,<i>S</i>) stereochemistry (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Perspective view of crystal structure of (<i>S</i>,<i>S</i>)-<b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 6-haloindazole scaffolds were prepared as drawn in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. <i>o</i>-Halobenzoic acids (<b>44</b>, <b>50</b>) were converted to corresponding ketone derivatives (<b>46</b>, <b>52</b>) via Wienreb amides <b>45</b> and <b>51</b>. Cyclization of <b>46</b> and <b>52</b> with hydrazine delivered expected haloindazole derivatives <b>47</b> and <b>53</b> in excellent yields. Copper catalyzed N-arylation of the indazole scaffolds with either boronic acids or 2-bromopyridines afforded 6-haloindazoles <b>48</b>, <b>49</b>, and <b>54</b>. The 3-methoxyindazole derivatives <b>60</b> were prepared starting from corresponding <i>o</i>-fluoromethylbenzoates <b>55</b>. Cycliszation of <b>55</b> with hydrazine followed by methylation of the hydroxy functionality using a Mitsunobu reaction and subsequent hydrolysis of the carbamate <b>58</b> provided the bromide <b>59</b>. Copper catalyzed N-arylation of <b>59</b> again provided bromides <b>60</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthesis of 6-Br-indazole Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) oxalyl dichloride, DCM, then MeONHMe·HCl, NEt<sub>3</sub>, 76%; (ii) MeMgBr, THF, 92%; (iii) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, THF, 80 °C, 86%; (iv) Cu(OAc)<sub>2</sub>, pyridine, DCM, R2 = H/R4 = Me 46%, R2 = F/R4 = Me 61%; (v) CuBr, K<sub>2</sub>CO<sub>3</sub>, <i>N</i>1,<i>N</i>2-dimethylethane-1,2-diamine, 1,4-dioxane, 105 °C, R2 = H/R4 = H, 50%; (vi) oxalyl dichloride, DCM, then MeONHMe·HCl, NEt<sub>3</sub>, 79%; (vii) MeMgBr, THF, 99%; (viii) N<sub>2</sub>H<sub>4</sub>.H<sub>2</sub>O, Et<sub>3</sub>N, <sup><i>i</i></sup>PrOH, 69%; (ix) CuBr, K<sub>2</sub>CO<sub>3</sub>, <i>N</i>1,<i>N</i>2-dimethylethane-1,2-diamine, 1,4-dioxane, 105 °C, B = N, 44%, B = CH, 81%; (x) N<sub>2</sub>H<sub>4</sub>.H<sub>2</sub>O, H<sub>2</sub>O/THF, R2 = H, 98%, R2 = F, 100%; (xi) EtOCOCl, H<sub>2</sub>O/pyridine, R2 = H, 73%, R2 = F, 86%; (xii) <sup><i>i</i></sup>PrO<sub>2</sub>N = NCO<sub>2</sub><sup><i>i</i></sup>Pr, Ph<sub>2</sub>Ppyridine or Ph<sub>3</sub>P, MeOH, THF, R2 = H, 51%, R2 = F, 61%; (xiii) KOH, H<sub>2</sub>O/EtOH, R2 = H, 90%, R2 = F, 91%; (xiv) conditions iv or v, 19–65%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Pharmacokinetic Properties and in Vivo Efficacy</h3><div class="NLM_p">For a number of compounds oral exposure in mouse was assessed and significant blood levels were obtained for most compounds (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). On the basis of these data, sufficient free cover above the GPR120 potency was predicted at a dose of 100 mg/kg with <b>31</b>–<b>34</b> all having similar oral and intravenous properties. Although <b>35</b> had lower fraction unbound and lower bioavailability, higher potency led to greater free cover but concerns that lower solubility may result in nonlinearity of the oral exposure with increasing dose led us to prioritize <b>31</b>–<b>34</b> for further in vivo assessment. Dose escalation was conducted with <b>31</b> initially, and at 50 mg/kg maximum oral exposure of 97 μM was obtained which was in line with expected dose linearity. Increase of dose to 150 mg/kg was not tolerated by mice beyond 2 h. The animals became subdued and were terminated. Pharmacokinetic analysis from mice at the 2 h time point revealed that the blood exposure was 97 μM, the same as for the previously tolerated 50 mg/kg dose but CNS exposure was measured at 147 μM. It is not common for carboxylic acids to have such high CNS exposure as they are generally expected to have difficulty penetrating the blood–brain barrier;<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> hence this was an unexpected observation. At the same time dose escalation of <b>32</b> was conducted and it was tolerated at 150 mg/kg with blood exposure of 126 μM but at 300 mg/kg was not tolerated by mice beyond 1 h. In this case blood exposure was 284 μM and CNS exposure was 207 μM, again an unexpectedly high level in the brain for a carboxylic acid. We attributed the tolerability issue to be due to the large exposure levels in the brain and sought to profile compounds with lower CNS penetration.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Mouse Pharmacokinetic, Permeability and Efflux Data for Potential in Vivo Probes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">PPB % free</th><th class="colsep0 rowsep0" align="center" char=".">iv CL (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">iv <i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">po <i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">predicted free cover<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>p</sub><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>p<sub>uu</sub></sub><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">Caco2 <i>P</i><sub>app</sub>(A–B) (×10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">MDCK-MDR1 efflux ratio<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">159</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">126</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">131</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">0.49</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">136</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Compound was dosed iv at 2.5 mg/kg (1 mg/kg for <b>33</b>) in 5% DMSO/95% hydroxypropyl β-cyclodextrin.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Compound was dosed po at 5 mg/kg in HPMC/Tween.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Calculated using po <i>C</i><sub>max</sub> at 5 mg/kg corrected for free fraction, scaled to 100 mg/kg and divided by GPR120 potency.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Ratio of the drug concentrations in homogenized brain tissue and blood, 2 h after po at 5 mg/kg in HPMC/Tween.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Calculated using free fraction measured in blood and brain (using rat brain slice method<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>).</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Compound was incubated at 10 μM in cultured MDCK-MDR1 cells, and permeability was measured in both the A to B and B to A direction.</p></div></div></div><div class="NLM_p">We revisited low dose (5 mg/kg) oral exposure and confirmed that both <b>31</b> and <b>32</b> had significant CNS exposure at this dose with <i>K</i><sub>p</sub> values above 2 and, <i>K</i><sub>p<sub>uu</sub></sub> values above 0.3. The <i>K</i><sub>p<sub>uu</sub></sub> value is conceptually inversely related to the therapeutic index of peripheral drugs with potential CNS side effects;<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> thus we sought to decrease this parameter. All of our probe candidates had high intrinsic permeability measured using a Caco2 assay, but we have previously reported that modulation of efflux in an MDCK-MDR1 assay can be useful for predicting CNS exposure within a chemical series.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Consistent with their high CNS exposure <b>31</b> and <b>32</b> exhibited low efflux in this assay, but we were encouraged that <b>33</b> and <b>34</b> exhibited higher efflux and this translated into low CNS exposure with <i>K</i><sub>p<sub>uu</sub></sub> values below 0.3. Consequently <b>33</b> and <b>34</b> were progressed to in vivo efficacy experiments</div><div class="NLM_p">Both <b>33</b> and <b>34</b> were evaluated in an oral glucose tolerance test (OGTT) in C57BL/6J mice at 100 mg/kg and exhibited significant 45% (<i>p</i> < 0.001) and 65% (<i>p</i> < 0.001) reduction in blood glucose excursion following a 2 g/kg glucose load (<a class="ref internalNav" href="#fig2a" aria-label="Figure 3">Figure 3</a>). The specificity of this efficacy was investigated using genetically altered mice lacking the GPR120 receptor (<a class="ref internalNav" href="#fig3" aria-label="Figure 4">Figure 4</a>). In the wild-type (WT) mice, similar reductions (47% (<i>p</i> < 0.001) for <b>33</b>, 58% (<i>p</i> < 0.001) for <b>34</b>) on blood glucose excursion occurred. However, in the null (KO) mice, no significant effects on blood glucose excursion were observed, confirming that the efficacy of <b>33</b> and <b>34</b> is mediated by GPR120. The link between efficacy and pharmacokinetics for OGTT is well understood,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and pharmacokinetic data from this study revealed that the exposure levels in WT and KO mice for each compound were similar and free blood exposure similar to the GPR120 EC<sub>50</sub> was achieved (<a class="ref internalNav" href="#fig4" aria-label="Figure 5">Figure 5</a>). Lower brain exposure (as predicted from the earlier low dose pharmacokinetic studies) was obtained with <b>33</b> exhibiting <i>K</i><sub>p<sub>uu</sub></sub> = 0.12 and <b>34</b> exhibiting <i>K</i><sub>p<sub>uu</sub></sub> = 0.27.</div><figure id="fig2a" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glucose lowering efficacy of <b>33</b> and <b>34</b> in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig2a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Glucose lowering efficacy of <b>33</b> and <b>34</b> in WT/KO GPR120 mice at 100 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Blood and brain exposure of <b>33</b> and <b>34</b> in WT/KO GP R120 mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Furthermore, in vitro pharmacological profiling<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> of <b>32</b> and <b>33</b> against a panel of over 30 diverse targets was conducted and exhibited excellent selectivity profiles (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_001.pdf" class="ext-link">Supporting Information</a>). No targets showed activity below 1 μM, and one target for each compound showed activity below 10 μM (<b>32</b>, phosphodiesterase 4D IC<sub>50</sub> = 1.6 μM; <b>33</b>, adenosine receptor A2α, <i>K</i><sub>i</sub> = 1.7 μM). Thus, we have not identified an off-target activity that could explain the tolerability issue of <b>32</b> at 300 mg/kg. Taking all these data together, <b>33</b> and <b>34</b> are excellent in vivo tool compounds for exploring the agonist pharmacology of the GPR120. They have been utilized to show that GPR120 is selectively present within the δ cells of murine islets and regulate somatostatin secretion,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and further studies will be reported in due course. Furthermore, a recent publication has highlighted the role of GPR120 agonism in the brain with food intake and reward behavior in mice,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and compounds such as <b>31</b> and <b>32</b> could be utilized at a tolerated dose to further explore the CNS effects of selective GPR120 agonists.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from a scaffold hop, a new GPR120 agonist indazole chemotype was identified. SAR exploration was conducted and a (<i>S</i>,<i>S</i>)-cyclopropylcarboxylic acid structural motif identified which gave selectivity against GPR40. Further SAR optimization led to identification of several selective GPR120 agonists with good oral exposure. Unexpected high CNS exposure was encountered for some compounds, and increased MDCK-MDR1 efflux was used to identify compounds with reduced CNS exposure. Two tool compounds, <b>33</b> ((1<i>S</i>,2<i>S</i>)-2-(3-fluoro-4-(3-methyl-1-(5-methylpyridin-2-yl)-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-6-yl)phenyl)cyclopropanecarboxylic acid, AZ13595491) and <b>34</b> ((1<i>S</i>,2<i>S</i>)-2-(4-(3-methyl-1-<i>p</i>-tolyl-1<i>H</i>-indazol-6-yl)phenyl)cyclopropanecarboxylic acid, AZ13595423) were progressed to in vivo studies and demonstrated significant reduction in blood glucose excursion in response to a glucose challenge. This efficacy was reproduced in GPR120 WT mice but not in KO mice, indicating that this effect occurs through a mechanism involving GPR120 agonism.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General</h3><div class="NLM_p last">All solvents and chemicals used were reagent grade. Anhydrous solvents THF, benzene, DCE, DCM, and DME were purchased from Aldrich. Flash column chromatography was carried out using prepacked silica cartridges (from 4 g up to 330 g) from Redisep or Silicycle and eluted using an Isco Companion system. Purity and characterization of compounds were established by a combination of liquid chromatography–mass spectrometry (LC–MS), gas chromatography–mass spectrometry (GC–MS), and NMR analytical techniques, and purity was >95% for all test compounds. <sup>1</sup>H NMR results were recorded on a Varian INOVA (600 MHz), Varian Gemini 2000 (300 MHz), or Bruker Avance DPX400 (400 MHz) and were determined in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub>. Chemical shifts are reported in ppm relative to TMS (0.00 ppm) or solvent peaks as the internal reference. Splitting patterns are indicated as follows: s, singlet; d, doublet; t, triplet; m, multiplet; br, broad peak. Elevated temperatures were used where necessary to sharpen broad NMR peaks due to rotamers, and the temperature used is noted for such compounds. Merck precoated TLC plates (silica gel 60 F<sub>254</sub>, 0.25 mm, art. 5715) were used for TLC analysis. Solutions were dried over anhydrous magnesium sulfate, and the solvent was removed by rotary evaporation under reduced pressure.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of Representative Key Examples (<b>33</b> and <b>34</b>). (<i>E</i>)-<i>tert</i>-Butyl 3-(4-Bromo-3-fluorophenyl)acrylate (<b>37</b>, R1 = F, <sup><i>t</i></sup>Bu Ester)</h3><div class="NLM_p last">Sodium hydride (0.90 g, 22.5 mmol) was added portionwise to 4-bromo-3-fluorobenzaldehyde (4.15 g, 20.4 mmol) and <i>tert</i>-butyl 2-(diethoxyphosphoryl)acetate (6.19 g, 24.5 mmol) in THF (100 mL) at rt over a period of 10 min under nitrogen. The resulting yellow mixture was stirred at rt for 1.5 h. The reaction mixture was quenched with saturated NH<sub>4</sub>Cl (50 mL), water (50 mL) and diluted with EtOAc (150 mL), and the organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude product was purified by flash silica chromatography, with elution gradient 0–5% EtOAc in heptane. Pure fractions were evaporated to dryness to afford the title compound (5.82 g, 95%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.53 (9H, s), 6.36 (1H, d), 7.15 (1H, dd), 7.23–7.27 (1H, m), 7.47 (1H, d), 7.55 (1H, dd).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>trans</i>-(1<i>S</i>,2<i>S</i>)/(1<i>R</i>,2<i>R</i>)-<i>tert</i>-Butyl 2-(4-Bromo-3-fluorophenyl)cyclopropanecarboxylate (<b>38</b>, R1 = F, <sup><i>t</i></sup>Bu Ester)</h3><div class="NLM_p last">Trimethylsulfoxonium iodide (0.950 g, 4.32 mmol) was added in one portion to potassium <i>tert</i>-butoxide (0.461 g, 3.98 mmol) in DMSO (10 mL) at rt under nitrogen. The resulting suspension was heated to 50 °C and stirred for 1.5 h. The solution was cooled to rt, and a solution of <b>37</b> (R1 = F, <sup><i>t</i></sup>Bu ester) (1 g, 3.32 mmol) in DMSO (5 mL) was added dropwise over 1 h. The reaction was stirred at rt for 5 h and then neutralized with saturated NH<sub>4</sub>Cl and extracted with 25% EtOAc in heptane. The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated to afford crude product which was purified by flash silica chromatography, with elution gradient 0–4% EtOAc in heptane. Pure fractions were evaporated to dryness to afford the title compound (0.64 g, 61%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) 1.18 (1H, ddd), 1.47 (9H, s), 1.53–1.58 (1H, m), 1.80 (1H, ddd), 2.36–2.42 (1H, m), 6.77 (1H, dd), 6.83 (1H, dd), 7.42 (1H, dd).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>trans</i>-(1<i>S</i>,2<i>S</i>)/(1<i>R</i>,2<i>R</i>)-2-(4-Bromo-3-fluorophenyl)cyclopropanecarboxylic Acid (<b>39</b>, R1 = F)</h3><div class="NLM_p last"><b>38</b> (R1 = F, <sup><i>t</i></sup>Bu ester) (6.67 g, 21.2 mmol) was solvated by DCM (70 mL). To this solution was added TFA (30 mL). The resulting solution was stirred at rt for 1 h, and then solvent was removed under reduced pressure. The residue was then azeotroped with toluene to provide the title compound (5.45 g, 99%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32–1.5 (2H, m), 1.87 (1H, ddd), 2.44 (1H, ddd), 7.02 (1H, dd), 7.22 (1H, dd), 7.52–7.63 (1H, m), 12.34 (1H, s); <i>m</i>/<i>z</i> (M – H)<sup>−</sup> = 259.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (<i>S</i>)-3-((1<i>S</i>,2<i>S</i>)-2-(4-Bromo-3-fluorophenyl)cyclopropanecarbonyl)-4-isopropyloxazolidin-2-one (<b>40</b>, R1 = F)</h3><div class="NLM_p last">Oxalyl dichloride (1.90 mL, 22.1 mmol) was added dropwise to <b>39</b> (R1 = F) (5.45 g, 21.0 mmol) and DMF (8.15 μL, 0.11 mmol) in DCM (43 mL) under nitrogen. The resulting mixture was stirred at rt for 2 h. The reaction mixture was evaporated to dryness and azeotroped with toluene. The resulting crude acid chloride was dissolved in DCM (43 mL). Triethylamine (5.87 mL, 42.1 mmol) was added followed by portionwise addition of (<i>S</i>)-4-isopropyloxazolidin-2-one (2.72 g, 21.0 mmol). The mixture was stirred at rt under nitrogen for 18 h. The reaction mixture was diluted with DCM and washed sequentially with water and saturated brine. The organic layer was filtered through a phase separation cartridge and evaporated. The crude product was purified by flash silica chromatography, with elution gradient 40% heptane in DCM. Pure fractions were evaporated to dryness to afford the title compound as white solid (2.66 g, 34%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.80 (3H, d), 0.85 (3H, d), 1.49–1.69 (2H, m), 2.17 (1H, ddq), 2.51–2.6 (1H, m), 3.40 (1H, ddd), 3.99–4.56 (3H, m), 7.02 (1H, dd), 7.26 (1H, dd), 7.5–7.84 (1H, m); <i>m</i>/<i>z</i> (M + H)<sup>+</sup> = 372.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (1<i>S</i>,2<i>S</i>)-2-(4-Bromo-3-fluorophenyl)cyclopropanecarboxylic Acid (<b>41</b>, R1 = F)</h3><div class="NLM_p last">Hydrogen peroxide (50 wt %, 2.36 mL, 28.7 mmol) was added dropwise to a solution of lithium hydroxide hydrate (0.482 g, 11.5 mmol) in water (5 mL) at rt. The resulting solution was stirred for 30 min and then cooled to 0 °C. This cooled solution was added portionwise to a cooled solution of <b>40</b> (R1 = F) (2.66 g, 7.18 mmol) in THF (24 mL) and water (5 mL). The internal temperature remained below 10 °C throughout the addition. The resulting solution was stirred for 2 h. Sodium sulfite (3.62 g, 28.7 mmol) in water (24 mL) was added. The mixture was extracted with EtOAc (2 × 50 mL). The aqueous phase was acidified with 2 M HCl, extracted with EtOAc (3 × 60 mL) and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated to afford a colorless oil. This was purified by ion exchange chromatography, using a PE AX column (20 g). The product was eluted from the column using 5% formic acid/MeCN. Solvent was then removed under reduced pressure to provide the title compound (1.58 g, 85%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.28–1.55 (2H, m), 1.87 (1H, ddd), 2.36–2.46 (1H, m), 7.01 (1H, dd), 7.22 (1H, dd), 7.48–7.64 (1H, m), 12.34 (1H, s); <i>m</i>/<i>z</i> (M – H)<sup>−</sup> = 257</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (1<i>S</i>,2<i>S</i>)-2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-fluorophenyl)cyclopropanecarboxylic Acid (<b>42</b>, R1 = F)</h3><div class="NLM_p last">Potassium acetate (957 mg, 9.75 mmol), <b>41</b> (R1 = F) (842 mg, 3.25 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (908 mg, 3.58 mmol), and 1,1′-bis(diphenylphosphino)ferrocenepalladium(II) dichloride DCM complex (131 mg, 0.16 mmol) were suspended in degassed 1,4-dioxane (12 mL). The resulting suspension was evacuated and purged with nitrogen 5 times and then heated to 90 °C for 16 h. The reaction mixture was filtered through Celite, washing through with DCM, then THF. The filtrate was concentrated to provide the title compound (995 mg, 100%), which was used without further purification. <i>m</i>/<i>z</i> (M – H)<sup>−</sup> = 305.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4,6-Dichloro-<i>N</i>-methoxy-<i>N</i>-methylnicotinamide (<b>51</b>)</h3><div class="NLM_p last">Oxalyl dichloride (4.60 mL, 52.6 mmol) was added portionwise to a suspension of 4,6-dichloronicotinic acid (10.1 g, 52.6 mmol) in DCM (150 mL)/DMF (3 mL) at 0 °C over a period of 3 min under nitrogen. The resulting suspension was stirred at 0 °C for 10 min and then allowed to warm to rt and stirred for a further 16 h. The solvent was evaporated in vacuo to yield 4,6-dichloronicotinoyl chloride which was used directly in the next reaction without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.53 (1H, s), 9.09 (1H, s). 4,6-Dichloronicotinoyl chloride (1.15 g, 5.47 mmol) in DCM (10 mL) was added to an ice-bath-cooled mixture of <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride (0.8 g, 8.21 mmol), triethylamine (2.67 mL, 19.2 mmol), and DCM (15 mL). The cooling batch was removed, and the mixture was stirred at rt for 7 h and left overnight on standing. The reaction mixture was quenched with saturated aqueous NaHCO<sub>3</sub> (25 mL), extracted with DCM (2 × 25 mL), and the organic layer was dried and evaporated. The crude product was purified by flash silica chromatography, with elution gradient 10–50% EtOAc in heptane. Pure fractions were evaporated to dryness to afford the title compound (1.01g, 79%) as a gum. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.40 (3H, s), 3.50 (3H, s), 7.45 (1H, s), 8.37 (1H, s); <i>m</i>/<i>z</i> (M + H)<sup>+</sup> = 237.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-(4,6-Dichloropyridin-3-yl)ethanone (<b>52</b>)</h3><div class="NLM_p last">Methylmagnesium bromide (1.4 M in toluene/THF (3:1), 67.7 mL, 94.8 mmol) was added portionwise to a stirred solution of <b>51</b> (10.1 g, 43.1 mmol) in THF (100 mL) at 0 °C under nitrogen. The resulting suspension was stirred at 0 °C for 2 h. The reaction mixture was quenched with saturated aqueous NH<sub>4</sub>Cl (50 mL) and then extracted with EtOAc (100 mL). The organic layer was washed with brine (50 mL) and then dried (MgSO<sub>4</sub>), filtered, and evaporated to yield the title compound (8.09 g, 99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.64 (3H, s), 7.93 (1H, s), 8.80 (1H, s); <i>m</i>/<i>z</i> (M + H)<sup>+</sup> = 190.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 6-Chloro-3-methyl-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine (<b>53</b>)</h3><div class="NLM_p last">Hydrazine hydrate (1.86 mL, 24.4 mmol) was added to a mixture of <b>52</b> (4.04 g, 21.3 mmol) and triethylamine (2.96 mL, 21.3 mmol) and isopropanol (13.8 mL) at rt under nitrogen. The resulting mixture was stirred at reflux for 16 h. The reaction mixture was then diluted with EtOAc/<i>n</i>-butanol (1:1) and washed with sat. aq NaHCO<sub>3</sub>. The aqueous phase was separated, and the organics were dried over MgSO<sub>4</sub>, filtered, and concentrated to small volume. The precipitate was filtered, washed with small amount of DCM, and dried under vacuum to afford the title compound (2.45 g, 69%) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.54 (3H, s), 7.51 (1H, d), 8.87 (1H, d), 13.25 (1H, s); <i>m</i>/<i>z</i> (M + H)<sup>+</sup> = 168.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 6-Chloro-3-methyl-1-(5-methylpyridin-2-yl)-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine (<b>54</b>, B = N)</h3><div class="NLM_p last">Potassium carbonate (1.11 g, 8.06 mmol) was added to <b>53</b> (1 g, 5.97 mmol), 2-bromo-5-methylpyridine (1.54 g, 8.95 mmol), <i>N</i>1,<i>N</i>2-dimethylethylene-1,2-diamine (1.05 mL, 8.35 mmol), and copper(I) bromide (0.428 g, 2.98 mmol) in 1,4-dioxane (20 mL). The resulting mixture was stirred at 105 °C for 2 h under nitrogen. The reaction was cooled to rt. EtOAc was added and the mixture filtered through Celite and evaporated to dryness to afford a crude product. The crude product was triturated with hot EtOH to give a solid which was collected by filtration and dried under vacuum to give the title compound (0.68 g, 44%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.34 (3H, s), 2.64 (3H, s), 7.77–7.85 (2H, m), 8.35–8.4 (1H, m), 8.47 (1H, d), 8.99 (1H, d); <i>m</i>/<i>z</i> (M + H)<sup>+</sup> = 259.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (1<i>S</i>,2<i>S</i>)-2-(3-Fluoro-4-(3-methyl-1-(5-methylpyridin-2-yl)-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-6-yl)phenyl)cyclopropanecarboxylic Acid (<b>33</b>)</h3><div class="NLM_p last">A mixture of <b>54</b> (B = N) (184 mg, 0.71 mmol), <b>42</b> (R1 = F) (218 mg, 0.71 mmol), tetrakis(triphenylphosphine)palladium(0) (82 mg, 0.07 mmol), isopropanol (3 mL), and sat. aq sodium bicarbonate (0.75 mL) was degassed and heated within a microwave reactor at 120 °C for 4 h. The reaction mixture was then passed through a PL-thiol MP SPE 500 mg/6 mL cartridge, eluting with EtOH, then MeOH/DCM. The filtrate was concentrated under reduced pressure. The crude product was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5 μm silica, 50 mm diameter, 150 mm length), using decreasingly polar mixtures of water (containing 0.5% ammonia) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford the title compound (109 mg, 38%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.23 (1H, t), 1.35–1.43 (1H, m), 1.79–1.88 (1H, m), 2.33 (4H, m), 2.68 (3H, s), 7–7.19 (2H, m), 7.74–7.89 (2H, m), 7.94 (1H, t), 8.38 (1H, s), 8.89 (1H, s), 9.22 (1H, d); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) 12.2, 17.5, 17.7, 25.1, 25.4, 109.1 (d, <i>J</i> = 10.9 Hz) 112.7, 114.0 (d, <i>J</i> = 24.5 Hz), 121.5, 122.7 (d, <i>J</i> = 2.7 Hz), 125.4 (d, <i>J</i> = 10.9 Hz) 130.4, 131.6 (d, <i>J</i> = 2.7 Hz), 140.0, 142.6, 144.7 (d, <i>J</i> = 8.2 Hz), 144.9, 145.7, 148.2, 149.0 (d, <i>J</i> = 2.7 Hz), 151.4, 160.3 (d, <i>J</i> = 248.0 Hz), 174.3; <i>m</i>/<i>z</i> (M + H)<sup>+</sup> = 403. HRMS (ES<sup>+</sup>) for C<sub>23</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>2</sub> (MH<sup>+</sup>): calcd 403.1570; found, 403.1556. α<sub>D</sub><sup>24.7</sup> +187.9 (<i>c</i> 0.62, EtOH).</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>E</i>)-Ethyl 3-(4-Bromophenyl)acrylate (<b>37</b>, R1 = H, Et Ester)</h3><div class="NLM_p last">Ethyl 2-(diethoxyphosphoryl)acetate (24.2 g, 108 mmol) was added dropwise to a suspension of sodium hydride (6.49 g, 162 mmol) in THF (125 mL) at 0 °C over a period of 20 min. The resulting solution was allowed to warm to rt and stirred for 1 h, cooled to 0 °C and a solution of 4-bromobenzaldehyde (10 g, 54.0 mmol) in THF (50 mL) added dropwise over a period of 15 min. The resulting solution was stirred at rt for 30 h. The reaction mixture was poured into saturated brine (750 mL), extracted with EtOAc (3 × 250 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a yellow liquid. This was purified by flash silica chromatography, with elution gradient 0–5% EtOAc in petroleum ether. Pure fractions were evaporated to dryness to afford the title compound (10 g, 72%) as a pale yellow liquid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.25 (3 H, t), 4.18 (2 H, q), 6.65 (1 H, d), 7.49–7.75 (5 H, m). HRMS (TOF) for C<sub>13</sub>H<sub>15</sub>O<sub>2</sub>Br (M<sup>+</sup>): calcd, 282.0255; found, 282.0272.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>trans</i>-(1<i>S</i>,2<i>S</i>)/(1<i>R</i>,2<i>R</i>)-Ethyl 2-(4-Bromophenyl)cyclopropanecarboxylate (<b>38</b>, R1 = H, Et Ester)</h3><div class="NLM_p last">Trimethylsulfoxonium iodide (56.1 g, 255 mmol) was added in one portion to potassium <i>tert</i>-butoxide (27.8 g, 235 mmol) in DMSO (405 mL) at rt under nitrogen. The resulting suspension was heated to 50 °C and stirred for 1 h. The pale yellow solution was cooled to rt, and a solution of <b>37</b> (R1 = H, Et ester) (50 g, 196 mmol) in DMSO (135 mL) was added dropwise over 1 h. The reaction was stirred at rt overnight. The reaction mixture was diluted with diethyl ether and washed with saturated aqueous NH<sub>4</sub>Cl. The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated to afford the title compound (36.8 g, 70%) as a yellow oil which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.19 (3H, t), 1.36 (1H, ddd), 1.41–1.5 (1H, m), 1.93 (1H, ddd), 2.42 (1H, ddd), 4.05–4.13 (2H, m), 7.11–7.17 (2H, m), 7.41–7.47 (2H, m).</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>trans</i>-(1<i>S</i>,2<i>S</i>)/(1<i>R</i>,2<i>R</i>)-2-(4-Bromophenyl)cyclopropanecarboxylic Acid (<b>39</b>, R1 = H)</h3><div class="NLM_p last">Lithium hydroxide hydrate (9.99 g, 238 mmol) was added to <b>38</b> (R1 = H, Et ester) (21.4 g, 79.4 mmol) in THF (225 mL) and water (75 mL). The resulting mixture was stirred at rt overnight. The reaction mixture was diluted with water (125 mL) and washed with diethyl ether (125 mL). The organic phase was extracted with water (60 mL). The combined aqueous phases were acidified with 2 M HCl (aq). The resulting suspension was extracted with DCM (600 mL). The organic phase was filtered through a phase separation cartridge and evaporated to afford the title compound (17.8 g, 93%) as a cream solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (1H, ddd), 1.42 (1H, ddd), 1.77–1.84 (1H, m), 2.38 (1H, ddd), 7.13 (2H, d), 7.44 (2H, d), 12.30 (1H, s); <i>m</i>/<i>z</i> (M – H)<sup>−</sup> = 241.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>)-3-((1<i>S</i>,2<i>S</i>)-2-(4-Bromophenyl)cyclopropanecarbonyl)-4-isopropyloxazolidin-2-one (<b>40</b>, R1 = H)</h3><div class="NLM_p last">Oxalyl dichloride (6.67 mL, 77.7 mmol) was added dropwise to <b>39</b> (R1 = H) (17.8 g, 74.0 mmol) and DMF (0.03 mL, 0.37 mmol) in DCM (150 mL) under nitrogen. The resulting mixture was stirred at rt for 1.5 h. The reaction mixture was evaporated to dryness and azeotroped with toluene. The resulting crude acid chloride was dissolved in DCM (150 mL). Triethylamine (20.6 mL, 148 mmol) was added followed by portionwise addition of (<i>S</i>)-4-isopropyloxazolidin-2-one (9.56 g, 74.0 mmol). The mixture was stirred at rt under nitrogen for 64 h. The reaction mixture was diluted with DCM and washed sequentially with water and saturated brine. The organic layer was filtered through a phase separation cartridge and evaporated. The crude product was purified by flash silica chromatography,with elution gradient 20% heptane in DCM. Pure fractions were evaporated to dryness to afford the title compound as a white solid after trituration with ether/heptane (7.13 g, 27%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.79 (3H, d), 0.84 (3H, d), 1.49 (1H, ddd), 1.59 (1H, ddd), 2.16 (1H, dp), 3.38 (1H, ddd), 4.25–4.35 (2H, m), 4.39 (1H, dt), 7.12–7.18 (2H, m), 7.43–7.48 (2H, m).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (1<i>S</i>,2<i>S</i>)-2-(4-Bromophenyl)cyclopropanecarboxylic Acid (<b>41</b>, R1 = H)</h3><div class="NLM_p last">Hydrogen peroxide (50 wt %, 2.03 mL, 35.2 mmol) was added dropwise to a solution of lithium hydroxide hydrate (0.591 g, 14.1 mmol) in water (8 mL) at rt. The resulting solution was stirred for 30 min and then cooled to 0 °C. This cooled solution was added portionwise to a cooled solution of <b>40</b> (R1 = H) (3.1 g, 8.80 mmol) in THF (40 mL) and water (10 mL). The internal temperature remained below 10 °C throughout the addition. The resulting solution was stirred for 3.5 h. Sodium sulfite (4.44 g, 35.2 mmol) in water (20 mL) was added. The mixture was extracted with EtOAc (2 × 50 mL). The aqueous phase was then acidified with 2 M HCl. The aqueous phase was extracted with EtOAc (3 × 60 mL) and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated to afford crude product. This was recrystallized from diethyl ether/heptane to give the title compound (1.39 g, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.31 (1H, ddd), 1.42 (1H, ddd), 1.80 (1H, ddd), 2.38 (1H, ddd), 7.1–7.15 (2H, m), 7.41–7.46 (2H, m), 12.29 (1H, s); <i>m</i>/<i>z</i> (M – H)<sup>−</sup> = 241.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (1<i>S</i>,2<i>S</i>)-2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxylic Acid (<b>42</b>, R1 = H)</h3><div class="NLM_p last">Potassium acetate (330 mg, 3.36 mmol), <b>41</b>, R1 = H (270 mg, 1.12 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (313 mg, 1.23 mmol), and 1,1′-bis(diphenylphosphino)ferrocenepalladium(II) dichloride DCM complex (45.7 mg, 0.06 mmol) were suspended in degassed 1,4-dioxane (3 mL). The resulting suspension was evacuated and purged with nitrogen 5 times and then heated to 90 °C for 5 h. The reaction mixture was filtered through Celite, washing through with DCM, then THF. The filtrate was concentrated to provide the title compound (625 mg, 100%), which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.15 (6H, s), 1.22–1.31 (6H, m), 1.61–1.71 (1H, m), 1.72–1.78 (1H, m), 2.11–2.22 (1H, m), 3.59 (1H, t), 7.06 (2H, d), 7.52 (1H, d); <i>m</i>/<i>z</i> (M – H)<sup>−</sup> = 287.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 6-Bromo-3-methyl-1-<i>p</i>-tolyl-1<i>H</i>-indazole (<b>48</b>, R2 = H, R4 = Me)</h3><div class="NLM_p last">Copper(II) acetate (2.58 g, 14.2 mmol) was added to a stirred mixture of 6-bromo-3-methyl-1<i>H</i>-indazole (2.00 g, 9.48 mmol), <i>p</i>-tolylboronic acid (1.93 g, 14.2 mmol), pyridine (2.3 mL, 28.4 mmol), and DCM (40 mL). The mixture was stirred at rt for 4 h under air. 35% ammonia solution (25 mL) was added, and the mixture was stirred for 15 min. The organic layer was separated and concentrated in vacuo. The crude product was purified by flash silica chromatography, with elution gradient 0–5% EtOAc in heptane. Pure fractions were evaporated to dryness and solid was washed with a small amount of diethyl ether to afford the title compound (1.32 g, 46%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.38 (3H, s), 2.57 (3H, s), 7.33–7.4 (3H, m), 7.57–7.62 (2H, m), 7.80 (1H, d), 7.89 (1H, d); <i>m</i>/<i>z</i> (M + H)<sup>+</sup> = 301.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (1<i>S</i>,2<i>S</i>)-2-(4-(3-Methyl-1-<i>p</i>-tolyl-1<i>H</i>-indazol-6-yl)phenyl)cyclopropanecarboxylic Acid (<b>34</b>)</h3><div class="NLM_p last">1,1′-Bis(di-<i>tert</i>-butylphosphino)ferrocenepalladium(II) dichloride (19 mg, 0.03 mmol) and tripotassium phosphate (251 mg, 1.2 mmol) were added to <b>42</b> (R1 = H) (138 mg, 0.48 mmol) and <b>48</b> (R2 = H, R4 = Me) (120 mg, 0.40 mmol) in degassed MeCN (1 mL) and water (1 mL) at 20 °C under nitrogen. The resulting mixture was further degassed and stirred within a microwave reactor at 100 °C for 1 h. The reaction mixture was acidified with acetic acid (0.25 mL) and extracted into DCM/MeOH (9:1 mixture). The organic phase was passed through a PL-thiol MP SPE 500 mg/6 mL cartridge, and the solid was washed with a 9:1 mixture of DCM/MeOH. The filtrate was concentrated. The crude product was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5 μm silica, 50 mm diameter, 150 mm length), using decreasingly polar mixtures of water (containing 0.5% ammonia) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford the title compound (106 mg, 70%) as solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.38 (1H, ddd), 1.46 (1H, dt), 1.82–1.88 (1H, m), 2.38 (3H, s), 2.41–2.46 (1H, m), 2.59 (3H, s), 7.27 (2H, d), 7.37 (2H, d), 7.49 (1H, dd), 7.66 (4H, dd), 7.83 (1H, s), 7.88 (1H, d), 12.28 (1H, s); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) 12.1, 17.2, 21.0, 24.8, 25.5, 108.1, 120.9, 121.6, 122.3, 124.0, 127.0, 127.8, 130.5, 135.8, 137.8, 138.8, 139.8, 139.9, 140.3, 143.6, 174.3; <i>m</i>/<i>z</i> (M + H)<sup>+</sup> = 383. HRMS (ES<sup>+</sup>) for C<sub>25</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub> (MH<sup>+</sup>): calcd 383.1760; found, 383.1742. α<sub>D</sub><sup>24.5</sup> +204.8 (<i>c</i> 0.62, EtOH).</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Biological Protocols. Human and Mouse GPR120 Dynamic Mass Redistribution (DMR) Assays</h3><div class="NLM_p">CHO FlpIn cryopreserved cells stably expressing human or mouse GPR120 were seeded in 30 μL of growth medium (DMEM/F-12 glutaMAX, 10% FCS, and 300 μg/mL hygromycin) into 384-well Corning EPIC fibronectin coated plates 48 h prior to assay and incubated at 37 °C in a CO<sub>2</sub> incubator. The growth medium was changed, 24 h prior to assay, to 30 μL of medium containing no serum, and the plates were returned to the CO<sub>2</sub> incubator. The medium was again changed, 2 h prior to assay, to 30 μL of assay buffer containing 0.5% DMSO (HBSS, 20 mM HEPES, 0.01% BSA at pH 7.4), and the plates were returned to the CO<sub>2</sub> incubator. Plates were equilibrated in the EPIC instrument and multiple baseline measurements were taken over a period of 10 min prior to adding 15 μL of test or control substance to the wells. Following addition, further measurements were taken over a period of 15 min to establish the agonist effect of test substance on the DMR of the cells.</div><div class="NLM_p">Test compounds were administered to the plates in duplicate in a 10-point concentration–response format with final concentrations from 16 μM to 0.8 nM. Two control agonist compounds were assessed in each assay run to determine interassay variability. Each plate contained 32 maximum and minimum controls. A maximal concentration of a control agonist compound was used to define the assay maximum. The minimum control wells received 15 μL of assay buffer and DMSO instead of test compound. Test compound effects were analyzed and represented in concentration–response format as percentage effect versus maximum control.</div><div class="NLM_p last">Active compounds were also tested for nonspecific activity using a CHO FlpIn null cell line in the same assay technology using the same protocol.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Mouse GPR40 Calcium Mobilization Assay</h3><div class="NLM_p">HEK293s cryopreserved cells stably expressing mouse GPR40 were seeded in 40 μL of growth medium (DMEM glutaMAX, 10% FCS, and 800 μg/mL G418) into 384 well poly-<span class="smallcaps smallerCapital">d</span>-lysine plates 24 h prior to assay and incubated at 37 °C in a CO<sub>2</sub> incubator. The growth medium was carefully replaced, 1 h prior to assay, with 30 μL per well of calcium 3 loading solution, and the plates were returned to the CO<sub>2</sub> incubator. For each plate the loading solution was prepared by adding 100 μL of calcium 3 stock (see molecular devices calcium 3 stock formulation) and 6 μL of 2 mM FLUO-4 AM to 12 mL of assay buffer (HBSS, 20 mM HEPES, 0.01% BSA, probenecid 2.5 mM at pH 7.4). Plates were equilibrated in the fluometric imaging plate reader (FLIPR) Tetra instrument, and 10 baseline measurements were taken prior to adding 15 μL of test or control substance to the wells. Following addition, further measurements were taken over a period of 5 min to establish the agonist effect of test substance on calcium mobilization in the cells.</div><div class="NLM_p">Test compounds were administered to the plates in duplicate in a 9-point concentration–response format with final concentrations from 100 μM to 7 nM. Two control agonist compounds were assessed in each assay run to determine interassay variability. Each plate contained 32 maximum and minimum controls. A maximal concentration of a control agonist compound (eladic acid) was used to define the assay maximum. The minimum control wells received 15 μL of assay buffer and DMSO instead of test compound. Test compound effects were analyzed and represented in concentration– response format as percentage effect versus maximum control.</div><div class="NLM_p last">Compounds were also tested for antagonist activity in the same assay by subsequently introducing an EC<sub>80</sub> concentration of eladic acid to the wells and analyzing for inhibition of the agonist effect.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Mouse OGTT</h3><div class="NLM_p last">Standard and combination OGTT studies were carried out using in-house C57BL/6J mice aged 10–11 weeks. GPR120 receptor KO and WT control mice were also bred in house, back-crossed onto a C57BL/6J background, and used at 9–10 weeks of age. For each experiment a concentrated stock of compound suspension was formulated at rt the day before study and diluted on day of study to the required dose concentrations. Powder was wetted and dispersed in vehicle by stirring and vortexing. Particle size reduction to <10 μm diameter was achieved by sonication for 15–20 min in an ultrasonic water bath and stirring overnight on a magnetic stirrer. Overnight (18 h) fasted mice were dosed via oral gavage (10 mL/kg) with either vehicle (HPMC/Tween) or compound. At 30 min after compound a 2 g/kg oral glucose load (10 mL/kg of 20% glucose in water) was administered. Tail prick blood samples were taken precompound (time −30), preglucose (time 0), and at 10, 25, 40, 60, and 90 min after glucose load to assess the glucose excursion profile. Glucose levels were measured on a Roche AccuChek hand-held monitor. Individual mouse glucose response AUCs (variable baseline), normalized to preglucose challenge (0 min) values, were calculated. The study was conducted on two separate occasions in order to assess reproducibility of the data, and data sets from both experiments were combined to enhance statistical power. Compound treated AUCs were compared to vehicle control by ANCOVA analysis. One sided Student <i>t</i> test for a decreasing effect using pooled interanimal variability was used. Time 0 blood glucose was used as covariate to account for differences in individual baseline glucose before glucose loading. Study day was included as a covariate to take into account any day effects. Differences with <i>p</i>-values of <0.05 were considered to be significant.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Pharmacokinetics</h3><div class="NLM_p last">Pharmacokinetic studies were performed in male C57BL/6J and CD-1 mice. Intravenous (iv) administration was via bolus administration in a vehicle containing 5% DMSO 95% hydroxypropyl-β-cyclodextrin 30% (w/v). Oral dosing was administered by gavage in a vehicle containing HPMC/Tween. Blood samples were collected over a 24 h period postdose into tubes containing EDTA-K2. Noncompartmental analysis was performed to estimate pharmacokinetic parameters using WinNonLin (version 5.0.1). For brain/blood drug concentrations, animals were euthanized at 2 h postdose, and terminal blood and brain samples were collected from each animal and analyzed as previously described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> All animal experiments were conducted with strict adherence to licenses issued under the U.K. Animals (Scientific Procedures) Act 1986 and after local ethical review and approval.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00210">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00210" class="ext-link">10.1021/acs.jmedchem.7b00210</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Preparation and additional characterization for final compounds; effect of <b>33</b> and <b>32</b> in in vitro radioligand binding, enzyme and funtional assays (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_001.pdf">jm7b00210_si_001.pdf (586.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_002.csv">jm7b00210_si_002.csv (1.8 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00210" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William McCoull</span> - <span class="hlFld-Affiliation affiliation">IMED
Oncology and Discovery Sciences, AstraZeneca, 310 Cambridge Science Park, Milton
Road, Cambridge, CB4 0WG, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2977-1744" title="Orcid link">http://orcid.org/0000-0002-2977-1744</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9cebf5f0f0f5fdf1b2f1fffff3e9f0f0dcfdefe8eefde6f9f2f9fffdb2fff3f1"><span class="__cf_email__" data-cfemail="46312f2a2a2f272b682b252529332a2a0627353234273c232823">[email protected]</span>ca.com</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Bailey</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Barton</span> - <span class="hlFld-Affiliation affiliation">IMED
Oncology and Discovery Sciences, AstraZeneca, 310 Cambridge Science Park, Milton
Road, Cambridge, CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan M. Birch</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alastair J. H. Brown</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hayley S. Butler</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Boyd</span> - <span class="hlFld-Affiliation affiliation">IMED
Oncology and Discovery Sciences, AstraZeneca, 310 Cambridge Science Park, Milton
Road, Cambridge, CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger J. Butlin</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Chappell</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Clarkson</span> - <span class="hlFld-Affiliation affiliation">IMED
Oncology and Discovery Sciences, AstraZeneca, 310 Cambridge Science Park, Milton
Road, Cambridge, CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shelley Collins</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert M. D. Davies</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Ertan</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clare D. Hammond</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane L. Holmes</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carol Lenaghan</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anita Midha</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pablo Morentin-Gutierrez</span> - <span class="hlFld-Affiliation affiliation">IMED
Oncology and Discovery Sciences, AstraZeneca, 310 Cambridge Science Park, Milton
Road, Cambridge, CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane E. Moore</span> - <span class="hlFld-Affiliation affiliation">IMED
CVMD, AstraZeneca, Mereside, Alderley Park, Macclesfield, SK10 4TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piotr Raubo</span> - <span class="hlFld-Affiliation affiliation">IMED
Oncology and Discovery Sciences, AstraZeneca, 310 Cambridge Science Park, Milton
Road, Cambridge, CB4 0WG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graeme Robb</span> - <span class="hlFld-Affiliation affiliation">IMED
Oncology and Discovery Sciences, AstraZeneca, 310 Cambridge Science Park, Milton
Road, Cambridge, CB4 0WG, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3545-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Alex Brough, Alex Brien, Mike Harding, Ewan Coates, Rebecca Ruscoe, Mike Harding, and Trystan Nicholls are thanked for synthesis contributions. Jenny Morrell and Steve Bloor are thanked for expert technical assistance in generating biological assay data. Scott Edmondson, Dave Smith, and Ruth MacDonald are thanked for useful discussions on this manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> Abbreviations Used</h2><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FFAR1</td><td class="NLM_def"><p class="first last">free fatty acid receptor 1</p></td></tr><tr><td class="NLM_term">FFAR4</td><td class="NLM_def"><p class="first last">free fatty acid receptor 4</p></td></tr><tr><td class="NLM_term">GPR40</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor 40</p></td></tr><tr><td class="NLM_term">GPR120</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor 120</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">OGTT</td><td class="NLM_def"><p class="first last">oral glucose tolerance test</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Information about T2D can be found in the<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">, </span><span class="NLM_edition">7</span>th edition of the IDF Diabetes Atlas at the Web site of the International Diabetes Federation. <a href="http://www.diabetesatlas.org" class="extLink">http://www.diabetesatlas.org</a> (accessed February 6, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Information+about+T2D+can+be+found+in+the+2015%2C+7th+edition+of+the+IDF+Diabetes+Atlas+at+the+Web+site+of+the+International+Diabetes+Federation.+http%3A%2F%2Fwww.diabetesatlas.org+%28accessed+February+6%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Boden, G.</span><span> </span><span class="NLM_article-title">Obesity and free fatty acids</span> <span class="citation_source-journal">Endocrinol. Metab. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1016/j.ecl.2008.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1016%2Fj.ecl.2008.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=18775356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kqs77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=635-646&author=G.+Boden&title=Obesity+and+free+fatty+acids&doi=10.1016%2Fj.ecl.2008.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Obesity and free fatty acids</span></div><div class="casAuthors">Boden, Guenther</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology and Metabolism Clinics of North America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-646</span>CODEN:
                <span class="NLM_cas:coden">ECNAER</span>;
        ISSN:<span class="NLM_cas:issn">0889-8529</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Plasma free fatty acid (FFA) levels are elevated in obesity.  FFAs cause insulin resistance in all major insulin target organs (skeletal muscle, liver, endothelial cells) and have emerged as a major link between obesity, the development of the metabolic syndrome, and atherosclerotic vascular disease.  FFAs also produce low-grade inflammation in skeletal muscle, liver, and fat, which may contribute to cardiovascular events.  The challenges for the future include the prevention or correction of obesity and elevated plasma FFA levels through methods that include decreased caloric intake and increased caloric expenditure, the development of methods to measure FFAs in small blood samples, and the development of efficient pharmacol. approaches to normalize increased plasma FFA levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro2Xj8y9_0k7Vg90H21EOLACvtfcHk0lhnYsdkQP4WCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kqs77J&md5=72e07cceef6f94028f5228be35dae928</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ecl.2008.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ecl.2008.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DBoden%26aufirst%3DG.%26atitle%3DObesity%2520and%2520free%2520fatty%2520acids%26jtitle%3DEndocrinol.%2520Metab.%2520Clin.%2520North%2520Am.%26date%3D2008%26volume%3D37%26spage%3D635%26epage%3D646%26doi%3D10.1016%2Fj.ecl.2008.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumaya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span> </span><span class="NLM_article-title">Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1038/nm1168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1038%2Fnm1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=15619630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A280%3ADC%252BD2M7gsFKqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=90-94&author=A.+Hirasawaauthor=K.+Tsumayaauthor=T.+Awajiauthor=S.+Katsumaauthor=T.+Adachiauthor=M.+Yamadaauthor=Y.+Sugimotoauthor=S.+Miyazakiauthor=G.+Tsujimoto&title=Free+fatty+acids+regulate+gut+incretin+glucagon-like+peptide-1+secretion+through+GPR120&doi=10.1038%2Fnm1168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120</span></div><div class="casAuthors">Hirasawa Akira; Tsumaya Keiko; Awaji Takeo; Katsuma Susumu; Adachi Tetsuya; Yamada Masateru; Sugimoto Yukihiko; Miyazaki Shunichi; Tsujimoto Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Nature medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-4</span>
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    </div><div class="casAbstract">Diabetes, a disease in which the body does not produce or use insulin properly, is a serious global health problem.  Gut polypeptides secreted in response to food intake, such as glucagon-like peptide-1 (GLP-1), are potent incretin hormones that enhance the glucose-dependent secretion of insulin from pancreatic beta cells.  Free fatty acids (FFAs) provide an important energy source and also act as signaling molecules in various cellular processes, including the secretion of gut incretin peptides.  Here we show that a G-protein-coupled receptor, GPR120, which is abundantly expressed in intestine, functions as a receptor for unsaturated long-chain FFAs.  Furthermore, we show that the stimulation of GPR120 by FFAs promotes the secretion of GLP-1 in vitro and in vivo, and increases circulating insulin.  Because GLP-1 is the most potent insulinotropic incretin, our results indicate that GPR120-mediated GLP-1 secretion induced by dietary FFAs is important in the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxB79dLZc5Pg5nADWVYHg1fW6udTcc2eab9JvkbvcEF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7gsFKqtw%253D%253D&md5=b66c76979857f0da440019ba5a06a007</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1168%26sid%3Dliteratum%253Aachs%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsumaya%26aufirst%3DK.%26aulast%3DAwaji%26aufirst%3DT.%26aulast%3DKatsuma%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DFree%2520fatty%2520acids%2520regulate%2520gut%2520incretin%2520glucagon-like%2520peptide-1%2520secretion%2520through%2520GPR120%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D90%26epage%3D94%26doi%3D10.1038%2Fnm1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ichimura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain-Godefroy, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnefond, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yengo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leloire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besnard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoeur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivequin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffeis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvelin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pigeyre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caiazzo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Hul, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gaal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy-Marchal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouskas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouvatsi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebebrand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherag, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolowczuk, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froguel, P.</span><span> </span><span class="NLM_article-title">Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1038/nature10798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1038%2Fnature10798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=22343897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=350-354&author=A.+Ichimuraauthor=A.+Hirasawaauthor=O.+Poulain-Godefroyauthor=A.+Bonnefondauthor=T.+Haraauthor=L.+Yengoauthor=I.+Kimuraauthor=A.+Leloireauthor=N.+Liuauthor=K.+Iidaauthor=H.+Choquetauthor=P.+Besnardauthor=C.+Lecoeurauthor=S.+Vivequinauthor=K.+Ayukawaauthor=M.+Takeuchiauthor=K.+Ozawaauthor=M.+Tauberauthor=C.+Maffeisauthor=A.+Morandiauthor=R.+Buzzettiauthor=P.+Elliottauthor=A.+Poutaauthor=M.+R.+Jarvelinauthor=A.+Kornerauthor=W.+Kiessauthor=M.+Pigeyreauthor=R.+Caiazzoauthor=W.+Van+Hulauthor=L.+Van+Gaalauthor=F.+Horberauthor=B.+Balkauauthor=C.+Levy-Marchalauthor=K.+Rouskasauthor=A.+Kouvatsiauthor=J.+Hebebrandauthor=A.+Hinneyauthor=A.+Scheragauthor=F.+Pattouauthor=D.+Meyreauthor=T.+Koshimizuauthor=I.+Wolowczukauthor=G.+Tsujimotoauthor=P.+Froguel&title=Dysfunction+of+lipid+sensor+GPR120+leads+to+obesity+in+both+mouse+and+human&doi=10.1038%2Fnature10798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human</span></div><div class="casAuthors">Ichimura, Atsuhiko; Hirasawa, Akira; Poulain-Godefroy, Odile; Bonnefond, Amelie; Hara, Takafumi; Yengo, Loic; Kimura, Ikuo; Leloire, Audrey; Liu, Ning; Iida, Keiko; Choquet, Helene; Besnard, Philippe; Lecoeur, Cecile; Vivequin, Sidonie; Ayukawa, Kumiko; Takeuchi, Masato; Ozawa, Kentaro; Tauber, Maithe; Maffeis, Claudio; Morandi, Anita; Buzzetti, Raffaella; Elliott, Paul; Pouta, Anneli; Jarvelin, Marjo-Riitta; Koerner, Antje; Kiess, Wieland; Pigeyre, Marie; Caiazzo, Roberto; Van Hul, Wim; Van Gaal, Luc; Horber, Fritz; Balkau, Beverley; Levy-Marchal, Claire; Rouskas, Konstantinos; Kouvatsi, Anastasia; Hebebrand, Johannes; Hinney, Anke; Scherag, Andre; Pattou, Francois; Meyre, David; Koshimizu, Taka-aki; Wolowczuk, Isabelle; Tsujimoto, Gozoh; Froguel, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7389</span>),
    <span class="NLM_cas:pages">350-354</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Free fatty acids provide an important energy source as nutrients, and act as signaling mols. in various cellular processes.  Several G-protein-coupled receptors have been identified as free-fatty-acid receptors important in physiol. as well as in several diseases.  GPR120 (also known as O3FAR1) functions as a receptor for unsatd. long-chain free fatty acids and has a crit. role in various physiol. homeostasis mechanisms such as adipogenesis, regulation of appetite and food preference.  Here we show that GPR120-deficient mice fed a high-fat diet develop obesity, glucose intolerance and fatty liver with decreased adipocyte differentiation and lipogenesis and enhanced hepatic lipogenesis.  Insulin resistance in such mice is assocd. with reduced insulin signaling and enhanced inflammation in adipose tissue.  In human, we show that GPR120 expression in adipose tissue is significantly higher in obese individuals than in lean controls.  GPR120 exon sequencing in obese subjects reveals a deleterious non-synonymous mutation (p.R270H) that inhibits GPR120 signaling activity.  Furthermore, the p.R270H variant increases the risk of obesity in European populations.  Overall, this study demonstrates that the lipid sensor GPR120 has a key role in sensing dietary fat and, therefore, in the control of energy balance in both humans and rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpszhNO66GQ67Vg90H21EOLACvtfcHk0lhjbp4Wb0ZYTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKru74%253D&md5=6e7377600220e33948bee0b0b0e8ead3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature10798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10798%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DA.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DPoulain-Godefroy%26aufirst%3DO.%26aulast%3DBonnefond%26aufirst%3DA.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DYengo%26aufirst%3DL.%26aulast%3DKimura%26aufirst%3DI.%26aulast%3DLeloire%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DChoquet%26aufirst%3DH.%26aulast%3DBesnard%26aufirst%3DP.%26aulast%3DLecoeur%26aufirst%3DC.%26aulast%3DVivequin%26aufirst%3DS.%26aulast%3DAyukawa%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOzawa%26aufirst%3DK.%26aulast%3DTauber%26aufirst%3DM.%26aulast%3DMaffeis%26aufirst%3DC.%26aulast%3DMorandi%26aufirst%3DA.%26aulast%3DBuzzetti%26aufirst%3DR.%26aulast%3DElliott%26aufirst%3DP.%26aulast%3DPouta%26aufirst%3DA.%26aulast%3DJarvelin%26aufirst%3DM.%2BR.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DKiess%26aufirst%3DW.%26aulast%3DPigeyre%26aufirst%3DM.%26aulast%3DCaiazzo%26aufirst%3DR.%26aulast%3DVan%2BHul%26aufirst%3DW.%26aulast%3DVan%2BGaal%26aufirst%3DL.%26aulast%3DHorber%26aufirst%3DF.%26aulast%3DBalkau%26aufirst%3DB.%26aulast%3DLevy-Marchal%26aufirst%3DC.%26aulast%3DRouskas%26aufirst%3DK.%26aulast%3DKouvatsi%26aufirst%3DA.%26aulast%3DHebebrand%26aufirst%3DJ.%26aulast%3DHinney%26aufirst%3DA.%26aulast%3DScherag%26aufirst%3DA.%26aulast%3DPattou%26aufirst%3DF.%26aulast%3DMeyre%26aufirst%3DD.%26aulast%3DKoshimizu%26aufirst%3DT.%26aulast%3DWolowczuk%26aufirst%3DI.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DFroguel%26aufirst%3DP.%26atitle%3DDysfunction%2520of%2520lipid%2520sensor%2520GPR120%2520leads%2520to%2520obesity%2520in%2520both%2520mouse%2520and%2520human%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D350%26epage%3D354%26doi%3D10.1038%2Fnature10798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walenta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagakos, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessentheiner, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powels, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armando, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quehenberger, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNelis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogner-Strauss, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span> </span><span class="NLM_article-title">A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span><span class="refDoi"> DOI: 10.1038/nm.3614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1038%2Fnm.3614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=24997608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=942-947&author=D.+Y.+Ohauthor=E.+Walentaauthor=T.+E.+Akiyamaauthor=W.+S.+Lagakosauthor=D.+Lackeyauthor=A.+R.+Pessentheinerauthor=R.+Sasikauthor=N.+Hahauthor=T.+J.+Chiauthor=J.+M.+Coxauthor=M.+A.+Powelsauthor=J.+Di+Salvoauthor=C.+Sinzauthor=S.+M.+Watkinsauthor=A.+M.+Armandoauthor=H.+Chungauthor=R.+M.+Evansauthor=O.+Quehenbergerauthor=J.+McNelisauthor=J.+G.+Bogner-Straussauthor=J.+M.+Olefsky&title=A+Gpr120-selective+agonist+improves+insulin+resistance+and+chronic+inflammation+in+obese+mice&doi=10.1038%2Fnm.3614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice</span></div><div class="casAuthors">Oh, Da Young; Walenta, Evelyn; Akiyama, Taro E.; Lagakos, William S.; Lackey, Denise; Pessentheiner, Ariane R.; Sasik, Roman; Hah, Nasun; Chi, Tyler J.; Cox, Jason M.; Powels, Mary Ann; Di Salvo, Jerry; Sinz, Christopher; Watkins, Steven M.; Armando, Aaron M.; Chung, Heekyung; Evans, Ronald M.; Quehenberger, Oswald; McNelis, Joanne; Bogner-Strauss, Juliane G.; Olefsky, Jerrold M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">942-947</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It is well known that the ω-3 fatty acids (ω-3-FAs; also known as n-3 fatty acids) can exert potent anti-inflammatory effects.  Commonly consumed as fish products, dietary supplements and pharmaceuticals, ω-3-FAs have a no. of health benefits ascribed to them, including reduced plasma triglyceride levels, amelioration of atherosclerosis and increased insulin sensitivity.  We reported that Gpr120 is the functional receptor for these fatty acids and that ω-3-FAs produce robust anti-inflammatory, insulin-sensitizing effects, both in vivo and in vitro, in a Gpr120-dependent manner.  Indeed, genetic variants that predispose to obesity and diabetes have been described in the gene encoding GPR120 in humans (FFAR4).  However, the amt. of fish oils that would have to be consumed to sustain chronic agonism of Gpr120 is too high to be practical, and, thus, a high-affinity small-mol. Gpr120 agonist would be of potential clin. benefit.  Accordingly, Gpr120 is a widely studied drug discovery target within the pharmaceutical industry.  Gpr40 is another lipid-sensing G protein-coupled receptor, and it has been difficult to identify compds. with a high degree of selectivity for Gpr120 over Gpr40 (ref. 11).  Here we report that a selective high-affinity, orally available, small-mol. Gpr120 agonist (cpdA) exerts potent anti-inflammatory effects on macrophages in vitro and in obese mice in vivo.  Gpr120 agonist treatment of high-fat diet-fed obese mice causes improved glucose tolerance, decreased hyperinsulinemia, increased insulin sensitivity and decreased hepatic steatosis.  This suggests that Gpr120 agonists could become new insulin-sensitizing drugs for the treatment of type 2 diabetes and other human insulin-resistant states in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1mbdTckjd-bVg90H21EOLACvtfcHk0lhITOVJ6-jrQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrL&md5=293d3048bb7840f98c2ae6772fd37087</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnm.3614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3614%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DWalenta%26aufirst%3DE.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DLagakos%26aufirst%3DW.%2BS.%26aulast%3DLackey%26aufirst%3DD.%26aulast%3DPessentheiner%26aufirst%3DA.%2BR.%26aulast%3DSasik%26aufirst%3DR.%26aulast%3DHah%26aufirst%3DN.%26aulast%3DChi%26aufirst%3DT.%2BJ.%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DPowels%26aufirst%3DM.%2BA.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DSinz%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DS.%2BM.%26aulast%3DArmando%26aufirst%3DA.%2BM.%26aulast%3DChung%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DQuehenberger%26aufirst%3DO.%26aulast%3DMcNelis%26aufirst%3DJ.%26aulast%3DBogner-Strauss%26aufirst%3DJ.%2BG.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Gpr120-selective%2520agonist%2520improves%2520insulin%2520resistance%2520and%2520chronic%2520inflammation%2520in%2520obese%2520mice%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D942%26epage%3D947%26doi%3D10.1038%2Fnm.3614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cornall, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathai, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hryciw, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAinch, A. J.</span><span> </span><span class="NLM_article-title">GPR120 agonism as a countermeasure against metabolic diseases</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span><span class="refDoi"> DOI: 10.1016/j.drudis.2013.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1016%2Fj.drudis.2013.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=24315954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWjt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=670-679&author=L.+M.+Cornallauthor=M.+L.+Mathaiauthor=D.+H.+Hryciwauthor=A.+J.+McAinch&title=GPR120+agonism+as+a+countermeasure+against+metabolic+diseases&doi=10.1016%2Fj.drudis.2013.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">GPR120 agonism as a countermeasure against metabolic diseases</span></div><div class="casAuthors">Cornall, Lauren M.; Mathai, Michael L.; Hryciw, Deanne H.; McAinch, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">670-679</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Obesity, type 2 diabetes mellitus and cardiovascular disease are at epidemic proportions in developed nations globally, representing major causes of ill-health and premature death.  The search for drug targets to counter the growing prevalence of metabolic diseases has uncovered G-protein-coupled receptor 120 (GPR120).  GPR120 agonism has been shown to improve inflammation and metabolic health on a systemic level via regulation of adiposity, gastrointestinal peptide secretion, taste preference and glucose homeostasis.  Therefore, GPR120 agonists present as a novel therapeutic option that could be exploited for the treatment of impaired metabolic health.  This review summarizes the current knowledge of GPR120 functionality and the potential applications of GPR120-specific agonists for the treatment of disease states such as obesity, type 2 diabetes mellitus and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAoRwGzdTNFrVg90H21EOLACvtfcHk0lhITOVJ6-jrQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWjt73J&md5=c474d70c237fb2be47ee2cec55dfa7d0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DCornall%26aufirst%3DL.%2BM.%26aulast%3DMathai%26aufirst%3DM.%2BL.%26aulast%3DHryciw%26aufirst%3DD.%2BH.%26aulast%3DMcAinch%26aufirst%3DA.%2BJ.%26atitle%3DGPR120%2520agonism%2520as%2520a%2520countermeasure%2520against%2520metabolic%2520diseases%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D670%26epage%3D679%26doi%3D10.1016%2Fj.drudis.2013.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Yu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Clinicopathological significance and potential drug target of RUNX3 in breast cancer</span> <span class="citation_source-journal">Drug Des., Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2430</span><span class="refDoi"> DOI: 10.2147/DDDT.S71815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.2147%2FDDDT.S71815" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=25525332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOitbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=2423-2430&author=Y.+Y.+Yuauthor=C.+Chenauthor=F.+F.+Kongauthor=W.+Zhang&title=Clinicopathological+significance+and+potential+drug+target+of+RUNX3+in+breast+cancer&doi=10.2147%2FDDDT.S71815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clinicopathological significance and potential drug target of RUNX3 in breast cancer</span></div><div class="casAuthors">Yu, Ying-Ying; Chen, Chao; Kong, Fan-Fei; Zhang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2423-2430, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Previous reports indicate that RUNX3 is a tumor suppressor in several types of human tumors, including breast cancer (BC).  However, the correlation between RUNX3 hypermethylation and the incidence of BC remains unclear.  In this study, we conducted a systematic review and meta-anal. aiming to comprehensively assess the potential role of RUNX3 hypermethylation in the pathogenesis of BC.  Methods: A detailed literature search was made to identify studies for related research publications.  Methodol. quality of the studies was evaluated.  Anal. of pooled data was performed.  Odds ratio (OR) was calcd. and summarized resp.  Results: Final anal. of 565 BC patients from eleven eligible studies was performed.  The results showed that RUNX3 hypermethylation was significantly higher in BC than in normal breast tissue, the pooled OR from nine studies including 339 BC and 248 normal breast tissue (OR = 24.12, 95% confidence interval [CI] = 13.50-43.11, Z = 10.75, P < 0.00001).  Further anal. also showed significantly increased OR of RUNX3 hypermethylation in estrogen receptor (ER)-pos. than in ER-neg. BC patients (OR = 5.67, 95% CI = 2.69-11.95, Z = 4.57, P < 0.00001).  In addn., RUNX3 mRNA (mRNA) high expression was found to be correlated to better overall survival in 3,455 cases of BC patients that were followed up for 20 years (hazard ratio [HR] 0.79, P = 8.8 × 10-5).  Interestingly, RUNX3 mRNA overexpression was found to be correlated to better overall survival in only 668 cases of ER-neg. patients (HR 0.72, P = 0.01), but not in 1,767 cases of ER-pos. patients (HR 0.87, P = 0.13).  Conclusion: The results of this meta-anal. suggest that RUNX3 hypermethylation may be implicated in the pathogenesis of BC.  Detection of RUNX3 mRNA may be a helpful and valuable biomarker for diagnosis of BC, esp. in ER-neg. BC.  We also discussed the significance of RUNX3 as a potential drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrJ40CazekN7Vg90H21EOLACvtfcHk0lhITOVJ6-jrQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOitbfF&md5=4d49432971e5d88871de11f083d8cdb8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S71815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S71815%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%2BY.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DF.%2BF.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DClinicopathological%2520significance%2520and%2520potential%2520drug%2520target%2520of%2520RUNX3%2520in%2520breast%2520cancer%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2014%26volume%3D8%26spage%3D2423%26epage%3D2430%26doi%3D10.2147%2FDDDT.S71815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Adams, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verras, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ujjainwalla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, S. D.</span><span> </span><span class="NLM_article-title">Discovery of chromane propionic acid analogues as selective agonists of GPR120 with in vivo activity in rodents</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFyrtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=96-101&author=G.+L.+Adamsauthor=F.+Velazquezauthor=C.+Jayneauthor=U.+Shahauthor=S.+Miaoauthor=E.+R.+Ashleyauthor=M.+Madeiraauthor=T.+E.+Akiyamaauthor=J.+Di+Salvoauthor=T.+Suzukiauthor=N.+Wangauthor=Q.+Truongauthor=E.+Gilbertauthor=D.+Zhouauthor=A.+Verrasauthor=M.+Kirklandauthor=M.+Pachanskiauthor=M.+Powlesauthor=W.+Yinauthor=F.+Ujjainwallaauthor=S.+Venkatramanauthor=S.+D.+Edmondson&title=Discovery+of+chromane+propionic+acid+analogues+as+selective+agonists+of+GPR120+with+in+vivo+activity+in+rodents&doi=10.1021%2Facsmedchemlett.6b00394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with in Vivo Activity in Rodents</span></div><div class="casAuthors">Adams, Gregory L.; Velazquez, Francisco; Jayne, Charles; Shah, Unmesh; Miao, Shouwu; Ashley, Eric R.; Madeira, Maria; Akiyama, Taro E.; Di Salvo, Jerry; Suzuki, Takao; Wang, Nengxue; Truong, Quang; Gilbert, Eric; Zhou, Dan; Verras, Andreas; Kirkland, Melissa; Pachanski, Michele; Powles, Maryann; Yin, Wu; Ujjainwalla, Feroze; Venkatraman, Srikanth; Edmondson, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-101</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR120 (FFAR4) is a fatty acid sensing G protein coupled receptor (GPCR) that has been identified as a target for possible treatment of type 2 diabetes.  A selective activator of GPR120 contg. a chromane scaffold has been designed, synthesized, and evaluated in vivo.  Results of these efforts suggest that chromane propionic acid 18 is a suitable tool mol. for further animal studies.  Compd. 18 is selective over the closely related target GPR40 (FFAR1), has a clean off-target profile, demonstrates suitable pharmacokinetic properties, and has been evaluated in wild-type/knockout GPR120 mouse oGTT studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgLVEM4MQ03LVg90H21EOLACvtfcHk0lj9U9VtPVy0mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFyrtbnE&md5=d83a3ff9743f4865f3543debcc58bc37</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00394%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DG.%2BL.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DJayne%26aufirst%3DC.%26aulast%3DShah%26aufirst%3DU.%26aulast%3DMiao%26aufirst%3DS.%26aulast%3DAshley%26aufirst%3DE.%2BR.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DTruong%26aufirst%3DQ.%26aulast%3DGilbert%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DVerras%26aufirst%3DA.%26aulast%3DKirkland%26aufirst%3DM.%26aulast%3DPachanski%26aufirst%3DM.%26aulast%3DPowles%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DUjjainwalla%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520chromane%2520propionic%2520acid%2520analogues%2520as%2520selective%2520agonists%2520of%2520GPR120%2520with%2520in%2520vivo%2520activity%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D96%26epage%3D101%26doi%3D10.1021%2Facsmedchemlett.6b00394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Azevedo, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wargent, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepczynska, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimpukade, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Non-acidic free fatty acid receptor 4 agonists with antidiabetic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8868</span><span class="NLM_x">–</span> <span class="NLM_lpage">8878</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00685</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVagu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8868-8878&author=C.+M.+Azevedoauthor=K.+R.+Wattersonauthor=E.+T.+Wargentauthor=S.+V.+Hansenauthor=B.+D.+Hudsonauthor=M.+A.+Kepczynskaauthor=J.+Dunlopauthor=B.+Shimpukadeauthor=E.+Christiansenauthor=G.+Milliganauthor=C.+J.+Stockerauthor=T.+Ulven&title=Non-acidic+free+fatty+acid+receptor+4+agonists+with+antidiabetic+activity&doi=10.1021%2Facs.jmedchem.6b00685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity</span></div><div class="casAuthors">Azevedo, Carlos M. G.; Watterson, Kenneth R.; Wargent, Ed T.; Hansen, Steffen V. F.; Hudson, Brian D.; Kepczynska, Malgorzata A.; Dunlop, Julia; Shimpukade, Bharat; Christiansen, Elisabeth; Milligan, Graeme; Stocker, Claire J.; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8868-8878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The free fatty acid receptor 4 (FFA4 or GPR120) has appeared as an interesting potential target for the treatment of metabolic disorders.  At present, most FFA4 ligands are carboxylic acids that are assumed to mimic the endogenous long-chain fatty acid agonists.  Here, the authors report preliminary structure-activity relationship studies of a previously disclosed non-acidic sulfonamide FFA4 agonist.  Mutagenesis studies indicate that the compds. are orthosteric agonists despite the absence of a carboxylate function.  The preferred compds. showed full agonist activity on FFA4 and complete selectivity over FFA1, although a significant fraction of these non-carboxylic acids also showed partial antagonistic activity on FFA1.  Studies in normal and diet-induced obese (DIO) mice with the preferred compd. 34 (2-(3-fluoro-5-(pyridin-2-yloxy)phenyl)-2,3-dihydrobenzo[d]isothiazole-1,1-dioxide) showed improved glucose tolerance after oral dosing in an oral glucose tolerance test.  Chronic dosing of 34 in DIO mice resulted in significantly increased insulin sensitivity and a moderate but significant redn. in bodyweight, effects that were also present in mice lacking FFA1 but absent in mice lacking FFA4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkGgmkcI6R37Vg90H21EOLACvtfcHk0lj9U9VtPVy0mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVagu7zL&md5=3dd72deea56fdf05153ff61c8a590ee8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00685%26sid%3Dliteratum%253Aachs%26aulast%3DAzevedo%26aufirst%3DC.%2BM.%26aulast%3DWatterson%26aufirst%3DK.%2BR.%26aulast%3DWargent%26aufirst%3DE.%2BT.%26aulast%3DHansen%26aufirst%3DS.%2BV.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DKepczynska%26aufirst%3DM.%2BA.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DStocker%26aufirst%3DC.%2BJ.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DNon-acidic%2520free%2520fatty%2520acid%2520receptor%25204%2520agonists%2520with%2520antidiabetic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8868%26epage%3D8878%26doi%3D10.1021%2Facs.jmedchem.6b00685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chelliah, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debenham, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotkin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alleyne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas-Fowlkes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinglass, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ujjainwalla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tata, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, C. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel and selective G-protein coupled receptor 120 (GPR120) spirocyclic agonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=49-54&author=J.+M.+Coxauthor=H.+D.+Chuauthor=M.+V.+Chelliahauthor=J.+S.+Debenhamauthor=K.+Eagenauthor=P.+Lanauthor=M.+Lombardoauthor=C.+Londonauthor=M.+A.+Plotkinauthor=U.+Shahauthor=Z.+Sunauthor=H.+M.+Vaccaroauthor=S.+Venkatramanauthor=T.+Suzukiauthor=N.+Wangauthor=E.+R.+Ashleyauthor=A.+Crespoauthor=M.+Madeiraauthor=D.+H.+Leungauthor=C.+Alleyneauthor=A.+M.+Ogawaauthor=S.+Souzaauthor=B.+Thomas-Fowlkesauthor=J.+Di+Salvoauthor=A.+Weinglassauthor=M.+Kirklandauthor=M.+Pachanskiauthor=M.+A.+Powlesauthor=E.+Tozzoauthor=T.+E.+Akiyamaauthor=F.+Ujjainwallaauthor=J.+R.+Tataauthor=C.+J.+Sinz&title=Design%2C+synthesis%2C+and+evaluation+of+novel+and+selective+G-protein+coupled+receptor+120+%28GPR120%29+spirocyclic+agonists&doi=10.1021%2Facsmedchemlett.6b00360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00360%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DChu%26aufirst%3DH.%2BD.%26aulast%3DChelliah%26aufirst%3DM.%2BV.%26aulast%3DDebenham%26aufirst%3DJ.%2BS.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DLan%26aufirst%3DP.%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DPlotkin%26aufirst%3DM.%2BA.%26aulast%3DShah%26aufirst%3DU.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DVaccaro%26aufirst%3DH.%2BM.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DAshley%26aufirst%3DE.%2BR.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DD.%2BH.%26aulast%3DAlleyne%26aufirst%3DC.%26aulast%3DOgawa%26aufirst%3DA.%2BM.%26aulast%3DSouza%26aufirst%3DS.%26aulast%3DThomas-Fowlkes%26aufirst%3DB.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DWeinglass%26aufirst%3DA.%26aulast%3DKirkland%26aufirst%3DM.%26aulast%3DPachanski%26aufirst%3DM.%26aulast%3DPowles%26aufirst%3DM.%2BA.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DUjjainwalla%26aufirst%3DF.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DSinz%26aufirst%3DC.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%2520and%2520selective%2520G-protein%2520coupled%2520receptor%2520120%2520%2528GPR120%2529%2520spirocyclic%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D49%26epage%3D54%26doi%3D10.1021%2Facsmedchemlett.6b00360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadakane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itsubo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span> </span><span class="NLM_article-title">Novel selective ligands for free fatty acid receptors GPR120 and GPR40</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">380</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1007/s00210-009-0425-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1007%2Fs00210-009-0425-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=19471906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVeks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2009&pages=247-255&author=T.+Haraauthor=A.+Hirasawaauthor=Q.+Sunauthor=K.+Sadakaneauthor=C.+Itsuboauthor=T.+Igaauthor=T.+Adachiauthor=T.+A.+Koshimizuauthor=T.+Hashimotoauthor=Y.+Asakawaauthor=G.+Tsujimoto&title=Novel+selective+ligands+for+free+fatty+acid+receptors+GPR120+and+GPR40&doi=10.1007%2Fs00210-009-0425-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective ligands for free fatty acid receptors GPR120 and GPR40</span></div><div class="casAuthors">Hara, Takafumi; Hirasawa, Akira; Sun, Qi; Sadakane, Keiko; Itsubo, Chisato; Iga, Tomoyo; Adachi, Tetsuya; Koshimizu, Taka-Aki; Hashimoto, Toshihiro; Asakawa, Yoshinori; Tsujimoto, Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-255</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">GPR120 and GPR40 are G-protein-coupled receptors whose endogenous ligands are medium- and long-chain free fatty acids, and they are thought to play an important physiol. role in insulin release.  Despite recent progress in understanding their roles, much still remains unclear about their pharmacol., and few specific ligands for GPR120 and GPR40 besides medium- to long-chain fatty acids have been reported so far.  To identify new selective ligands for these receptors, more than 80 natural compds. were screened, together with a ref. compd. MEDICA16, which is known to activate GPR40, by monitoring the extracellular regulated kinase (ERK) and [Ca2+]i responses in inducible and stable expression cell lines for GPR40 and GPR120, resp.  MEDICA16 selectively activated [Ca2+]i response in GPR40-expressing cells but not in GPR120-expressing cells.  Among the natural compds. tested, grifolin derivs., grifolic acid and grifolic acid Me ether, promoted ERK and [Ca2+]i responses in GPR120-expressing cells, but not in GPR40-expressing cells, and inhibited the α-linolenic acid (LA)-induced ERK and [Ca2+]i responses in GPR120-expressing cells.  Interestingly, in accordance with the pharmacol. profiles of these compds., similar profiles of glucagon-like peptide-1 secretion were seen for mouse enteroendocrine cell line, STC-1 cells, which express GPR120 endogenously.  Taken together, these studies identified a selective GPR40 agonist and several GPR120 partial agonists.  These compds. would be useful probes to further investigate the physiol. and pharmacol. functions of GPR40 and GPR120.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZj6JUTJzo0rVg90H21EOLACvtfcHk0ljygrg0myjiIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVeks7w%253D&md5=47456c614252d4efe22f730017c21633</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00210-009-0425-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-009-0425-9%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DT.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DSadakane%26aufirst%3DK.%26aulast%3DItsubo%26aufirst%3DC.%26aulast%3DIga%26aufirst%3DT.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DKoshimizu%26aufirst%3DT.%2BA.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DAsakawa%26aufirst%3DY.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DNovel%2520selective%2520ligands%2520for%2520free%2520fatty%2520acid%2520receptors%2520GPR120%2520and%2520GPR40%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2009%26volume%3D380%26spage%3D247%26epage%3D255%26doi%3D10.1007%2Fs00210-009-0425-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotkin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geissler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pols, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uebele, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alleyne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusca, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ujjainwalla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tata, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, C. J.</span><span> </span><span class="NLM_article-title">Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5724</span><span class="NLM_x">–</span> <span class="NLM_lpage">5728</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1016%2Fj.bmcl.2016.10.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5724-5728&author=M.+Lombardoauthor=K.+Benderauthor=C.+Londonauthor=M.+A.+Plotkinauthor=M.+Kirklandauthor=J.+Maneauthor=M.+Pachanskiauthor=W.+Geisslerauthor=J.+Cummingsauthor=B.+Habulihazauthor=T.+E.+Akiyamaauthor=J.+Di+Salvoauthor=M.+Madeiraauthor=J.+Polsauthor=M.+A.+Powlesauthor=M.+F.+Finleyauthor=E.+Johnsonauthor=T.+Rousselauthor=V.+N.+Uebeleauthor=A.+Crespoauthor=D.+Leungauthor=C.+Alleyneauthor=D.+Truscaauthor=Y.+Leiauthor=A.+D.+Howardauthor=F.+Ujjainwallaauthor=J.+R.+Tataauthor=C.+J.+Sinz&title=Discovery+of+benzofuran+propanoic+acid+GPR120+agonists%3A+From+uHTS+hit+to+mechanism-based+pharmacodynamic+effects&doi=10.1016%2Fj.bmcl.2016.10.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DBender%26aufirst%3DK.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DPlotkin%26aufirst%3DM.%2BA.%26aulast%3DKirkland%26aufirst%3DM.%26aulast%3DMane%26aufirst%3DJ.%26aulast%3DPachanski%26aufirst%3DM.%26aulast%3DGeissler%26aufirst%3DW.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DPols%26aufirst%3DJ.%26aulast%3DPowles%26aufirst%3DM.%2BA.%26aulast%3DFinley%26aufirst%3DM.%2BF.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DRoussel%26aufirst%3DT.%26aulast%3DUebele%26aufirst%3DV.%2BN.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DAlleyne%26aufirst%3DC.%26aulast%3DTrusca%26aufirst%3DD.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DUjjainwalla%26aufirst%3DF.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DSinz%26aufirst%3DC.%2BJ.%26atitle%3DDiscovery%2520of%2520benzofuran%2520propanoic%2520acid%2520GPR120%2520agonists%253A%2520From%2520uHTS%2520hit%2520to%2520mechanism-based%2520pharmacodynamic%2520effects%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5724%26epage%3D5728%26doi%3D10.1016%2Fj.bmcl.2016.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Shimpukade, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovgaard, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective GPR120 agonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4511</span><span class="NLM_x">–</span> <span class="NLM_lpage">4515</span><span class="refDoi"> DOI: 10.1021/jm300215x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300215x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2lu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4511-4515&author=B.+Shimpukadeauthor=B.+D.+Hudsonauthor=C.+K.+Hovgaardauthor=G.+Milliganauthor=T.+Ulven&title=Discovery+of+a+potent+and+selective+GPR120+agonist&doi=10.1021%2Fjm300215x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective GPR120 Agonist</span></div><div class="casAuthors">Shimpukade, Bharat; Hudson, Brian D.; Hovgaard, Christine Kiel; Milligan, Graeme; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4511-4515</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR120 is a receptor of unsatd. long-chain fatty acids reported to mediate GLP-1 secretion, insulin sensitization, anti-inflammatory, and anti-obesity effects and is therefore emerging as a new potential target for treatment of type 2 diabetes and metabolic diseases.  Further investigation is however hindered by the lack of suitable receptor modulators.  Screening of FFA1 ligands provided a lead with moderate activity on GPR120 and moderate selectivity over FFA1.  Optimization led to the discovery of the first potent and selective GPR120 agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqneyWUSNeSX7Vg90H21EOLACvtfcHk0lgcl6y6zAQaNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2lu7w%253D&md5=e096ad8ee598c0de36dfdfc500d84b0f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm300215x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300215x%26sid%3Dliteratum%253Aachs%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DHovgaard%26aufirst%3DC.%2BK.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520GPR120%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4511%26epage%3D4515%26doi%3D10.1021%2Fjm300215x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujieda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makishima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7640</span><span class="NLM_x">–</span> <span class="NLM_lpage">7644</span><span class="refDoi"> DOI: 10.1021/jm800970b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800970b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7640-7644&author=T.+Suzukiauthor=S.+Igariauthor=A.+Hirasawaauthor=M.+Hataauthor=M.+Ishiguroauthor=H.+Fujiedaauthor=Y.+Itohauthor=T.+Hiranoauthor=H.+Nakagawaauthor=M.+Oguraauthor=M.+Makishimaauthor=G.+Tsujimotoauthor=N.+Miyata&title=Identification+of+G+protein-coupled+receptor+120-selective+agonists+derived+from+PPARgamma+agonists&doi=10.1021%2Fjm800970b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm800970b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800970b%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIgari%26aufirst%3DS.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DHata%26aufirst%3DM.%26aulast%3DIshiguro%26aufirst%3DM.%26aulast%3DFujieda%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DOgura%26aufirst%3DM.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520G%2520protein-coupled%2520receptor%2520120-selective%2520agonists%2520derived%2520from%2520PPARgamma%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7640%26epage%3D7644%26doi%3D10.1021%2Fjm800970b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimpukade, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pediani, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcote, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span> </span><span class="NLM_article-title">The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span><span class="refDoi"> DOI: 10.1124/mol.113.087783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1124%2Fmol.113.087783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=710-725&author=B.+D.+Hudsonauthor=B.+Shimpukadeauthor=A.+E.+Mackenzieauthor=A.+J.+Butcherauthor=J.+D.+Pedianiauthor=E.+Christiansenauthor=H.+Heathcoteauthor=A.+B.+Tobinauthor=T.+Ulvenauthor=G.+Milligan&title=The+pharmacology+of+TUG-891%2C+a+potent+and+selective+agonist+of+the+free+fatty+acid+receptor+4+%28FFA4%2FGPR120%29%2C+demonstrates+both+potential+opportunity+and+possible+challenges+to+therapeutic+agonism&doi=10.1124%2Fmol.113.087783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087783%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DMackenzie%26aufirst%3DA.%2BE.%26aulast%3DButcher%26aufirst%3DA.%2BJ.%26aulast%3DPediani%26aufirst%3DJ.%2BD.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DHeathcote%26aufirst%3DH.%26aulast%3DTobin%26aufirst%3DA.%2BB.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DThe%2520pharmacology%2520of%2520TUG-891%252C%2520a%2520potent%2520and%2520selective%2520agonist%2520of%2520the%2520free%2520fatty%2520acid%2520receptor%25204%2520%2528FFA4%252FGPR120%2529%252C%2520demonstrates%2520both%2520potential%2520opportunity%2520and%2520possible%2520challenges%2520to%2520therapeutic%2520agonism%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D710%26epage%3D725%26doi%3D10.1124%2Fmol.113.087783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ma, J.; Novack, A.; Nashashibi, I.; Pham, P.; Rabbat, C. J.; Song, J.; Shi, D. F.; Zhao, Z.; Choi, Y.-J.; Chen, X.</span><span> </span><span class="NLM_article-title">[(Heterocyclylmethoxy)aryl]alkanoic acid derivatives as GPR120 receptor agonists and preparation and uses thereof</span>. Patent WO2010/048207,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Ma&author=A.+Novack&author=I.+Nashashibi&author=P.+Pham&author=C.+J.+Rabbat&author=J.+Song&author=D.+F.+Shi&author=Z.+Zhao&author=Y.-J.+Choi&author=X.+Chen&title=%5B%28Heterocyclylmethoxy%29aryl%5Dalkanoic+acid+derivatives+as+GPR120+receptor+agonists+and+preparation+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26atitle%3D%255B%2528Heterocyclylmethoxy%2529aryl%255Dalkanoic%2520acid%2520derivatives%2520as%2520GPR120%2520receptor%2520agonists%2520and%2520preparation%2520and%2520uses%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Holliday, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J. H.</span><span> </span><span class="NLM_article-title">Drug discovery opportunities and challenges at G protein coupled receptors for long chain free Fatty acids</span> <span class="citation_source-journal">Front. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="refDoi"> DOI: 10.3389/fendo.2011.00112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.3389%2Ffendo.2011.00112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=22649399" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=112&author=N.+D.+Hollidayauthor=S.-J.+Watsonauthor=A.+J.+H.+Brown&title=Drug+discovery+opportunities+and+challenges+at+G+protein+coupled+receptors+for+long+chain+free+Fatty+acids&doi=10.3389%2Ffendo.2011.00112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2011.00112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2011.00112%26sid%3Dliteratum%253Aachs%26aulast%3DHolliday%26aufirst%3DN.%2BD.%26aulast%3DWatson%26aufirst%3DS.-J.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26atitle%3DDrug%2520discovery%2520opportunities%2520and%2520challenges%2520at%2520G%2520protein%2520coupled%2520receptors%2520for%2520long%2520chain%2520free%2520Fatty%2520acids%26jtitle%3DFront.%2520Endocrinol.%26date%3D2012%26volume%3D2%26spage%3D112%26doi%3D10.3389%2Ffendo.2011.00112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lee, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkleeren, R.</span><span> </span><span class="NLM_article-title">Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1089/adt.2007.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1089%2Fadt.2007.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=18336088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=83-94&author=P.+H.+Leeauthor=A.+Gaoauthor=C.+van+Stadenauthor=J.+Lyauthor=J.+Salonauthor=A.+Xuauthor=Y.+Fangauthor=R.+Verkleeren&title=Evaluation+of+dynamic+mass+redistribution+technology+for+pharmacological+studies+of+recombinant+and+endogenously+expressed+g+protein-coupled+receptors&doi=10.1089%2Fadt.2007.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Dynamic Mass Redistribution Technology for Pharmacological Studies of Recombinant and Endogenously Expressed G Protein-Coupled Receptors</span></div><div class="casAuthors">Lee, Paul H.; Gao, Alice; van Staden, Carlo; Ly, Jenny; Salon, John; Xu, Arron; Fang, Ye; Verkleeren, Ron</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The Epic cell assay technol. (Corning Inc., Corning, NY) uses a resonant waveguide grating optical biosensor to measure cellular response to ligands manifested through dynamic mass redistribution (DMR) of cellular contents.  The DMR measurement is a noninvasive, label-free assay that can be used to assess the pharmacol. properties of compds.  In this study, a panel of 12 compds. was evaluated against two G protein-coupled receptor (GPCR) targets in recombinant expressed cell lines using the Corning Epic system in 384-well microplates.  The evaluation was performed in a double-blinded fashion such that the identity and properties of both the GPCR targets and compds. were unknown to the researchers at the time of the study.  Anal. of the DMR response from cell stimulation was used to identify compds. that functioned as agonists or antagonists and to evaluate the assocd. efficacy and potency.  DMR results were shown to have good agreement with data obtained from cAMP and calcium flux assays for compds. evaluated.  A further anal. was performed and successfully identified the signaling pathways that the two GPCRs activated.  In addn., the DMR measurement was able to detect responses from an endogenous receptor in these cells.  The Epic DMR technol. provides a generic platform amenable to pharmacol. evaluation of cellular responses to GPCR activation in a label-free live cell assay format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohWThU7pO167Vg90H21EOLACvtfcHk0lgiHEFclLMlVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtbw%253D&md5=0f2d1ebca70b4954eaaf0b9440791829</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.126%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DP.%2BH.%26aulast%3DGao%26aufirst%3DA.%26aulast%3Dvan%2BStaden%26aufirst%3DC.%26aulast%3DLy%26aufirst%3DJ.%26aulast%3DSalon%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DVerkleeren%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520dynamic%2520mass%2520redistribution%2520technology%2520for%2520pharmacological%2520studies%2520of%2520recombinant%2520and%2520endogenously%2520expressed%2520g%2520protein-coupled%2520receptors%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D83%26epage%3D94%26doi%3D10.1089%2Fadt.2007.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Talele, T. T.</span><span> </span><span class="NLM_article-title">The ″cyclopropyl fragment″ is a versatile player that frequently appears in preclinical/clinical drug molecules</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8712</span><span class="NLM_x">–</span> <span class="NLM_lpage">8756</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&author=T.+T.+Talele&title=The+%E2%80%B3cyclopropyl+fragment%E2%80%B3+is+a+versatile+player+that+frequently+appears+in+preclinical%2Fclinical+drug+molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules</span></div><div class="casAuthors">Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8712-8756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclin. to clin. stage.  Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes.  The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs contg. it.  Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects, (c) increasing metabolic stability, (d) increasing brain permeability, (e) decreasing plasma clearance, (f) contributing to an entropically more favorable binding to the receptor, (g) conformational restriction of peptides/peptidomimetics to prevent proteolytic hydrolysis, and (h) altering drug pKa to reduce its P-glycoprotein efflux ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVIJAG1XVRG7Vg90H21EOLACvtfcHk0lgiHEFclLMlVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D&md5=b5586458ec4ab5e2d7586f5739663d1f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2580%25B3cyclopropyl%2520fragment%25E2%2580%25B3%2520is%2520a%2520versatile%2520player%2520that%2520frequently%2520appears%2520in%2520preclinical%252Fclinical%2520drug%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Molecular formula = C<sub>10</sub>H<sub>9</sub>BrO<sub>2</sub>. Formula weight = 241.08. Crystal system = orthorhombic. Space group = <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>, <i>a</i> = 6.5493(4) Å, <i>b</i> = 6.9515(5) Å, <i>c</i> = 20.6297(14) Å, α = 90°, β = 90°, γ = 90°, <i>V</i> = 939.218 Å<sup>3</sup>, <i>T</i> = 200K, <i>Z</i> = 4, <i>D</i><sub>c</sub> = 1.705 gcm<sup>–1</sup>, λ<sub>(Mo-Kα)</sub> = 0.71073, μ = 4.338 mm<sup>–1</sup>, 3188 reflections measured, 2243 independent reflections, 1754 observed reflections [<i>I</i> > 2.0σ(<i>I</i>)], <i>R</i>[<i>F</i><sup>2</sup> > 2σ(<i>F</i><sup>2</sup><i>)</i>] = 0.0293, goodness of fit = 1.027. Flack’s <i>x</i> parameter = 0.014(14), indicating correctly defined chirality. Crystallographic data have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 1530875.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eYYcbrumQ20Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducrozet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Development of a high-throughput brain slice method for studying drug distribution in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span><span class="refDoi"> DOI: 10.1124/dmd.108.026377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1124%2Fdmd.108.026377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=19299522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslamu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1226-1233&author=M.+Fridenauthor=F.+Ducrozetauthor=B.+Middletonauthor=M.+Antonssonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=Development+of+a+high-throughput+brain+slice+method+for+studying+drug+distribution+in+the+central+nervous+system&doi=10.1124%2Fdmd.108.026377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high-throughput brain slice method for studying drug distribution in the central nervous system</span></div><div class="casAuthors">Friden, Markus; Ducrozet, Frederic; Middleton, Brian; Antonsson, Madeleine; Bredberg, Ulf; Hammarlund-Udenaes, Margareta</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1226-1233</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">New, more efficient methods of estg. unbound drug concns. in the central nervous system (CNS) combine the amt. of drug in whole brain tissue samples measured by conventional methods with in vitro ests. of the unbound brain vol. of distribution (Vu,brain).  Although the brain slice method is the most reliable in vitro method for measuring Vu,brain, it has not previously been adapted for the needs of drug discovery research.  The aim of this study was to increase the throughput and optimize the exptl. conditions of this method.  Equil. of drug between the buffer and the brain slice within the 4 to 5 h of incubation is a fundamental requirement.  However, it is difficult to meet this requirement for many of the extensively binding, lipophilic compds. in drug discovery programs.  In this study, the dimensions of the incubation vessel and mode of stirring influenced the equilibration time, as did the amt. of brain tissue per unit of buffer vol.  The use of cassette expts. for investigating Vu,brain in a linear drug concn. range increased the throughput of the method.  The Vu,brain for the model compds. ranged from 4 to 3000 mL/g brain-1, and the sources of variability are discussed.  The optimized setup of the brain slice method allows precise, robust estn. of Vu,brain for drugs with diverse properties, including highly lipophilic compds.  This is a crit. step forward for the implementation of relevant measurements of CNS exposure in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbw00E2WUX2LVg90H21EOLACvtfcHk0lgqGeYxcEX72w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslamu70%253D&md5=907441179cc476ca489a1e036832f3ee</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.026377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.026377%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DDucrozet%26aufirst%3DF.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DAntonsson%26aufirst%3DM.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520high-throughput%2520brain%2520slice%2520method%2520for%2520studying%2520drug%2520distribution%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1226%26epage%3D1233%26doi%3D10.1124%2Fdmd.108.026377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcombe, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pointon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span> </span><span class="NLM_article-title">Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6128</span><span class="NLM_x">–</span> <span class="NLM_lpage">6140</span><span class="refDoi"> DOI: 10.1021/jm500610n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500610n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6128-6140&author=W.+McCoullauthor=P.+Bartonauthor=A.+J.+Brownauthor=S.+S.+Bowkerauthor=J.+Cameronauthor=D.+S.+Clarkeauthor=R.+D.+Daviesauthor=A.+G.+Dossetterauthor=A.+Ertanauthor=M.+Fenwickauthor=C.+Greenauthor=J.+L.+Holmesauthor=N.+Martinauthor=D.+Mastersauthor=J.+E.+Mooreauthor=N.+J.+Newcombeauthor=C.+Newtonauthor=H.+Pointonauthor=G.+R.+Robbauthor=C.+Sheldonauthor=S.+Stokesauthor=D.+Morgan&title=Identification%2C+optimization%2C+and+pharmacology+of+acylurea+GHS-R1a+inverse+agonists&doi=10.1021%2Fjm500610n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm500610n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500610n%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DBowker%26aufirst%3DS.%2BS.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavies%26aufirst%3DR.%2BD.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DFenwick%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%2BE.%26aulast%3DNewcombe%26aufirst%3DN.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DPointon%26aufirst%3DH.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSheldon%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DD.%26atitle%3DIdentification%252C%2520optimization%252C%2520and%2520pharmacology%2520of%2520acylurea%2520GHS-R1a%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6128%26epage%3D6140%26doi%3D10.1021%2Fjm500610n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gabrielsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlfinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peletier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pehrson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsson, P.</span><span> </span><span class="NLM_article-title">Modeling and design of challenge tests: inflammatory and metabolic biomarker study examples</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/j.ejps.2014.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1016%2Fj.ejps.2014.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=25435491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=144-159&author=J.+Gabrielssonauthor=S.+Hjorthauthor=B.+Voggauthor=S.+Harlfingerauthor=P.+M.+Gutierrezauthor=L.+Peletierauthor=R.+Pehrsonauthor=P.+Davidsson&title=Modeling+and+design+of+challenge+tests%3A+inflammatory+and+metabolic+biomarker+study+examples&doi=10.1016%2Fj.ejps.2014.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples</span></div><div class="casAuthors">Gabrielsson, Johan; Hjorth, Stephan; Vogg, Barbara; Harlfinger, Stephanie; Gutierrez, Pablo Morentin; Peletier, Lambertus; Pehrson, Rikard; Davidsson, Pia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144-159</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Given the complexity of pharmacol. challenge expts., it is perhaps not surprising that design and anal., and in turn interpretation and communication of results from a quant. point of view, is often suboptimal.  Here we report an inventory of common designs sampled from anti-inflammatory, respiratory and metabolic disease drug discovery studies, all of which are based on animal models of disease involving pharmacol. and/or patho/physiol. interaction challenges.  The corresponding data are modeled and analyzed quant., the merits of the resp. approach discussed and inferences made with respect to future design improvements.  Although our anal. is limited to these disease model examples, the challenge approach is generally applicable to the vast majority of pharmacol. intervention studies.  In the present five Case Studies results from pharmacodynamic effect models from different therapeutic areas were explored and analyzed according to five typical designs.  Plasma exposures of test compds. were assayed by either liq. chromatog./mass spectrometry or ligand binding assays.  To describe how drug intervention can regulate diverse processes, turnover models of test compd.-challenger interaction, transduction processes, and biophase time courses were applied for biomarker response in eosinophil count, IL6 response, paw-swelling, TNFα response and glucose turnover in vivo.  Case Study 1 shows results from intratracheal administration of Sephadex, which is a glucocorticoid-sensitive model of airway inflammation in rats.  Eosinophils in bronchoalveolar fluid were obtained at different time points via destructive sampling and then regressed by the mixed-effects modeling.  A biophase function of the Sephadex time course was inferred from the modeled eosinophil time courses.  In Case Study 2, a mouse model showed that the time course of cytokine-induced IL1β challenge was altered with or without drug intervention.  Anakinra reversed the IL1β induced cytokine IL6 response in a dose-dependent manner.  This Case Study contained time courses of test compd. (drug), challenger (IL1β) and cytokine response (IL6), which resulted in high parameter precision.  Case Study 3 illustrates collagen-induced arthritis progression in the rat.  Swelling scores (based on severity of hind paw swelling) were used to describe arthritis progression after the challenge and the inhibitory effect of two doses of an orally administered test compd.  In Case Study 4, a cynomolgus monkey model for lipopolysaccharide LPS-induced TNFα synthesis and/or release was investigated.  This model provides integrated information on pharmacokinetics and in vivo potency of the test compds.  Case Study 5 contains data from an oral glucose tolerance test in rats, where the challenger is the same as the pharmacodynamic response biomarker (glucose).  It is therefore convenient to model the extra input of glucose simultaneously with baseline data and during intervention of a glucose-lowering compd. at different dose levels.  Typically time-series analyses of challenger- and biomarker-time data are necessary if an accurate and precise est. of the pharmacodynamic properties of a test compd. is sought.  Erosion of data, resulting in the single-point assessment of drug action after a challenge test, should generally be avoided.  This is particularly relevant for situations where one expects time-curve shifts, tolerance/rebound, impact of disease, or hormetic concn.-response relationships to occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEqwRzFXFhAbVg90H21EOLACvtfcHk0lgqGeYxcEX72w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWktrvL&md5=ce9db0cd96b7dc3c04c307b2b5d03083</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2014.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2014.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DGabrielsson%26aufirst%3DJ.%26aulast%3DHjorth%26aufirst%3DS.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DHarlfinger%26aufirst%3DS.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DPeletier%26aufirst%3DL.%26aulast%3DPehrson%26aufirst%3DR.%26aulast%3DDavidsson%26aufirst%3DP.%26atitle%3DModeling%2520and%2520design%2520of%2520challenge%2520tests%253A%2520inflammatory%2520and%2520metabolic%2520biomarker%2520study%2520examples%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D67%26spage%3D144%26epage%3D159%26doi%3D10.1016%2Fj.ejps.2014.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bowes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarolimek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitebread, S.</span><span> </span><span class="NLM_article-title">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1038/nrd3845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1038%2Fnrd3845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=23197038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=909-922&author=J.+Bowesauthor=A.+J.+Brownauthor=J.+Hamonauthor=W.+Jarolimekauthor=A.+Sridharauthor=G.+Waldronauthor=S.+Whitebread&title=Reducing+safety-related+drug+attrition%3A+the+use+of+in+vitro+pharmacological+profiling&doi=10.1038%2Fnrd3845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span></div><div class="casAuthors">Bowes, Joanne; Brown, Andrew J.; Hamon, Jacques; Jarolimek, Wolfgang; Sridhar, Arun; Waldron, Gareth; Whitebread, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-922</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In vitro pharmacol. profiling is increasingly being used earlier in the drug discovery process to identify undesirable off-target activity profiles that could hinder or halt the development of candidate drugs or even lead to market withdrawal if discovered after a drug is approved.  Here, for the first time, the rationale, strategies and methodologies for in vitro pharmacol. profiling at four major pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Novartis and Pfizer) are presented and illustrated with examples of their impact on the drug discovery process.  We hope that this will enable other companies and academic institutions to benefit from this knowledge and consider joining us in our collaborative knowledge sharing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVp3wnTONWrVg90H21EOLACvtfcHk0lgqGeYxcEX72w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ&md5=7559001563ef3febd610535b8f096a45</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3845%26sid%3Dliteratum%253Aachs%26aulast%3DBowes%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DHamon%26aufirst%3DJ.%26aulast%3DJarolimek%26aufirst%3DW.%26aulast%3DSridhar%26aufirst%3DA.%26aulast%3DWaldron%26aufirst%3DG.%26aulast%3DWhitebread%26aufirst%3DS.%26atitle%3DReducing%2520safety-related%2520drug%2520attrition%253A%2520the%2520use%2520of%2520in%2520vitro%2520pharmacological%2520profiling%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D909%26epage%3D922%26doi%3D10.1038%2Fnrd3845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Stone, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhayal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocklehurst, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenaghan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorhede Winzell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, N. G.</span><span> </span><span class="NLM_article-title">GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1182</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span><span class="refDoi"> DOI: 10.1007/s00125-014-3213-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1007%2Fs00125-014-3213-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=24663807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFyiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1182-1191&author=V.+M.+Stoneauthor=S.+Dhayalauthor=K.+J.+Brocklehurstauthor=C.+Lenaghanauthor=M.+Sorhede+Winzellauthor=M.+Hammarauthor=X.+Xuauthor=D.+M.+Smithauthor=N.+G.+Morgan&title=GPR120+%28FFAR4%29+is+preferentially+expressed+in+pancreatic+delta+cells+and+regulates+somatostatin+secretion+from+murine+islets+of+Langerhans&doi=10.1007%2Fs00125-014-3213-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans</span></div><div class="casAuthors">Stone, Virginia M.; Dhayal, Shalinee; Brocklehurst, Katy J.; Lenaghan, Carol; Sorhede Winzell, Maria; Hammar, Marten; Xu, Xiufeng; Smith, David M.; Morgan, Noel G.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1182-1191</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: The NEFA-responsive G-protein coupled receptor 120 (GPR120) has been implicated in the regulation of inflammation, in the control of incretin secretion and as a predisposing factor influencing the development of type 2 diabetes by regulation of islet cell apoptosis.  However, there is still considerable controversy about the tissue distribution of GPR120 and, in particular, it remains unclear which islet cell types express this mol.  In the present study, we have addressed this issue by constructing a Gpr120-knockout/β-galactosidase (LacZ) knock-in (KO/KI) mouse to examine the distribution and functional role of GPR120 in the endocrine pancreas.  Methods: A KO/KI mouse was generated in which exon 1 of the Gpr120 gene (also known as Ffar4) was replaced in frame by LacZ, thereby allowing for regulated expression of β-galactosidase under the control of the endogenous GPR120 promoter.  The distribution of GPR120 was inferred from expression studies detecting β-galactosidase activity and protein prodn.  Islet hormone secretion was measured from isolated mouse islets treated with selective GPR120 agonists.  Results: β-galactosidase activity was detected as a surrogate for GPR120 expression exclusively in a small population of islet endocrine cells located peripherally within the islet mantle.  Immunofluorescence anal. revealed co-localization with somatostatin suggesting that GPR120 is preferentially produced in islet delta cells.  In confirmation of this, glucose-induced somatostatin secretion was inhibited by a range of selective GPR120 agonists.  This response was lost in GPR120-knockout mice.  Conclusions/interpretation: The results imply that GPR120 is selectively present within the delta cells of murine islets and that it regulates somatostatin secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyFZRMy8eGLVg90H21EOLACvtfcHk0ljrdWyEEcJYcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFyiuro%253D&md5=bcff90e76b5b8ea1908376cd8c909c77</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00125-014-3213-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-014-3213-0%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DV.%2BM.%26aulast%3DDhayal%26aufirst%3DS.%26aulast%3DBrocklehurst%26aufirst%3DK.%2BJ.%26aulast%3DLenaghan%26aufirst%3DC.%26aulast%3DSorhede%2BWinzell%26aufirst%3DM.%26aulast%3DHammar%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DMorgan%26aufirst%3DN.%2BG.%26atitle%3DGPR120%2520%2528FFAR4%2529%2520is%2520preferentially%2520expressed%2520in%2520pancreatic%2520delta%2520cells%2520and%2520regulates%2520somatostatin%2520secretion%2520from%2520murine%2520islets%2520of%2520Langerhans%26jtitle%3DDiabetologia%26date%3D2014%26volume%3D57%26spage%3D1182%26epage%3D1191%26doi%3D10.1007%2Fs00125-014-3213-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Auguste, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hryhorczuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitout, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alquier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, S.</span><span> </span><span class="NLM_article-title">Central agonism of GPR120 acutely inhibits food intake and food reward and chronically suppresses anxiety-like behavior in mice</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">pyw014</span><span class="refDoi"> DOI: 10.1093/ijnp/pyw014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1093%2Fijnp%2Fpyw014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=26888796" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=pyw014&author=S.+Augusteauthor=A.+Fisetteauthor=M.+F.+Fernandesauthor=C.+Hryhorczukauthor=V.+Poitoutauthor=T.+Alquierauthor=S.+Fulton&title=Central+agonism+of+GPR120+acutely+inhibits+food+intake+and+food+reward+and+chronically+suppresses+anxiety-like+behavior+in+mice&doi=10.1093%2Fijnp%2Fpyw014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fijnp%2Fpyw014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fijnp%252Fpyw014%26sid%3Dliteratum%253Aachs%26aulast%3DAuguste%26aufirst%3DS.%26aulast%3DFisette%26aufirst%3DA.%26aulast%3DFernandes%26aufirst%3DM.%2BF.%26aulast%3DHryhorczuk%26aufirst%3DC.%26aulast%3DPoitout%26aufirst%3DV.%26aulast%3DAlquier%26aufirst%3DT.%26aulast%3DFulton%26aufirst%3DS.%26atitle%3DCentral%2520agonism%2520of%2520GPR120%2520acutely%2520inhibits%2520food%2520intake%2520and%2520food%2520reward%2520and%2520chronically%2520suppresses%2520anxiety-like%2520behavior%2520in%2520mice%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2016%26volume%3D19%26spage%3Dpyw014%26doi%3D10.1093%2Fijnp%2Fpyw014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Goldberg, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmitt, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deSchoolmeester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swales, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, M. J.</span><span> </span><span class="NLM_article-title">Optimization of brain penetrant 11beta-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese mice</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span><span class="refDoi"> DOI: 10.1021/jm4016729</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4016729" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=970-986&author=F.+W.+Goldbergauthor=A.+G.+Dossetterauthor=J.+S.+Scottauthor=G.+R.+Robbauthor=S.+Boydauthor=S.+D.+Groombridgeauthor=P.+D.+Kemmittauthor=T.+Sjogrenauthor=P.+M.+Gutierrezauthor=J.+deSchoolmeesterauthor=J.+G.+Swalesauthor=A.+V.+Turnbullauthor=M.+J.+Wild&title=Optimization+of+brain+penetrant+11beta-hydroxysteroid+dehydrogenase+type+I+inhibitors+and+in+vivo+testing+in+diet-induced+obese+mice&doi=10.1021%2Fjm4016729"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm4016729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4016729%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DF.%2BW.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DSjogren%26aufirst%3DT.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DdeSchoolmeester%26aufirst%3DJ.%26aulast%3DSwales%26aufirst%3DJ.%2BG.%26aulast%3DTurnbull%26aufirst%3DA.%2BV.%26aulast%3DWild%26aufirst%3DM.%2BJ.%26atitle%3DOptimization%2520of%2520brain%2520penetrant%252011beta-hydroxysteroid%2520dehydrogenase%2520type%2520I%2520inhibitors%2520and%2520in%2520vivo%2520testing%2520in%2520diet-induced%2520obese%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D970%26epage%3D986%26doi%3D10.1021%2Fjm4016729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':[],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gabriele Carullo, Sarah Mazzotta, Margarita Vega-Holm, Fernando Iglesias-Guerra, José Manuel Vega-Pérez, Francesca Aiello, <span class="NLM_string-name hlFld-ContribAuthor">Antonella Brizzi</span>. </span><span class="cited-content_cbyCitation_article-title">GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4312-4332. <a href="https://doi.org/10.1021/acs.jmedchem.0c01002" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGPR120%25252FFFAR4%252BPharmacology%25253A%252BFocus%252Bon%252BAgonists%252Bin%252BType%252B2%252BDiabetes%252BMellitus%252BDrug%252BDiscovery%26aulast%3DCarullo%26aufirst%3DGabriele%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12062020%26date%3D10042021%26volume%3D64%26issue%3D8%26spage%3D4312%26epage%3D4332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brandon
A. Wright, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Ardolino</span>. </span><span class="cited-content_cbyCitation_article-title">Surprising Reactivity in NiXantphos/Palladium-Catalyzed α-Arylation of Substituted Cyclopropyl Nitriles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4670-4679. <a href="https://doi.org/10.1021/acs.joc.8b02238" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02238%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSurprising%252BReactivity%252Bin%252BNiXantphos%25252FPalladium-Catalyzed%252B%2525CE%2525B1-Arylation%252Bof%252BSubstituted%252BCyclopropyl%252BNitriles%26aulast%3DWright%26aufirst%3DBrandon%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D29082018%26date%3D19112018%26date%3D09112018%26volume%3D84%26issue%3D8%26spage%3D4670%26epage%3D4679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangfang  Xu</span>, <span class="hlFld-ContribAuthor ">Pan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiuli  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Hou</span>, <span class="hlFld-ContribAuthor ">Lala  Qu</span>, <span class="hlFld-ContribAuthor ">Chaoran  Wang</span>, <span class="hlFld-ContribAuthor ">Jixia  Wang</span>, <span class="hlFld-ContribAuthor ">Yanfang  Liu</span>, <span class="hlFld-ContribAuthor ">Xinmiao  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and target-pathway deconvolution of FFA4 agonists with anti-diabetic activity from Arnebia euchroma (Royle) Johnst. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>163 </em>, 105173. <a href="https://doi.org/10.1016/j.phrs.2020.105173" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.105173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.105173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.105173%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DIdentification%252Band%252Btarget-pathway%252Bdeconvolution%252Bof%252BFFA4%252Bagonists%252Bwith%252Banti-diabetic%252Bactivity%252Bfrom%252BArnebia%252Beuchroma%252B%252528Royle%252529%252BJohnst%26aulast%3DXu%26aufirst%3DFangfang%26date%3D2021%26volume%3D163%26spage%3D105173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangfang  Xu</span>, <span class="hlFld-ContribAuthor ">Yaopeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Han  Zhou</span>, <span class="hlFld-ContribAuthor ">Chunzhi  Li</span>, <span class="hlFld-ContribAuthor ">Xiuli  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Hou</span>, <span class="hlFld-ContribAuthor ">Lala  Qu</span>, <span class="hlFld-ContribAuthor ">Lai  Wei</span>, <span class="hlFld-ContribAuthor ">Jixia  Wang</span>, <span class="hlFld-ContribAuthor ">Yanfang  Liu</span>, <span class="hlFld-ContribAuthor ">Xinmiao  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (24)
                                     , 127650. <a href="https://doi.org/10.1016/j.bmcl.2020.127650" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127650%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B3-%2525284-%252528phenoxymethyl%252529phenyl%252529propanoic%252Bacid%252Band%252BN-phenylbenzenesulfonamide%252Bderivatives%252Bas%252BFFA4%252Bagonists%26aulast%3DXu%26aufirst%3DFangfang%26date%3D2020%26volume%3D30%26issue%3D24%26spage%3D127650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunlei  Wang</span>, <span class="hlFld-ContribAuthor ">Yanmei  Liu</span>, <span class="hlFld-ContribAuthor ">Yuan  Pan</span>, <span class="hlFld-ContribAuthor ">Hui  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of GSK-137647A, the first non-carboxylic FFA4 agonist, on the osteogenic and adipogenic differentiation of bone mesenchymal stem cells in
              db/db
              mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2020,</strong> <em>72 </em>
                                    (3)
                                     , 461-469. <a href="https://doi.org/10.1111/jphp.13217" title="DOI URL">https://doi.org/10.1111/jphp.13217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jphp.13217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjphp.13217%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DEffect%252Bof%252BGSK-137647A%25252C%252Bthe%252Bfirst%252Bnon-carboxylic%252BFFA4%252Bagonist%25252C%252Bon%252Bthe%252Bosteogenic%252Band%252Badipogenic%252Bdifferentiation%252Bof%252Bbone%252Bmesenchymal%252Bstem%252Bcells%252Bin%252Bdb%25252Fdb%252Bmice%26aulast%3DWang%26aufirst%3DChunlei%26date%3D2020%26date%3D2019%26volume%3D72%26issue%3D3%26spage%3D461%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-Hua  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Meng  Sun</span>, <span class="hlFld-ContribAuthor ">Jin-Jing  Qin</span>, <span class="hlFld-ContribAuthor ">Zhi-Yong  Tan</span>, <span class="hlFld-ContribAuthor ">Wen-Biao  Wang</span>, <span class="hlFld-ContribAuthor ">Yao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent strategy for the chemoselective synthesis of N-Arylbenzimidazoles and N-Arylindazoles from arylamino oximes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (8)
                                     , 130945. <a href="https://doi.org/10.1016/j.tet.2020.130945" title="DOI URL">https://doi.org/10.1016/j.tet.2020.130945</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.130945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.130945%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDivergent%252Bstrategy%252Bfor%252Bthe%252Bchemoselective%252Bsynthesis%252Bof%252BN-Arylbenzimidazoles%252Band%252BN-Arylindazoles%252Bfrom%252Barylamino%252Boximes%26aulast%3DLi%26aufirst%3DZhen-Hua%26date%3D2020%26volume%3D76%26issue%3D8%26spage%3D130945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janos  Sapi</span>, <span class="hlFld-ContribAuthor ">Stéphane  Gérard</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems: Three Heteroatoms 2:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00021-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00021-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00021-4%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%25253A%252BThree%252BHeteroatoms%252B2%25253A1%26aulast%3DSapi%26aufirst%3DJanos%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathilde  Pauton</span>, <span class="hlFld-ContribAuthor ">Raphaël  Gillet</span>, <span class="hlFld-ContribAuthor ">Catherine  Aubert</span>, <span class="hlFld-ContribAuthor ">Guillaume  Bluet</span>, <span class="hlFld-ContribAuthor ">Florence  Gruss-Leleu</span>, <span class="hlFld-ContribAuthor ">Sébastien  Roy</span>, <span class="hlFld-ContribAuthor ">Cécile  Perrio</span>. </span><span class="cited-content_cbyCitation_article-title">The first radiosynthesis of 2-amino-5-[
              18
              F]fluoropyridines
              via
              a “minimalist” radiofluorination/palladium-catalyzed amination sequence from anisyl(2-bromopyridinyl)iodonium triflate. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (26)
                                     , 6359-6363. <a href="https://doi.org/10.1039/C9OB01187K" title="DOI URL">https://doi.org/10.1039/C9OB01187K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01187K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01187K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Bfirst%252Bradiosynthesis%252Bof%252B2-amino-5-%25255B%252B18%252BF%25255Dfluoropyridines%252Bvia%252Ba%252B%2525E2%252580%25259Cminimalist%2525E2%252580%25259D%252Bradiofluorination%25252Fpalladium-catalyzed%252Bamination%252Bsequence%252Bfrom%252Banisyl%2525282-bromopyridinyl%252529iodonium%252Btriflate%26aulast%3DPauton%26aufirst%3DMathilde%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D26%26spage%3D6359%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yantao  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Methylation: A Guide for Selecting Methylation Reagents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (14)
                                     , 3405-3439. <a href="https://doi.org/10.1002/chem.201803642" title="DOI URL">https://doi.org/10.1002/chem.201803642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201803642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201803642%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DRecent%252BAdvances%252Bin%252BMethylation%25253A%252BA%252BGuide%252Bfor%252BSelecting%252BMethylation%252BReagents%26aulast%3DChen%26aufirst%3DYantao%26date%3D2019%26date%3D2018%26volume%3D25%26issue%3D14%26spage%3D3405%26epage%3D3439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Soon  Im</span>. </span><span class="cited-content_cbyCitation_article-title">FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Aspects of Medicine</span><span> <strong>2018,</strong> <em>64 </em>, 92-108. <a href="https://doi.org/10.1016/j.mam.2017.09.001" title="DOI URL">https://doi.org/10.1016/j.mam.2017.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mam.2017.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mam.2017.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Aspects%2520of%2520Medicine%26atitle%3DFFA4%252B%252528GPR120%252529%252Bas%252Ba%252Bfatty%252Bacid%252Bsensor%252Binvolved%252Bin%252Bappetite%252Bcontrol%25252C%252Binsulin%252Bsensitivity%252Band%252Binflammation%252Bregulation%26aulast%3DIm%26aufirst%3DDong-Soon%26date%3D2018%26volume%3D64%26spage%3D92%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongbing  Xie</span>, <span class="hlFld-ContribAuthor ">Linbi  Zhou</span>, <span class="hlFld-ContribAuthor ">Hongbin  Cao</span>, <span class="hlFld-ContribAuthor ">Chenming  Liu</span>, <span class="hlFld-ContribAuthor ">Qingzhen  Han</span>, <span class="hlFld-ContribAuthor ">Weiwei  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">Reaction condition optimization and degradation pathway in wet oxidation of benzopyrazole revealed by computational and experimental approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hazardous Materials</span><span> <strong>2018,</strong> <em>351 </em>, 169-176. <a href="https://doi.org/10.1016/j.jhazmat.2018.02.042" title="DOI URL">https://doi.org/10.1016/j.jhazmat.2018.02.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jhazmat.2018.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jhazmat.2018.02.042%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hazardous%2520Materials%26atitle%3DReaction%252Bcondition%252Boptimization%252Band%252Bdegradation%252Bpathway%252Bin%252Bwet%252Boxidation%252Bof%252Bbenzopyrazole%252Brevealed%252Bby%252Bcomputational%252Band%252Bexperimental%252Bapproaches%26aulast%3DXie%26aufirst%3DYongbing%26date%3D2018%26volume%3D351%26spage%3D169%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linbi  Zhou</span>, <span class="hlFld-ContribAuthor ">Hongbin  Cao</span>, <span class="hlFld-ContribAuthor ">Claude  Descorme</span>, <span class="hlFld-ContribAuthor ">He  Zhao</span>, <span class="hlFld-ContribAuthor ">Yongbing  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Wet air oxidation of indole, benzopyrazole, and benzotriazole: Effects of operating conditions and reaction mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Chemical Engineering Journal</span><span> <strong>2018,</strong> <em>338 </em>, 496-503. <a href="https://doi.org/10.1016/j.cej.2018.01.070" title="DOI URL">https://doi.org/10.1016/j.cej.2018.01.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cej.2018.01.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cej.2018.01.070%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Engineering%2520Journal%26atitle%3DWet%252Bair%252Boxidation%252Bof%252Bindole%25252C%252Bbenzopyrazole%25252C%252Band%252Bbenzotriazole%25253A%252BEffects%252Bof%252Boperating%252Bconditions%252Band%252Breaction%252Bmechanisms%26aulast%3DZhou%26aufirst%3DLinbi%26date%3D2018%26volume%3D338%26spage%3D496%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael P.  Winters</span>, <span class="hlFld-ContribAuthor ">Zhihua  Sui</span>, <span class="hlFld-ContribAuthor ">Mark  Wall</span>, <span class="hlFld-ContribAuthor ">Yuanping  Wang</span>, <span class="hlFld-ContribAuthor ">Joseph  Gunnet</span>, <span class="hlFld-ContribAuthor ">James  Leonard</span>, <span class="hlFld-ContribAuthor ">Hong  Hua</span>, <span class="hlFld-ContribAuthor ">Wen  Yan</span>, <span class="hlFld-ContribAuthor ">Arthur  Suckow</span>, <span class="hlFld-ContribAuthor ">Austin  Bell</span>, <span class="hlFld-ContribAuthor ">Wilmelenne  Clapper</span>, <span class="hlFld-ContribAuthor ">Celia  Jenkinson</span>, <span class="hlFld-ContribAuthor ">Peter  Haug</span>, <span class="hlFld-ContribAuthor ">Tatiana  Koudriakova</span>, <span class="hlFld-ContribAuthor ">Norman  Huebert</span>, <span class="hlFld-ContribAuthor ">William V.  Murray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N -arylpyrroles as agonists of GPR120 for the treatment of type II diabetes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (5)
                                     , 841-846. <a href="https://doi.org/10.1016/j.bmcl.2018.02.013" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.02.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.02.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN%252B-arylpyrroles%252Bas%252Bagonists%252Bof%252BGPR120%252Bfor%252Bthe%252Btreatment%252Bof%252Btype%252BII%252Bdiabetes%26aulast%3DWinters%26aufirst%3DMichael%2BP.%26date%3D2018%26volume%3D28%26issue%3D5%26spage%3D841%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Xue  Xu</span>, <span class="hlFld-ContribAuthor ">Gang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoting  Fu</span>, <span class="hlFld-ContribAuthor ">Yanzhi  Liu</span>, <span class="hlFld-ContribAuthor ">Yufeng  Feng</span>, <span class="hlFld-ContribAuthor ">Mingyan  Wang</span>, <span class="hlFld-ContribAuthor ">Yunting  Ouyang</span>, <span class="hlFld-ContribAuthor ">Jing  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Improving metabolic stability with deuterium: The discovery of GPU-028, a potent free fatty acid receptor 4 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6647-6652. <a href="https://doi.org/10.1016/j.bmc.2017.10.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DImproving%252Bmetabolic%252Bstability%252Bwith%252Bdeuterium%25253A%252BThe%252Bdiscovery%252Bof%252BGPU-028%25252C%252Ba%252Bpotent%252Bfree%252Bfatty%252Bacid%252Breceptor%252B4%252Bagonists%26aulast%3DLi%26aufirst%3DZheng%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6647%26epage%3D6652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Runisha  Moodaley</span>, <span class="hlFld-ContribAuthor ">David M  Smith</span>, <span class="hlFld-ContribAuthor ">Iain R  Tough</span>, <span class="hlFld-ContribAuthor ">Marcus  Schindler</span>, <span class="hlFld-ContribAuthor ">Helen M  Cox</span>. </span><span class="cited-content_cbyCitation_article-title">Agonism of free fatty acid receptors 1 and 4 generates peptide YY-mediated inhibitory responses in mouse colon. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2017,</strong> <em>174 </em>
                                    (23)
                                     , 4508-4522. <a href="https://doi.org/10.1111/bph.14054" title="DOI URL">https://doi.org/10.1111/bph.14054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14054%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DAgonism%252Bof%252Bfree%252Bfatty%252Bacid%252Breceptors%252B1%252Band%252B4%252Bgenerates%252Bpeptide%252BYY-mediated%252Binhibitory%252Bresponses%252Bin%252Bmouse%252Bcolon%26aulast%3DMoodaley%26aufirst%3DRunisha%26date%3D2017%26date%3D2017%26volume%3D174%26issue%3D23%26spage%3D4508%26epage%3D4522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Scaffold hop strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of (<i>S</i>,<i>S</i>)-Indazole-6-phenylcyclopropylcarboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) RO<sub>2</sub>CCH<sub>2</sub>P(O) (OEt)<sub>2</sub>, NaH, THF, R1 = H, 72%, R1 = F, 95%; (ii) I(OSMe<sub>3</sub>), <sup><i>t</i></sup>BuOK, DMSO, R1 = H, 70%, R1 = F, 61%. (iii) R1 = H, Et ester: LiOH, H<sub>2</sub>O/THF, 93%. R1 = F, <sup><i>t</i></sup>Bu ester: TFA, DCM, 99%. (iv) Oxalyl chloride, NEt<sub>3</sub>, (<i>S</i>)-4-isopropyloxazolidin-2-one, DCM, separate diastereomers, R1 = H, 27%, R1 = F, 34%; (v) LiOH, H<sub>2</sub>O<sub>2</sub>, H<sub>2</sub>O/THF, R1 = H, 66%, R1 = F, 85%; (vi) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bis(1,3,2-dioxaborolane), Pd(dppf)Cl<sub>2</sub>, KOAc, 1,4-dioxane, R1 = H/F, 100%; (vii) Pd-118, K<sub>3</sub>PO<sub>4</sub>, H<sub>2</sub>O/MeCN, 100 °C, microwave, 19–70%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Perspective view of crystal structure of (<i>S</i>,<i>S</i>)-<b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthesis of 6-Br-indazole Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) oxalyl dichloride, DCM, then MeONHMe·HCl, NEt<sub>3</sub>, 76%; (ii) MeMgBr, THF, 92%; (iii) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, THF, 80 °C, 86%; (iv) Cu(OAc)<sub>2</sub>, pyridine, DCM, R2 = H/R4 = Me 46%, R2 = F/R4 = Me 61%; (v) CuBr, K<sub>2</sub>CO<sub>3</sub>, <i>N</i>1,<i>N</i>2-dimethylethane-1,2-diamine, 1,4-dioxane, 105 °C, R2 = H/R4 = H, 50%; (vi) oxalyl dichloride, DCM, then MeONHMe·HCl, NEt<sub>3</sub>, 79%; (vii) MeMgBr, THF, 99%; (viii) N<sub>2</sub>H<sub>4</sub>.H<sub>2</sub>O, Et<sub>3</sub>N, <sup><i>i</i></sup>PrOH, 69%; (ix) CuBr, K<sub>2</sub>CO<sub>3</sub>, <i>N</i>1,<i>N</i>2-dimethylethane-1,2-diamine, 1,4-dioxane, 105 °C, B = N, 44%, B = CH, 81%; (x) N<sub>2</sub>H<sub>4</sub>.H<sub>2</sub>O, H<sub>2</sub>O/THF, R2 = H, 98%, R2 = F, 100%; (xi) EtOCOCl, H<sub>2</sub>O/pyridine, R2 = H, 73%, R2 = F, 86%; (xii) <sup><i>i</i></sup>PrO<sub>2</sub>N = NCO<sub>2</sub><sup><i>i</i></sup>Pr, Ph<sub>2</sub>Ppyridine or Ph<sub>3</sub>P, MeOH, THF, R2 = H, 51%, R2 = F, 61%; (xiii) KOH, H<sub>2</sub>O/EtOH, R2 = H, 90%, R2 = F, 91%; (xiv) conditions iv or v, 19–65%.</p></p></figure><figure data-id="fig2a" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glucose lowering efficacy of <b>33</b> and <b>34</b> in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig2a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Glucose lowering efficacy of <b>33</b> and <b>34</b> in WT/KO GPR120 mice at 100 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/medium/jm-2017-002105_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Blood and brain exposure of <b>33</b> and <b>34</b> in WT/KO GP R120 mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.7b00210/20170407/images/large/jm-2017-002105_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00210&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53453" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53453" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Information about T2D can be found in the<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">, </span><span class="NLM_edition">7</span>th edition of the IDF Diabetes Atlas at the Web site of the International Diabetes Federation. <a href="http://www.diabetesatlas.org" class="extLink">http://www.diabetesatlas.org</a> (accessed February 6, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Information+about+T2D+can+be+found+in+the+2015%2C+7th+edition+of+the+IDF+Diabetes+Atlas+at+the+Web+site+of+the+International+Diabetes+Federation.+http%3A%2F%2Fwww.diabetesatlas.org+%28accessed+February+6%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Boden, G.</span><span> </span><span class="NLM_article-title">Obesity and free fatty acids</span> <span class="citation_source-journal">Endocrinol. Metab. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1016/j.ecl.2008.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1016%2Fj.ecl.2008.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=18775356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kqs77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=635-646&author=G.+Boden&title=Obesity+and+free+fatty+acids&doi=10.1016%2Fj.ecl.2008.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Obesity and free fatty acids</span></div><div class="casAuthors">Boden, Guenther</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology and Metabolism Clinics of North America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-646</span>CODEN:
                <span class="NLM_cas:coden">ECNAER</span>;
        ISSN:<span class="NLM_cas:issn">0889-8529</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Plasma free fatty acid (FFA) levels are elevated in obesity.  FFAs cause insulin resistance in all major insulin target organs (skeletal muscle, liver, endothelial cells) and have emerged as a major link between obesity, the development of the metabolic syndrome, and atherosclerotic vascular disease.  FFAs also produce low-grade inflammation in skeletal muscle, liver, and fat, which may contribute to cardiovascular events.  The challenges for the future include the prevention or correction of obesity and elevated plasma FFA levels through methods that include decreased caloric intake and increased caloric expenditure, the development of methods to measure FFAs in small blood samples, and the development of efficient pharmacol. approaches to normalize increased plasma FFA levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro2Xj8y9_0k7Vg90H21EOLACvtfcHk0ljyJGnuU2dUuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kqs77J&md5=72e07cceef6f94028f5228be35dae928</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ecl.2008.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ecl.2008.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DBoden%26aufirst%3DG.%26atitle%3DObesity%2520and%2520free%2520fatty%2520acids%26jtitle%3DEndocrinol.%2520Metab.%2520Clin.%2520North%2520Am.%26date%3D2008%26volume%3D37%26spage%3D635%26epage%3D646%26doi%3D10.1016%2Fj.ecl.2008.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumaya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span> </span><span class="NLM_article-title">Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1038/nm1168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1038%2Fnm1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=15619630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A280%3ADC%252BD2M7gsFKqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=90-94&author=A.+Hirasawaauthor=K.+Tsumayaauthor=T.+Awajiauthor=S.+Katsumaauthor=T.+Adachiauthor=M.+Yamadaauthor=Y.+Sugimotoauthor=S.+Miyazakiauthor=G.+Tsujimoto&title=Free+fatty+acids+regulate+gut+incretin+glucagon-like+peptide-1+secretion+through+GPR120&doi=10.1038%2Fnm1168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120</span></div><div class="casAuthors">Hirasawa Akira; Tsumaya Keiko; Awaji Takeo; Katsuma Susumu; Adachi Tetsuya; Yamada Masateru; Sugimoto Yukihiko; Miyazaki Shunichi; Tsujimoto Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Nature medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-4</span>
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    </div><div class="casAbstract">Diabetes, a disease in which the body does not produce or use insulin properly, is a serious global health problem.  Gut polypeptides secreted in response to food intake, such as glucagon-like peptide-1 (GLP-1), are potent incretin hormones that enhance the glucose-dependent secretion of insulin from pancreatic beta cells.  Free fatty acids (FFAs) provide an important energy source and also act as signaling molecules in various cellular processes, including the secretion of gut incretin peptides.  Here we show that a G-protein-coupled receptor, GPR120, which is abundantly expressed in intestine, functions as a receptor for unsaturated long-chain FFAs.  Furthermore, we show that the stimulation of GPR120 by FFAs promotes the secretion of GLP-1 in vitro and in vivo, and increases circulating insulin.  Because GLP-1 is the most potent insulinotropic incretin, our results indicate that GPR120-mediated GLP-1 secretion induced by dietary FFAs is important in the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxB79dLZc5Pg5nADWVYHg1fW6udTcc2eYQiG81lGifCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7gsFKqtw%253D%253D&md5=b66c76979857f0da440019ba5a06a007</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1168%26sid%3Dliteratum%253Aachs%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DTsumaya%26aufirst%3DK.%26aulast%3DAwaji%26aufirst%3DT.%26aulast%3DKatsuma%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DFree%2520fatty%2520acids%2520regulate%2520gut%2520incretin%2520glucagon-like%2520peptide-1%2520secretion%2520through%2520GPR120%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D90%26epage%3D94%26doi%3D10.1038%2Fnm1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ichimura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain-Godefroy, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnefond, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yengo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leloire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besnard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoeur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivequin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffeis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvelin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pigeyre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caiazzo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Hul, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gaal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy-Marchal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouskas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouvatsi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebebrand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherag, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolowczuk, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froguel, P.</span><span> </span><span class="NLM_article-title">Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1038/nature10798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1038%2Fnature10798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=22343897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=350-354&author=A.+Ichimuraauthor=A.+Hirasawaauthor=O.+Poulain-Godefroyauthor=A.+Bonnefondauthor=T.+Haraauthor=L.+Yengoauthor=I.+Kimuraauthor=A.+Leloireauthor=N.+Liuauthor=K.+Iidaauthor=H.+Choquetauthor=P.+Besnardauthor=C.+Lecoeurauthor=S.+Vivequinauthor=K.+Ayukawaauthor=M.+Takeuchiauthor=K.+Ozawaauthor=M.+Tauberauthor=C.+Maffeisauthor=A.+Morandiauthor=R.+Buzzettiauthor=P.+Elliottauthor=A.+Poutaauthor=M.+R.+Jarvelinauthor=A.+Kornerauthor=W.+Kiessauthor=M.+Pigeyreauthor=R.+Caiazzoauthor=W.+Van+Hulauthor=L.+Van+Gaalauthor=F.+Horberauthor=B.+Balkauauthor=C.+Levy-Marchalauthor=K.+Rouskasauthor=A.+Kouvatsiauthor=J.+Hebebrandauthor=A.+Hinneyauthor=A.+Scheragauthor=F.+Pattouauthor=D.+Meyreauthor=T.+Koshimizuauthor=I.+Wolowczukauthor=G.+Tsujimotoauthor=P.+Froguel&title=Dysfunction+of+lipid+sensor+GPR120+leads+to+obesity+in+both+mouse+and+human&doi=10.1038%2Fnature10798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human</span></div><div class="casAuthors">Ichimura, Atsuhiko; Hirasawa, Akira; Poulain-Godefroy, Odile; Bonnefond, Amelie; Hara, Takafumi; Yengo, Loic; Kimura, Ikuo; Leloire, Audrey; Liu, Ning; Iida, Keiko; Choquet, Helene; Besnard, Philippe; Lecoeur, Cecile; Vivequin, Sidonie; Ayukawa, Kumiko; Takeuchi, Masato; Ozawa, Kentaro; Tauber, Maithe; Maffeis, Claudio; Morandi, Anita; Buzzetti, Raffaella; Elliott, Paul; Pouta, Anneli; Jarvelin, Marjo-Riitta; Koerner, Antje; Kiess, Wieland; Pigeyre, Marie; Caiazzo, Roberto; Van Hul, Wim; Van Gaal, Luc; Horber, Fritz; Balkau, Beverley; Levy-Marchal, Claire; Rouskas, Konstantinos; Kouvatsi, Anastasia; Hebebrand, Johannes; Hinney, Anke; Scherag, Andre; Pattou, Francois; Meyre, David; Koshimizu, Taka-aki; Wolowczuk, Isabelle; Tsujimoto, Gozoh; Froguel, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7389</span>),
    <span class="NLM_cas:pages">350-354</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Free fatty acids provide an important energy source as nutrients, and act as signaling mols. in various cellular processes.  Several G-protein-coupled receptors have been identified as free-fatty-acid receptors important in physiol. as well as in several diseases.  GPR120 (also known as O3FAR1) functions as a receptor for unsatd. long-chain free fatty acids and has a crit. role in various physiol. homeostasis mechanisms such as adipogenesis, regulation of appetite and food preference.  Here we show that GPR120-deficient mice fed a high-fat diet develop obesity, glucose intolerance and fatty liver with decreased adipocyte differentiation and lipogenesis and enhanced hepatic lipogenesis.  Insulin resistance in such mice is assocd. with reduced insulin signaling and enhanced inflammation in adipose tissue.  In human, we show that GPR120 expression in adipose tissue is significantly higher in obese individuals than in lean controls.  GPR120 exon sequencing in obese subjects reveals a deleterious non-synonymous mutation (p.R270H) that inhibits GPR120 signaling activity.  Furthermore, the p.R270H variant increases the risk of obesity in European populations.  Overall, this study demonstrates that the lipid sensor GPR120 has a key role in sensing dietary fat and, therefore, in the control of energy balance in both humans and rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpszhNO66GQ67Vg90H21EOLACvtfcHk0ljyJGnuU2dUuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKru74%253D&md5=6e7377600220e33948bee0b0b0e8ead3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature10798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10798%26sid%3Dliteratum%253Aachs%26aulast%3DIchimura%26aufirst%3DA.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DPoulain-Godefroy%26aufirst%3DO.%26aulast%3DBonnefond%26aufirst%3DA.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DYengo%26aufirst%3DL.%26aulast%3DKimura%26aufirst%3DI.%26aulast%3DLeloire%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DIida%26aufirst%3DK.%26aulast%3DChoquet%26aufirst%3DH.%26aulast%3DBesnard%26aufirst%3DP.%26aulast%3DLecoeur%26aufirst%3DC.%26aulast%3DVivequin%26aufirst%3DS.%26aulast%3DAyukawa%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOzawa%26aufirst%3DK.%26aulast%3DTauber%26aufirst%3DM.%26aulast%3DMaffeis%26aufirst%3DC.%26aulast%3DMorandi%26aufirst%3DA.%26aulast%3DBuzzetti%26aufirst%3DR.%26aulast%3DElliott%26aufirst%3DP.%26aulast%3DPouta%26aufirst%3DA.%26aulast%3DJarvelin%26aufirst%3DM.%2BR.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DKiess%26aufirst%3DW.%26aulast%3DPigeyre%26aufirst%3DM.%26aulast%3DCaiazzo%26aufirst%3DR.%26aulast%3DVan%2BHul%26aufirst%3DW.%26aulast%3DVan%2BGaal%26aufirst%3DL.%26aulast%3DHorber%26aufirst%3DF.%26aulast%3DBalkau%26aufirst%3DB.%26aulast%3DLevy-Marchal%26aufirst%3DC.%26aulast%3DRouskas%26aufirst%3DK.%26aulast%3DKouvatsi%26aufirst%3DA.%26aulast%3DHebebrand%26aufirst%3DJ.%26aulast%3DHinney%26aufirst%3DA.%26aulast%3DScherag%26aufirst%3DA.%26aulast%3DPattou%26aufirst%3DF.%26aulast%3DMeyre%26aufirst%3DD.%26aulast%3DKoshimizu%26aufirst%3DT.%26aulast%3DWolowczuk%26aufirst%3DI.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DFroguel%26aufirst%3DP.%26atitle%3DDysfunction%2520of%2520lipid%2520sensor%2520GPR120%2520leads%2520to%2520obesity%2520in%2520both%2520mouse%2520and%2520human%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D350%26epage%3D354%26doi%3D10.1038%2Fnature10798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walenta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagakos, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessentheiner, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powels, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armando, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quehenberger, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNelis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogner-Strauss, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span> </span><span class="NLM_article-title">A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span><span class="refDoi"> DOI: 10.1038/nm.3614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1038%2Fnm.3614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=24997608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=942-947&author=D.+Y.+Ohauthor=E.+Walentaauthor=T.+E.+Akiyamaauthor=W.+S.+Lagakosauthor=D.+Lackeyauthor=A.+R.+Pessentheinerauthor=R.+Sasikauthor=N.+Hahauthor=T.+J.+Chiauthor=J.+M.+Coxauthor=M.+A.+Powelsauthor=J.+Di+Salvoauthor=C.+Sinzauthor=S.+M.+Watkinsauthor=A.+M.+Armandoauthor=H.+Chungauthor=R.+M.+Evansauthor=O.+Quehenbergerauthor=J.+McNelisauthor=J.+G.+Bogner-Straussauthor=J.+M.+Olefsky&title=A+Gpr120-selective+agonist+improves+insulin+resistance+and+chronic+inflammation+in+obese+mice&doi=10.1038%2Fnm.3614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice</span></div><div class="casAuthors">Oh, Da Young; Walenta, Evelyn; Akiyama, Taro E.; Lagakos, William S.; Lackey, Denise; Pessentheiner, Ariane R.; Sasik, Roman; Hah, Nasun; Chi, Tyler J.; Cox, Jason M.; Powels, Mary Ann; Di Salvo, Jerry; Sinz, Christopher; Watkins, Steven M.; Armando, Aaron M.; Chung, Heekyung; Evans, Ronald M.; Quehenberger, Oswald; McNelis, Joanne; Bogner-Strauss, Juliane G.; Olefsky, Jerrold M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">942-947</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It is well known that the ω-3 fatty acids (ω-3-FAs; also known as n-3 fatty acids) can exert potent anti-inflammatory effects.  Commonly consumed as fish products, dietary supplements and pharmaceuticals, ω-3-FAs have a no. of health benefits ascribed to them, including reduced plasma triglyceride levels, amelioration of atherosclerosis and increased insulin sensitivity.  We reported that Gpr120 is the functional receptor for these fatty acids and that ω-3-FAs produce robust anti-inflammatory, insulin-sensitizing effects, both in vivo and in vitro, in a Gpr120-dependent manner.  Indeed, genetic variants that predispose to obesity and diabetes have been described in the gene encoding GPR120 in humans (FFAR4).  However, the amt. of fish oils that would have to be consumed to sustain chronic agonism of Gpr120 is too high to be practical, and, thus, a high-affinity small-mol. Gpr120 agonist would be of potential clin. benefit.  Accordingly, Gpr120 is a widely studied drug discovery target within the pharmaceutical industry.  Gpr40 is another lipid-sensing G protein-coupled receptor, and it has been difficult to identify compds. with a high degree of selectivity for Gpr120 over Gpr40 (ref. 11).  Here we report that a selective high-affinity, orally available, small-mol. Gpr120 agonist (cpdA) exerts potent anti-inflammatory effects on macrophages in vitro and in obese mice in vivo.  Gpr120 agonist treatment of high-fat diet-fed obese mice causes improved glucose tolerance, decreased hyperinsulinemia, increased insulin sensitivity and decreased hepatic steatosis.  This suggests that Gpr120 agonists could become new insulin-sensitizing drugs for the treatment of type 2 diabetes and other human insulin-resistant states in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1mbdTckjd-bVg90H21EOLACvtfcHk0lg3HM0lr2EZVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrL&md5=293d3048bb7840f98c2ae6772fd37087</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnm.3614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3614%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DWalenta%26aufirst%3DE.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DLagakos%26aufirst%3DW.%2BS.%26aulast%3DLackey%26aufirst%3DD.%26aulast%3DPessentheiner%26aufirst%3DA.%2BR.%26aulast%3DSasik%26aufirst%3DR.%26aulast%3DHah%26aufirst%3DN.%26aulast%3DChi%26aufirst%3DT.%2BJ.%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DPowels%26aufirst%3DM.%2BA.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DSinz%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DS.%2BM.%26aulast%3DArmando%26aufirst%3DA.%2BM.%26aulast%3DChung%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DQuehenberger%26aufirst%3DO.%26aulast%3DMcNelis%26aufirst%3DJ.%26aulast%3DBogner-Strauss%26aufirst%3DJ.%2BG.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Gpr120-selective%2520agonist%2520improves%2520insulin%2520resistance%2520and%2520chronic%2520inflammation%2520in%2520obese%2520mice%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D942%26epage%3D947%26doi%3D10.1038%2Fnm.3614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cornall, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathai, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hryciw, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAinch, A. J.</span><span> </span><span class="NLM_article-title">GPR120 agonism as a countermeasure against metabolic diseases</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span><span class="refDoi"> DOI: 10.1016/j.drudis.2013.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1016%2Fj.drudis.2013.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=24315954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWjt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=670-679&author=L.+M.+Cornallauthor=M.+L.+Mathaiauthor=D.+H.+Hryciwauthor=A.+J.+McAinch&title=GPR120+agonism+as+a+countermeasure+against+metabolic+diseases&doi=10.1016%2Fj.drudis.2013.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">GPR120 agonism as a countermeasure against metabolic diseases</span></div><div class="casAuthors">Cornall, Lauren M.; Mathai, Michael L.; Hryciw, Deanne H.; McAinch, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">670-679</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Obesity, type 2 diabetes mellitus and cardiovascular disease are at epidemic proportions in developed nations globally, representing major causes of ill-health and premature death.  The search for drug targets to counter the growing prevalence of metabolic diseases has uncovered G-protein-coupled receptor 120 (GPR120).  GPR120 agonism has been shown to improve inflammation and metabolic health on a systemic level via regulation of adiposity, gastrointestinal peptide secretion, taste preference and glucose homeostasis.  Therefore, GPR120 agonists present as a novel therapeutic option that could be exploited for the treatment of impaired metabolic health.  This review summarizes the current knowledge of GPR120 functionality and the potential applications of GPR120-specific agonists for the treatment of disease states such as obesity, type 2 diabetes mellitus and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAoRwGzdTNFrVg90H21EOLACvtfcHk0lg3HM0lr2EZVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWjt73J&md5=c474d70c237fb2be47ee2cec55dfa7d0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DCornall%26aufirst%3DL.%2BM.%26aulast%3DMathai%26aufirst%3DM.%2BL.%26aulast%3DHryciw%26aufirst%3DD.%2BH.%26aulast%3DMcAinch%26aufirst%3DA.%2BJ.%26atitle%3DGPR120%2520agonism%2520as%2520a%2520countermeasure%2520against%2520metabolic%2520diseases%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D670%26epage%3D679%26doi%3D10.1016%2Fj.drudis.2013.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Yu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Clinicopathological significance and potential drug target of RUNX3 in breast cancer</span> <span class="citation_source-journal">Drug Des., Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2430</span><span class="refDoi"> DOI: 10.2147/DDDT.S71815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.2147%2FDDDT.S71815" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=25525332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFOitbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=2423-2430&author=Y.+Y.+Yuauthor=C.+Chenauthor=F.+F.+Kongauthor=W.+Zhang&title=Clinicopathological+significance+and+potential+drug+target+of+RUNX3+in+breast+cancer&doi=10.2147%2FDDDT.S71815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Clinicopathological significance and potential drug target of RUNX3 in breast cancer</span></div><div class="casAuthors">Yu, Ying-Ying; Chen, Chao; Kong, Fan-Fei; Zhang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2423-2430, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Previous reports indicate that RUNX3 is a tumor suppressor in several types of human tumors, including breast cancer (BC).  However, the correlation between RUNX3 hypermethylation and the incidence of BC remains unclear.  In this study, we conducted a systematic review and meta-anal. aiming to comprehensively assess the potential role of RUNX3 hypermethylation in the pathogenesis of BC.  Methods: A detailed literature search was made to identify studies for related research publications.  Methodol. quality of the studies was evaluated.  Anal. of pooled data was performed.  Odds ratio (OR) was calcd. and summarized resp.  Results: Final anal. of 565 BC patients from eleven eligible studies was performed.  The results showed that RUNX3 hypermethylation was significantly higher in BC than in normal breast tissue, the pooled OR from nine studies including 339 BC and 248 normal breast tissue (OR = 24.12, 95% confidence interval [CI] = 13.50-43.11, Z = 10.75, P < 0.00001).  Further anal. also showed significantly increased OR of RUNX3 hypermethylation in estrogen receptor (ER)-pos. than in ER-neg. BC patients (OR = 5.67, 95% CI = 2.69-11.95, Z = 4.57, P < 0.00001).  In addn., RUNX3 mRNA (mRNA) high expression was found to be correlated to better overall survival in 3,455 cases of BC patients that were followed up for 20 years (hazard ratio [HR] 0.79, P = 8.8 × 10-5).  Interestingly, RUNX3 mRNA overexpression was found to be correlated to better overall survival in only 668 cases of ER-neg. patients (HR 0.72, P = 0.01), but not in 1,767 cases of ER-pos. patients (HR 0.87, P = 0.13).  Conclusion: The results of this meta-anal. suggest that RUNX3 hypermethylation may be implicated in the pathogenesis of BC.  Detection of RUNX3 mRNA may be a helpful and valuable biomarker for diagnosis of BC, esp. in ER-neg. BC.  We also discussed the significance of RUNX3 as a potential drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrJ40CazekN7Vg90H21EOLACvtfcHk0lhJEWnyYw3JoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFOitbfF&md5=4d49432971e5d88871de11f083d8cdb8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S71815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S71815%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%2BY.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DF.%2BF.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DClinicopathological%2520significance%2520and%2520potential%2520drug%2520target%2520of%2520RUNX3%2520in%2520breast%2520cancer%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2014%26volume%3D8%26spage%3D2423%26epage%3D2430%26doi%3D10.2147%2FDDDT.S71815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Adams, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verras, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ujjainwalla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, S. D.</span><span> </span><span class="NLM_article-title">Discovery of chromane propionic acid analogues as selective agonists of GPR120 with in vivo activity in rodents</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFyrtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=96-101&author=G.+L.+Adamsauthor=F.+Velazquezauthor=C.+Jayneauthor=U.+Shahauthor=S.+Miaoauthor=E.+R.+Ashleyauthor=M.+Madeiraauthor=T.+E.+Akiyamaauthor=J.+Di+Salvoauthor=T.+Suzukiauthor=N.+Wangauthor=Q.+Truongauthor=E.+Gilbertauthor=D.+Zhouauthor=A.+Verrasauthor=M.+Kirklandauthor=M.+Pachanskiauthor=M.+Powlesauthor=W.+Yinauthor=F.+Ujjainwallaauthor=S.+Venkatramanauthor=S.+D.+Edmondson&title=Discovery+of+chromane+propionic+acid+analogues+as+selective+agonists+of+GPR120+with+in+vivo+activity+in+rodents&doi=10.1021%2Facsmedchemlett.6b00394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with in Vivo Activity in Rodents</span></div><div class="casAuthors">Adams, Gregory L.; Velazquez, Francisco; Jayne, Charles; Shah, Unmesh; Miao, Shouwu; Ashley, Eric R.; Madeira, Maria; Akiyama, Taro E.; Di Salvo, Jerry; Suzuki, Takao; Wang, Nengxue; Truong, Quang; Gilbert, Eric; Zhou, Dan; Verras, Andreas; Kirkland, Melissa; Pachanski, Michele; Powles, Maryann; Yin, Wu; Ujjainwalla, Feroze; Venkatraman, Srikanth; Edmondson, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-101</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR120 (FFAR4) is a fatty acid sensing G protein coupled receptor (GPCR) that has been identified as a target for possible treatment of type 2 diabetes.  A selective activator of GPR120 contg. a chromane scaffold has been designed, synthesized, and evaluated in vivo.  Results of these efforts suggest that chromane propionic acid 18 is a suitable tool mol. for further animal studies.  Compd. 18 is selective over the closely related target GPR40 (FFAR1), has a clean off-target profile, demonstrates suitable pharmacokinetic properties, and has been evaluated in wild-type/knockout GPR120 mouse oGTT studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgLVEM4MQ03LVg90H21EOLACvtfcHk0lhJEWnyYw3JoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFyrtbnE&md5=d83a3ff9743f4865f3543debcc58bc37</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00394%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DG.%2BL.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DJayne%26aufirst%3DC.%26aulast%3DShah%26aufirst%3DU.%26aulast%3DMiao%26aufirst%3DS.%26aulast%3DAshley%26aufirst%3DE.%2BR.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DTruong%26aufirst%3DQ.%26aulast%3DGilbert%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DVerras%26aufirst%3DA.%26aulast%3DKirkland%26aufirst%3DM.%26aulast%3DPachanski%26aufirst%3DM.%26aulast%3DPowles%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DUjjainwalla%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520chromane%2520propionic%2520acid%2520analogues%2520as%2520selective%2520agonists%2520of%2520GPR120%2520with%2520in%2520vivo%2520activity%2520in%2520rodents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D96%26epage%3D101%26doi%3D10.1021%2Facsmedchemlett.6b00394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Azevedo, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wargent, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepczynska, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimpukade, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Non-acidic free fatty acid receptor 4 agonists with antidiabetic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8868</span><span class="NLM_x">–</span> <span class="NLM_lpage">8878</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00685</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVagu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8868-8878&author=C.+M.+Azevedoauthor=K.+R.+Wattersonauthor=E.+T.+Wargentauthor=S.+V.+Hansenauthor=B.+D.+Hudsonauthor=M.+A.+Kepczynskaauthor=J.+Dunlopauthor=B.+Shimpukadeauthor=E.+Christiansenauthor=G.+Milliganauthor=C.+J.+Stockerauthor=T.+Ulven&title=Non-acidic+free+fatty+acid+receptor+4+agonists+with+antidiabetic+activity&doi=10.1021%2Facs.jmedchem.6b00685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity</span></div><div class="casAuthors">Azevedo, Carlos M. G.; Watterson, Kenneth R.; Wargent, Ed T.; Hansen, Steffen V. F.; Hudson, Brian D.; Kepczynska, Malgorzata A.; Dunlop, Julia; Shimpukade, Bharat; Christiansen, Elisabeth; Milligan, Graeme; Stocker, Claire J.; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8868-8878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The free fatty acid receptor 4 (FFA4 or GPR120) has appeared as an interesting potential target for the treatment of metabolic disorders.  At present, most FFA4 ligands are carboxylic acids that are assumed to mimic the endogenous long-chain fatty acid agonists.  Here, the authors report preliminary structure-activity relationship studies of a previously disclosed non-acidic sulfonamide FFA4 agonist.  Mutagenesis studies indicate that the compds. are orthosteric agonists despite the absence of a carboxylate function.  The preferred compds. showed full agonist activity on FFA4 and complete selectivity over FFA1, although a significant fraction of these non-carboxylic acids also showed partial antagonistic activity on FFA1.  Studies in normal and diet-induced obese (DIO) mice with the preferred compd. 34 (2-(3-fluoro-5-(pyridin-2-yloxy)phenyl)-2,3-dihydrobenzo[d]isothiazole-1,1-dioxide) showed improved glucose tolerance after oral dosing in an oral glucose tolerance test.  Chronic dosing of 34 in DIO mice resulted in significantly increased insulin sensitivity and a moderate but significant redn. in bodyweight, effects that were also present in mice lacking FFA1 but absent in mice lacking FFA4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkGgmkcI6R37Vg90H21EOLACvtfcHk0lhJEWnyYw3JoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVagu7zL&md5=3dd72deea56fdf05153ff61c8a590ee8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00685%26sid%3Dliteratum%253Aachs%26aulast%3DAzevedo%26aufirst%3DC.%2BM.%26aulast%3DWatterson%26aufirst%3DK.%2BR.%26aulast%3DWargent%26aufirst%3DE.%2BT.%26aulast%3DHansen%26aufirst%3DS.%2BV.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DKepczynska%26aufirst%3DM.%2BA.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DStocker%26aufirst%3DC.%2BJ.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DNon-acidic%2520free%2520fatty%2520acid%2520receptor%25204%2520agonists%2520with%2520antidiabetic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8868%26epage%3D8878%26doi%3D10.1021%2Facs.jmedchem.6b00685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cox, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chelliah, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debenham, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotkin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashley, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alleyne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas-Fowlkes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinglass, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ujjainwalla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tata, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, C. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel and selective G-protein coupled receptor 120 (GPR120) spirocyclic agonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=49-54&author=J.+M.+Coxauthor=H.+D.+Chuauthor=M.+V.+Chelliahauthor=J.+S.+Debenhamauthor=K.+Eagenauthor=P.+Lanauthor=M.+Lombardoauthor=C.+Londonauthor=M.+A.+Plotkinauthor=U.+Shahauthor=Z.+Sunauthor=H.+M.+Vaccaroauthor=S.+Venkatramanauthor=T.+Suzukiauthor=N.+Wangauthor=E.+R.+Ashleyauthor=A.+Crespoauthor=M.+Madeiraauthor=D.+H.+Leungauthor=C.+Alleyneauthor=A.+M.+Ogawaauthor=S.+Souzaauthor=B.+Thomas-Fowlkesauthor=J.+Di+Salvoauthor=A.+Weinglassauthor=M.+Kirklandauthor=M.+Pachanskiauthor=M.+A.+Powlesauthor=E.+Tozzoauthor=T.+E.+Akiyamaauthor=F.+Ujjainwallaauthor=J.+R.+Tataauthor=C.+J.+Sinz&title=Design%2C+synthesis%2C+and+evaluation+of+novel+and+selective+G-protein+coupled+receptor+120+%28GPR120%29+spirocyclic+agonists&doi=10.1021%2Facsmedchemlett.6b00360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00360%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BM.%26aulast%3DChu%26aufirst%3DH.%2BD.%26aulast%3DChelliah%26aufirst%3DM.%2BV.%26aulast%3DDebenham%26aufirst%3DJ.%2BS.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DLan%26aufirst%3DP.%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DPlotkin%26aufirst%3DM.%2BA.%26aulast%3DShah%26aufirst%3DU.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DVaccaro%26aufirst%3DH.%2BM.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DAshley%26aufirst%3DE.%2BR.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DD.%2BH.%26aulast%3DAlleyne%26aufirst%3DC.%26aulast%3DOgawa%26aufirst%3DA.%2BM.%26aulast%3DSouza%26aufirst%3DS.%26aulast%3DThomas-Fowlkes%26aufirst%3DB.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DWeinglass%26aufirst%3DA.%26aulast%3DKirkland%26aufirst%3DM.%26aulast%3DPachanski%26aufirst%3DM.%26aulast%3DPowles%26aufirst%3DM.%2BA.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DUjjainwalla%26aufirst%3DF.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DSinz%26aufirst%3DC.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%2520and%2520selective%2520G-protein%2520coupled%2520receptor%2520120%2520%2528GPR120%2529%2520spirocyclic%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D49%26epage%3D54%26doi%3D10.1021%2Facsmedchemlett.6b00360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadakane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itsubo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshimizu, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span> </span><span class="NLM_article-title">Novel selective ligands for free fatty acid receptors GPR120 and GPR40</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">380</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1007/s00210-009-0425-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1007%2Fs00210-009-0425-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=19471906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVeks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2009&pages=247-255&author=T.+Haraauthor=A.+Hirasawaauthor=Q.+Sunauthor=K.+Sadakaneauthor=C.+Itsuboauthor=T.+Igaauthor=T.+Adachiauthor=T.+A.+Koshimizuauthor=T.+Hashimotoauthor=Y.+Asakawaauthor=G.+Tsujimoto&title=Novel+selective+ligands+for+free+fatty+acid+receptors+GPR120+and+GPR40&doi=10.1007%2Fs00210-009-0425-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective ligands for free fatty acid receptors GPR120 and GPR40</span></div><div class="casAuthors">Hara, Takafumi; Hirasawa, Akira; Sun, Qi; Sadakane, Keiko; Itsubo, Chisato; Iga, Tomoyo; Adachi, Tetsuya; Koshimizu, Taka-Aki; Hashimoto, Toshihiro; Asakawa, Yoshinori; Tsujimoto, Gozoh</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-255</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">GPR120 and GPR40 are G-protein-coupled receptors whose endogenous ligands are medium- and long-chain free fatty acids, and they are thought to play an important physiol. role in insulin release.  Despite recent progress in understanding their roles, much still remains unclear about their pharmacol., and few specific ligands for GPR120 and GPR40 besides medium- to long-chain fatty acids have been reported so far.  To identify new selective ligands for these receptors, more than 80 natural compds. were screened, together with a ref. compd. MEDICA16, which is known to activate GPR40, by monitoring the extracellular regulated kinase (ERK) and [Ca2+]i responses in inducible and stable expression cell lines for GPR40 and GPR120, resp.  MEDICA16 selectively activated [Ca2+]i response in GPR40-expressing cells but not in GPR120-expressing cells.  Among the natural compds. tested, grifolin derivs., grifolic acid and grifolic acid Me ether, promoted ERK and [Ca2+]i responses in GPR120-expressing cells, but not in GPR40-expressing cells, and inhibited the α-linolenic acid (LA)-induced ERK and [Ca2+]i responses in GPR120-expressing cells.  Interestingly, in accordance with the pharmacol. profiles of these compds., similar profiles of glucagon-like peptide-1 secretion were seen for mouse enteroendocrine cell line, STC-1 cells, which express GPR120 endogenously.  Taken together, these studies identified a selective GPR40 agonist and several GPR120 partial agonists.  These compds. would be useful probes to further investigate the physiol. and pharmacol. functions of GPR40 and GPR120.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZj6JUTJzo0rVg90H21EOLACvtfcHk0lj9u3uXGcv8QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVeks7w%253D&md5=47456c614252d4efe22f730017c21633</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00210-009-0425-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-009-0425-9%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DT.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DSadakane%26aufirst%3DK.%26aulast%3DItsubo%26aufirst%3DC.%26aulast%3DIga%26aufirst%3DT.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DKoshimizu%26aufirst%3DT.%2BA.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DAsakawa%26aufirst%3DY.%26aulast%3DTsujimoto%26aufirst%3DG.%26atitle%3DNovel%2520selective%2520ligands%2520for%2520free%2520fatty%2520acid%2520receptors%2520GPR120%2520and%2520GPR40%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2009%26volume%3D380%26spage%3D247%26epage%3D255%26doi%3D10.1007%2Fs00210-009-0425-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotkin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geissler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pols, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uebele, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alleyne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusca, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ujjainwalla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tata, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinz, C. J.</span><span> </span><span class="NLM_article-title">Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5724</span><span class="NLM_x">–</span> <span class="NLM_lpage">5728</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1016%2Fj.bmcl.2016.10.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5724-5728&author=M.+Lombardoauthor=K.+Benderauthor=C.+Londonauthor=M.+A.+Plotkinauthor=M.+Kirklandauthor=J.+Maneauthor=M.+Pachanskiauthor=W.+Geisslerauthor=J.+Cummingsauthor=B.+Habulihazauthor=T.+E.+Akiyamaauthor=J.+Di+Salvoauthor=M.+Madeiraauthor=J.+Polsauthor=M.+A.+Powlesauthor=M.+F.+Finleyauthor=E.+Johnsonauthor=T.+Rousselauthor=V.+N.+Uebeleauthor=A.+Crespoauthor=D.+Leungauthor=C.+Alleyneauthor=D.+Truscaauthor=Y.+Leiauthor=A.+D.+Howardauthor=F.+Ujjainwallaauthor=J.+R.+Tataauthor=C.+J.+Sinz&title=Discovery+of+benzofuran+propanoic+acid+GPR120+agonists%3A+From+uHTS+hit+to+mechanism-based+pharmacodynamic+effects&doi=10.1016%2Fj.bmcl.2016.10.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DBender%26aufirst%3DK.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DPlotkin%26aufirst%3DM.%2BA.%26aulast%3DKirkland%26aufirst%3DM.%26aulast%3DMane%26aufirst%3DJ.%26aulast%3DPachanski%26aufirst%3DM.%26aulast%3DGeissler%26aufirst%3DW.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DMadeira%26aufirst%3DM.%26aulast%3DPols%26aufirst%3DJ.%26aulast%3DPowles%26aufirst%3DM.%2BA.%26aulast%3DFinley%26aufirst%3DM.%2BF.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DRoussel%26aufirst%3DT.%26aulast%3DUebele%26aufirst%3DV.%2BN.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DAlleyne%26aufirst%3DC.%26aulast%3DTrusca%26aufirst%3DD.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DUjjainwalla%26aufirst%3DF.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DSinz%26aufirst%3DC.%2BJ.%26atitle%3DDiscovery%2520of%2520benzofuran%2520propanoic%2520acid%2520GPR120%2520agonists%253A%2520From%2520uHTS%2520hit%2520to%2520mechanism-based%2520pharmacodynamic%2520effects%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5724%26epage%3D5728%26doi%3D10.1016%2Fj.bmcl.2016.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Shimpukade, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovgaard, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective GPR120 agonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4511</span><span class="NLM_x">–</span> <span class="NLM_lpage">4515</span><span class="refDoi"> DOI: 10.1021/jm300215x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300215x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2lu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4511-4515&author=B.+Shimpukadeauthor=B.+D.+Hudsonauthor=C.+K.+Hovgaardauthor=G.+Milliganauthor=T.+Ulven&title=Discovery+of+a+potent+and+selective+GPR120+agonist&doi=10.1021%2Fjm300215x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective GPR120 Agonist</span></div><div class="casAuthors">Shimpukade, Bharat; Hudson, Brian D.; Hovgaard, Christine Kiel; Milligan, Graeme; Ulven, Trond</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4511-4515</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR120 is a receptor of unsatd. long-chain fatty acids reported to mediate GLP-1 secretion, insulin sensitization, anti-inflammatory, and anti-obesity effects and is therefore emerging as a new potential target for treatment of type 2 diabetes and metabolic diseases.  Further investigation is however hindered by the lack of suitable receptor modulators.  Screening of FFA1 ligands provided a lead with moderate activity on GPR120 and moderate selectivity over FFA1.  Optimization led to the discovery of the first potent and selective GPR120 agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqneyWUSNeSX7Vg90H21EOLACvtfcHk0lge83jZ0dGXaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2lu7w%253D&md5=e096ad8ee598c0de36dfdfc500d84b0f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm300215x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300215x%26sid%3Dliteratum%253Aachs%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DHovgaard%26aufirst%3DC.%2BK.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DUlven%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520GPR120%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4511%26epage%3D4515%26doi%3D10.1021%2Fjm300215x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirasawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujieda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makishima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7640</span><span class="NLM_x">–</span> <span class="NLM_lpage">7644</span><span class="refDoi"> DOI: 10.1021/jm800970b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800970b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7640-7644&author=T.+Suzukiauthor=S.+Igariauthor=A.+Hirasawaauthor=M.+Hataauthor=M.+Ishiguroauthor=H.+Fujiedaauthor=Y.+Itohauthor=T.+Hiranoauthor=H.+Nakagawaauthor=M.+Oguraauthor=M.+Makishimaauthor=G.+Tsujimotoauthor=N.+Miyata&title=Identification+of+G+protein-coupled+receptor+120-selective+agonists+derived+from+PPARgamma+agonists&doi=10.1021%2Fjm800970b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm800970b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800970b%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIgari%26aufirst%3DS.%26aulast%3DHirasawa%26aufirst%3DA.%26aulast%3DHata%26aufirst%3DM.%26aulast%3DIshiguro%26aufirst%3DM.%26aulast%3DFujieda%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DHirano%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DOgura%26aufirst%3DM.%26aulast%3DMakishima%26aufirst%3DM.%26aulast%3DTsujimoto%26aufirst%3DG.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520G%2520protein-coupled%2520receptor%2520120-selective%2520agonists%2520derived%2520from%2520PPARgamma%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7640%26epage%3D7644%26doi%3D10.1021%2Fjm800970b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hudson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimpukade, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pediani, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcote, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulven, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span> </span><span class="NLM_article-title">The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span><span class="refDoi"> DOI: 10.1124/mol.113.087783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1124%2Fmol.113.087783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=710-725&author=B.+D.+Hudsonauthor=B.+Shimpukadeauthor=A.+E.+Mackenzieauthor=A.+J.+Butcherauthor=J.+D.+Pedianiauthor=E.+Christiansenauthor=H.+Heathcoteauthor=A.+B.+Tobinauthor=T.+Ulvenauthor=G.+Milligan&title=The+pharmacology+of+TUG-891%2C+a+potent+and+selective+agonist+of+the+free+fatty+acid+receptor+4+%28FFA4%2FGPR120%29%2C+demonstrates+both+potential+opportunity+and+possible+challenges+to+therapeutic+agonism&doi=10.1124%2Fmol.113.087783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.087783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.087783%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DShimpukade%26aufirst%3DB.%26aulast%3DMackenzie%26aufirst%3DA.%2BE.%26aulast%3DButcher%26aufirst%3DA.%2BJ.%26aulast%3DPediani%26aufirst%3DJ.%2BD.%26aulast%3DChristiansen%26aufirst%3DE.%26aulast%3DHeathcote%26aufirst%3DH.%26aulast%3DTobin%26aufirst%3DA.%2BB.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DThe%2520pharmacology%2520of%2520TUG-891%252C%2520a%2520potent%2520and%2520selective%2520agonist%2520of%2520the%2520free%2520fatty%2520acid%2520receptor%25204%2520%2528FFA4%252FGPR120%2529%252C%2520demonstrates%2520both%2520potential%2520opportunity%2520and%2520possible%2520challenges%2520to%2520therapeutic%2520agonism%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D710%26epage%3D725%26doi%3D10.1124%2Fmol.113.087783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ma, J.; Novack, A.; Nashashibi, I.; Pham, P.; Rabbat, C. J.; Song, J.; Shi, D. F.; Zhao, Z.; Choi, Y.-J.; Chen, X.</span><span> </span><span class="NLM_article-title">[(Heterocyclylmethoxy)aryl]alkanoic acid derivatives as GPR120 receptor agonists and preparation and uses thereof</span>. Patent WO2010/048207,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Ma&author=A.+Novack&author=I.+Nashashibi&author=P.+Pham&author=C.+J.+Rabbat&author=J.+Song&author=D.+F.+Shi&author=Z.+Zhao&author=Y.-J.+Choi&author=X.+Chen&title=%5B%28Heterocyclylmethoxy%29aryl%5Dalkanoic+acid+derivatives+as+GPR120+receptor+agonists+and+preparation+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26atitle%3D%255B%2528Heterocyclylmethoxy%2529aryl%255Dalkanoic%2520acid%2520derivatives%2520as%2520GPR120%2520receptor%2520agonists%2520and%2520preparation%2520and%2520uses%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Holliday, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J. H.</span><span> </span><span class="NLM_article-title">Drug discovery opportunities and challenges at G protein coupled receptors for long chain free Fatty acids</span> <span class="citation_source-journal">Front. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="refDoi"> DOI: 10.3389/fendo.2011.00112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.3389%2Ffendo.2011.00112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=22649399" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=112&author=N.+D.+Hollidayauthor=S.-J.+Watsonauthor=A.+J.+H.+Brown&title=Drug+discovery+opportunities+and+challenges+at+G+protein+coupled+receptors+for+long+chain+free+Fatty+acids&doi=10.3389%2Ffendo.2011.00112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2011.00112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2011.00112%26sid%3Dliteratum%253Aachs%26aulast%3DHolliday%26aufirst%3DN.%2BD.%26aulast%3DWatson%26aufirst%3DS.-J.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26atitle%3DDrug%2520discovery%2520opportunities%2520and%2520challenges%2520at%2520G%2520protein%2520coupled%2520receptors%2520for%2520long%2520chain%2520free%2520Fatty%2520acids%26jtitle%3DFront.%2520Endocrinol.%26date%3D2012%26volume%3D2%26spage%3D112%26doi%3D10.3389%2Ffendo.2011.00112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lee, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkleeren, R.</span><span> </span><span class="NLM_article-title">Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1089/adt.2007.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1089%2Fadt.2007.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=18336088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=83-94&author=P.+H.+Leeauthor=A.+Gaoauthor=C.+van+Stadenauthor=J.+Lyauthor=J.+Salonauthor=A.+Xuauthor=Y.+Fangauthor=R.+Verkleeren&title=Evaluation+of+dynamic+mass+redistribution+technology+for+pharmacological+studies+of+recombinant+and+endogenously+expressed+g+protein-coupled+receptors&doi=10.1089%2Fadt.2007.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Dynamic Mass Redistribution Technology for Pharmacological Studies of Recombinant and Endogenously Expressed G Protein-Coupled Receptors</span></div><div class="casAuthors">Lee, Paul H.; Gao, Alice; van Staden, Carlo; Ly, Jenny; Salon, John; Xu, Arron; Fang, Ye; Verkleeren, Ron</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The Epic cell assay technol. (Corning Inc., Corning, NY) uses a resonant waveguide grating optical biosensor to measure cellular response to ligands manifested through dynamic mass redistribution (DMR) of cellular contents.  The DMR measurement is a noninvasive, label-free assay that can be used to assess the pharmacol. properties of compds.  In this study, a panel of 12 compds. was evaluated against two G protein-coupled receptor (GPCR) targets in recombinant expressed cell lines using the Corning Epic system in 384-well microplates.  The evaluation was performed in a double-blinded fashion such that the identity and properties of both the GPCR targets and compds. were unknown to the researchers at the time of the study.  Anal. of the DMR response from cell stimulation was used to identify compds. that functioned as agonists or antagonists and to evaluate the assocd. efficacy and potency.  DMR results were shown to have good agreement with data obtained from cAMP and calcium flux assays for compds. evaluated.  A further anal. was performed and successfully identified the signaling pathways that the two GPCRs activated.  In addn., the DMR measurement was able to detect responses from an endogenous receptor in these cells.  The Epic DMR technol. provides a generic platform amenable to pharmacol. evaluation of cellular responses to GPCR activation in a label-free live cell assay format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohWThU7pO167Vg90H21EOLACvtfcHk0lg9hxjAycpGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtbw%253D&md5=0f2d1ebca70b4954eaaf0b9440791829</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.126%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DP.%2BH.%26aulast%3DGao%26aufirst%3DA.%26aulast%3Dvan%2BStaden%26aufirst%3DC.%26aulast%3DLy%26aufirst%3DJ.%26aulast%3DSalon%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DVerkleeren%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520dynamic%2520mass%2520redistribution%2520technology%2520for%2520pharmacological%2520studies%2520of%2520recombinant%2520and%2520endogenously%2520expressed%2520g%2520protein-coupled%2520receptors%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D83%26epage%3D94%26doi%3D10.1089%2Fadt.2007.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Talele, T. T.</span><span> </span><span class="NLM_article-title">The ″cyclopropyl fragment″ is a versatile player that frequently appears in preclinical/clinical drug molecules</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">8712</span><span class="NLM_x">–</span> <span class="NLM_lpage">8756</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&author=T.+T.+Talele&title=The+%E2%80%B3cyclopropyl+fragment%E2%80%B3+is+a+versatile+player+that+frequently+appears+in+preclinical%2Fclinical+drug+molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules</span></div><div class="casAuthors">Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8712-8756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing use of the cyclopropyl ring in drug development to transition drug candidates from the preclin. to clin. stage.  Important features of the cyclopropane ring are, the (1) coplanarity of the three carbon atoms, (2) relatively shorter (1.51 Å) C-C bonds, (3) enhanced π-character of C-C bonds, and (4) C-H bonds are shorter and stronger than those in alkanes.  The present review will focus on the contributions that a cyclopropyl ring makes to the properties of drugs contg. it.  Consequently, the cyclopropyl ring addresses multiple roadblocks that can occur during drug discovery such as (a) enhancing potency, (b) reducing off-target effects, (c) increasing metabolic stability, (d) increasing brain permeability, (e) decreasing plasma clearance, (f) contributing to an entropically more favorable binding to the receptor, (g) conformational restriction of peptides/peptidomimetics to prevent proteolytic hydrolysis, and (h) altering drug pKa to reduce its P-glycoprotein efflux ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVIJAG1XVRG7Vg90H21EOLACvtfcHk0lg9hxjAycpGdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWguro%253D&md5=b5586458ec4ab5e2d7586f5739663d1f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2580%25B3cyclopropyl%2520fragment%25E2%2580%25B3%2520is%2520a%2520versatile%2520player%2520that%2520frequently%2520appears%2520in%2520preclinical%252Fclinical%2520drug%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Molecular formula = C<sub>10</sub>H<sub>9</sub>BrO<sub>2</sub>. Formula weight = 241.08. Crystal system = orthorhombic. Space group = <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>, <i>a</i> = 6.5493(4) Å, <i>b</i> = 6.9515(5) Å, <i>c</i> = 20.6297(14) Å, α = 90°, β = 90°, γ = 90°, <i>V</i> = 939.218 Å<sup>3</sup>, <i>T</i> = 200K, <i>Z</i> = 4, <i>D</i><sub>c</sub> = 1.705 gcm<sup>–1</sup>, λ<sub>(Mo-Kα)</sub> = 0.71073, μ = 4.338 mm<sup>–1</sup>, 3188 reflections measured, 2243 independent reflections, 1754 observed reflections [<i>I</i> > 2.0σ(<i>I</i>)], <i>R</i>[<i>F</i><sup>2</sup> > 2σ(<i>F</i><sup>2</sup><i>)</i>] = 0.0293, goodness of fit = 1.027. Flack’s <i>x</i> parameter = 0.014(14), indicating correctly defined chirality. Crystallographic data have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 1530875.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eZUllLzEddlTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducrozet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Development of a high-throughput brain slice method for studying drug distribution in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span><span class="refDoi"> DOI: 10.1124/dmd.108.026377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1124%2Fdmd.108.026377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=19299522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslamu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1226-1233&author=M.+Fridenauthor=F.+Ducrozetauthor=B.+Middletonauthor=M.+Antonssonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=Development+of+a+high-throughput+brain+slice+method+for+studying+drug+distribution+in+the+central+nervous+system&doi=10.1124%2Fdmd.108.026377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high-throughput brain slice method for studying drug distribution in the central nervous system</span></div><div class="casAuthors">Friden, Markus; Ducrozet, Frederic; Middleton, Brian; Antonsson, Madeleine; Bredberg, Ulf; Hammarlund-Udenaes, Margareta</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1226-1233</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">New, more efficient methods of estg. unbound drug concns. in the central nervous system (CNS) combine the amt. of drug in whole brain tissue samples measured by conventional methods with in vitro ests. of the unbound brain vol. of distribution (Vu,brain).  Although the brain slice method is the most reliable in vitro method for measuring Vu,brain, it has not previously been adapted for the needs of drug discovery research.  The aim of this study was to increase the throughput and optimize the exptl. conditions of this method.  Equil. of drug between the buffer and the brain slice within the 4 to 5 h of incubation is a fundamental requirement.  However, it is difficult to meet this requirement for many of the extensively binding, lipophilic compds. in drug discovery programs.  In this study, the dimensions of the incubation vessel and mode of stirring influenced the equilibration time, as did the amt. of brain tissue per unit of buffer vol.  The use of cassette expts. for investigating Vu,brain in a linear drug concn. range increased the throughput of the method.  The Vu,brain for the model compds. ranged from 4 to 3000 mL/g brain-1, and the sources of variability are discussed.  The optimized setup of the brain slice method allows precise, robust estn. of Vu,brain for drugs with diverse properties, including highly lipophilic compds.  This is a crit. step forward for the implementation of relevant measurements of CNS exposure in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbw00E2WUX2LVg90H21EOLACvtfcHk0lgh0hGxB7Ij_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslamu70%253D&md5=907441179cc476ca489a1e036832f3ee</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.026377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.026377%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DDucrozet%26aufirst%3DF.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DAntonsson%26aufirst%3DM.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520high-throughput%2520brain%2520slice%2520method%2520for%2520studying%2520drug%2520distribution%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1226%26epage%3D1233%26doi%3D10.1124%2Fdmd.108.026377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ertan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcombe, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pointon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span> </span><span class="NLM_article-title">Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6128</span><span class="NLM_x">–</span> <span class="NLM_lpage">6140</span><span class="refDoi"> DOI: 10.1021/jm500610n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500610n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6128-6140&author=W.+McCoullauthor=P.+Bartonauthor=A.+J.+Brownauthor=S.+S.+Bowkerauthor=J.+Cameronauthor=D.+S.+Clarkeauthor=R.+D.+Daviesauthor=A.+G.+Dossetterauthor=A.+Ertanauthor=M.+Fenwickauthor=C.+Greenauthor=J.+L.+Holmesauthor=N.+Martinauthor=D.+Mastersauthor=J.+E.+Mooreauthor=N.+J.+Newcombeauthor=C.+Newtonauthor=H.+Pointonauthor=G.+R.+Robbauthor=C.+Sheldonauthor=S.+Stokesauthor=D.+Morgan&title=Identification%2C+optimization%2C+and+pharmacology+of+acylurea+GHS-R1a+inverse+agonists&doi=10.1021%2Fjm500610n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm500610n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500610n%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DBowker%26aufirst%3DS.%2BS.%26aulast%3DCameron%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavies%26aufirst%3DR.%2BD.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DFenwick%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DHolmes%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%2BE.%26aulast%3DNewcombe%26aufirst%3DN.%2BJ.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DPointon%26aufirst%3DH.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DSheldon%26aufirst%3DC.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DMorgan%26aufirst%3DD.%26atitle%3DIdentification%252C%2520optimization%252C%2520and%2520pharmacology%2520of%2520acylurea%2520GHS-R1a%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6128%26epage%3D6140%26doi%3D10.1021%2Fjm500610n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gabrielsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlfinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peletier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pehrson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsson, P.</span><span> </span><span class="NLM_article-title">Modeling and design of challenge tests: inflammatory and metabolic biomarker study examples</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1016/j.ejps.2014.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1016%2Fj.ejps.2014.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=25435491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=144-159&author=J.+Gabrielssonauthor=S.+Hjorthauthor=B.+Voggauthor=S.+Harlfingerauthor=P.+M.+Gutierrezauthor=L.+Peletierauthor=R.+Pehrsonauthor=P.+Davidsson&title=Modeling+and+design+of+challenge+tests%3A+inflammatory+and+metabolic+biomarker+study+examples&doi=10.1016%2Fj.ejps.2014.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples</span></div><div class="casAuthors">Gabrielsson, Johan; Hjorth, Stephan; Vogg, Barbara; Harlfinger, Stephanie; Gutierrez, Pablo Morentin; Peletier, Lambertus; Pehrson, Rikard; Davidsson, Pia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144-159</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Given the complexity of pharmacol. challenge expts., it is perhaps not surprising that design and anal., and in turn interpretation and communication of results from a quant. point of view, is often suboptimal.  Here we report an inventory of common designs sampled from anti-inflammatory, respiratory and metabolic disease drug discovery studies, all of which are based on animal models of disease involving pharmacol. and/or patho/physiol. interaction challenges.  The corresponding data are modeled and analyzed quant., the merits of the resp. approach discussed and inferences made with respect to future design improvements.  Although our anal. is limited to these disease model examples, the challenge approach is generally applicable to the vast majority of pharmacol. intervention studies.  In the present five Case Studies results from pharmacodynamic effect models from different therapeutic areas were explored and analyzed according to five typical designs.  Plasma exposures of test compds. were assayed by either liq. chromatog./mass spectrometry or ligand binding assays.  To describe how drug intervention can regulate diverse processes, turnover models of test compd.-challenger interaction, transduction processes, and biophase time courses were applied for biomarker response in eosinophil count, IL6 response, paw-swelling, TNFα response and glucose turnover in vivo.  Case Study 1 shows results from intratracheal administration of Sephadex, which is a glucocorticoid-sensitive model of airway inflammation in rats.  Eosinophils in bronchoalveolar fluid were obtained at different time points via destructive sampling and then regressed by the mixed-effects modeling.  A biophase function of the Sephadex time course was inferred from the modeled eosinophil time courses.  In Case Study 2, a mouse model showed that the time course of cytokine-induced IL1β challenge was altered with or without drug intervention.  Anakinra reversed the IL1β induced cytokine IL6 response in a dose-dependent manner.  This Case Study contained time courses of test compd. (drug), challenger (IL1β) and cytokine response (IL6), which resulted in high parameter precision.  Case Study 3 illustrates collagen-induced arthritis progression in the rat.  Swelling scores (based on severity of hind paw swelling) were used to describe arthritis progression after the challenge and the inhibitory effect of two doses of an orally administered test compd.  In Case Study 4, a cynomolgus monkey model for lipopolysaccharide LPS-induced TNFα synthesis and/or release was investigated.  This model provides integrated information on pharmacokinetics and in vivo potency of the test compds.  Case Study 5 contains data from an oral glucose tolerance test in rats, where the challenger is the same as the pharmacodynamic response biomarker (glucose).  It is therefore convenient to model the extra input of glucose simultaneously with baseline data and during intervention of a glucose-lowering compd. at different dose levels.  Typically time-series analyses of challenger- and biomarker-time data are necessary if an accurate and precise est. of the pharmacodynamic properties of a test compd. is sought.  Erosion of data, resulting in the single-point assessment of drug action after a challenge test, should generally be avoided.  This is particularly relevant for situations where one expects time-curve shifts, tolerance/rebound, impact of disease, or hormetic concn.-response relationships to occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEqwRzFXFhAbVg90H21EOLACvtfcHk0lgh0hGxB7Ij_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWktrvL&md5=ce9db0cd96b7dc3c04c307b2b5d03083</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2014.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2014.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DGabrielsson%26aufirst%3DJ.%26aulast%3DHjorth%26aufirst%3DS.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DHarlfinger%26aufirst%3DS.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DPeletier%26aufirst%3DL.%26aulast%3DPehrson%26aufirst%3DR.%26aulast%3DDavidsson%26aufirst%3DP.%26atitle%3DModeling%2520and%2520design%2520of%2520challenge%2520tests%253A%2520inflammatory%2520and%2520metabolic%2520biomarker%2520study%2520examples%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D67%26spage%3D144%26epage%3D159%26doi%3D10.1016%2Fj.ejps.2014.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bowes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarolimek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitebread, S.</span><span> </span><span class="NLM_article-title">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1038/nrd3845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1038%2Fnrd3845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=23197038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=909-922&author=J.+Bowesauthor=A.+J.+Brownauthor=J.+Hamonauthor=W.+Jarolimekauthor=A.+Sridharauthor=G.+Waldronauthor=S.+Whitebread&title=Reducing+safety-related+drug+attrition%3A+the+use+of+in+vitro+pharmacological+profiling&doi=10.1038%2Fnrd3845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing safety-related drug attrition: the use of in vitro pharmacological profiling</span></div><div class="casAuthors">Bowes, Joanne; Brown, Andrew J.; Hamon, Jacques; Jarolimek, Wolfgang; Sridhar, Arun; Waldron, Gareth; Whitebread, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">909-922</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In vitro pharmacol. profiling is increasingly being used earlier in the drug discovery process to identify undesirable off-target activity profiles that could hinder or halt the development of candidate drugs or even lead to market withdrawal if discovered after a drug is approved.  Here, for the first time, the rationale, strategies and methodologies for in vitro pharmacol. profiling at four major pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Novartis and Pfizer) are presented and illustrated with examples of their impact on the drug discovery process.  We hope that this will enable other companies and academic institutions to benefit from this knowledge and consider joining us in our collaborative knowledge sharing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomVp3wnTONWrVg90H21EOLACvtfcHk0lgh0hGxB7Ij_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnur%252FJ&md5=7559001563ef3febd610535b8f096a45</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3845%26sid%3Dliteratum%253Aachs%26aulast%3DBowes%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DHamon%26aufirst%3DJ.%26aulast%3DJarolimek%26aufirst%3DW.%26aulast%3DSridhar%26aufirst%3DA.%26aulast%3DWaldron%26aufirst%3DG.%26aulast%3DWhitebread%26aufirst%3DS.%26atitle%3DReducing%2520safety-related%2520drug%2520attrition%253A%2520the%2520use%2520of%2520in%2520vitro%2520pharmacological%2520profiling%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D909%26epage%3D922%26doi%3D10.1038%2Fnrd3845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Stone, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhayal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocklehurst, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenaghan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorhede Winzell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, N. G.</span><span> </span><span class="NLM_article-title">GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1182</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span><span class="refDoi"> DOI: 10.1007/s00125-014-3213-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1007%2Fs00125-014-3213-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=24663807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFyiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1182-1191&author=V.+M.+Stoneauthor=S.+Dhayalauthor=K.+J.+Brocklehurstauthor=C.+Lenaghanauthor=M.+Sorhede+Winzellauthor=M.+Hammarauthor=X.+Xuauthor=D.+M.+Smithauthor=N.+G.+Morgan&title=GPR120+%28FFAR4%29+is+preferentially+expressed+in+pancreatic+delta+cells+and+regulates+somatostatin+secretion+from+murine+islets+of+Langerhans&doi=10.1007%2Fs00125-014-3213-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans</span></div><div class="casAuthors">Stone, Virginia M.; Dhayal, Shalinee; Brocklehurst, Katy J.; Lenaghan, Carol; Sorhede Winzell, Maria; Hammar, Marten; Xu, Xiufeng; Smith, David M.; Morgan, Noel G.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1182-1191</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: The NEFA-responsive G-protein coupled receptor 120 (GPR120) has been implicated in the regulation of inflammation, in the control of incretin secretion and as a predisposing factor influencing the development of type 2 diabetes by regulation of islet cell apoptosis.  However, there is still considerable controversy about the tissue distribution of GPR120 and, in particular, it remains unclear which islet cell types express this mol.  In the present study, we have addressed this issue by constructing a Gpr120-knockout/β-galactosidase (LacZ) knock-in (KO/KI) mouse to examine the distribution and functional role of GPR120 in the endocrine pancreas.  Methods: A KO/KI mouse was generated in which exon 1 of the Gpr120 gene (also known as Ffar4) was replaced in frame by LacZ, thereby allowing for regulated expression of β-galactosidase under the control of the endogenous GPR120 promoter.  The distribution of GPR120 was inferred from expression studies detecting β-galactosidase activity and protein prodn.  Islet hormone secretion was measured from isolated mouse islets treated with selective GPR120 agonists.  Results: β-galactosidase activity was detected as a surrogate for GPR120 expression exclusively in a small population of islet endocrine cells located peripherally within the islet mantle.  Immunofluorescence anal. revealed co-localization with somatostatin suggesting that GPR120 is preferentially produced in islet delta cells.  In confirmation of this, glucose-induced somatostatin secretion was inhibited by a range of selective GPR120 agonists.  This response was lost in GPR120-knockout mice.  Conclusions/interpretation: The results imply that GPR120 is selectively present within the delta cells of murine islets and that it regulates somatostatin secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGyFZRMy8eGLVg90H21EOLACvtfcHk0ljiwVcHF4wQvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFyiuro%253D&md5=bcff90e76b5b8ea1908376cd8c909c77</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00125-014-3213-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-014-3213-0%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DV.%2BM.%26aulast%3DDhayal%26aufirst%3DS.%26aulast%3DBrocklehurst%26aufirst%3DK.%2BJ.%26aulast%3DLenaghan%26aufirst%3DC.%26aulast%3DSorhede%2BWinzell%26aufirst%3DM.%26aulast%3DHammar%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DMorgan%26aufirst%3DN.%2BG.%26atitle%3DGPR120%2520%2528FFAR4%2529%2520is%2520preferentially%2520expressed%2520in%2520pancreatic%2520delta%2520cells%2520and%2520regulates%2520somatostatin%2520secretion%2520from%2520murine%2520islets%2520of%2520Langerhans%26jtitle%3DDiabetologia%26date%3D2014%26volume%3D57%26spage%3D1182%26epage%3D1191%26doi%3D10.1007%2Fs00125-014-3213-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Auguste, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hryhorczuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitout, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alquier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, S.</span><span> </span><span class="NLM_article-title">Central agonism of GPR120 acutely inhibits food intake and food reward and chronically suppresses anxiety-like behavior in mice</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">pyw014</span><span class="refDoi"> DOI: 10.1093/ijnp/pyw014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=10.1093%2Fijnp%2Fpyw014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;key=26888796" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=pyw014&author=S.+Augusteauthor=A.+Fisetteauthor=M.+F.+Fernandesauthor=C.+Hryhorczukauthor=V.+Poitoutauthor=T.+Alquierauthor=S.+Fulton&title=Central+agonism+of+GPR120+acutely+inhibits+food+intake+and+food+reward+and+chronically+suppresses+anxiety-like+behavior+in+mice&doi=10.1093%2Fijnp%2Fpyw014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fijnp%2Fpyw014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fijnp%252Fpyw014%26sid%3Dliteratum%253Aachs%26aulast%3DAuguste%26aufirst%3DS.%26aulast%3DFisette%26aufirst%3DA.%26aulast%3DFernandes%26aufirst%3DM.%2BF.%26aulast%3DHryhorczuk%26aufirst%3DC.%26aulast%3DPoitout%26aufirst%3DV.%26aulast%3DAlquier%26aufirst%3DT.%26aulast%3DFulton%26aufirst%3DS.%26atitle%3DCentral%2520agonism%2520of%2520GPR120%2520acutely%2520inhibits%2520food%2520intake%2520and%2520food%2520reward%2520and%2520chronically%2520suppresses%2520anxiety-like%2520behavior%2520in%2520mice%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2016%26volume%3D19%26spage%3Dpyw014%26doi%3D10.1093%2Fijnp%2Fpyw014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Goldberg, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossetter, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmitt, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deSchoolmeester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swales, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, M. J.</span><span> </span><span class="NLM_article-title">Optimization of brain penetrant 11beta-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese mice</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span><span class="refDoi"> DOI: 10.1021/jm4016729</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4016729" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=970-986&author=F.+W.+Goldbergauthor=A.+G.+Dossetterauthor=J.+S.+Scottauthor=G.+R.+Robbauthor=S.+Boydauthor=S.+D.+Groombridgeauthor=P.+D.+Kemmittauthor=T.+Sjogrenauthor=P.+M.+Gutierrezauthor=J.+deSchoolmeesterauthor=J.+G.+Swalesauthor=A.+V.+Turnbullauthor=M.+J.+Wild&title=Optimization+of+brain+penetrant+11beta-hydroxysteroid+dehydrogenase+type+I+inhibitors+and+in+vivo+testing+in+diet-induced+obese+mice&doi=10.1021%2Fjm4016729"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm4016729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4016729%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DF.%2BW.%26aulast%3DDossetter%26aufirst%3DA.%2BG.%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DBoyd%26aufirst%3DS.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DSjogren%26aufirst%3DT.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DdeSchoolmeester%26aufirst%3DJ.%26aulast%3DSwales%26aufirst%3DJ.%2BG.%26aulast%3DTurnbull%26aufirst%3DA.%2BV.%26aulast%3DWild%26aufirst%3DM.%2BJ.%26atitle%3DOptimization%2520of%2520brain%2520penetrant%252011beta-hydroxysteroid%2520dehydrogenase%2520type%2520I%2520inhibitors%2520and%2520in%2520vivo%2520testing%2520in%2520diet-induced%2520obese%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D970%26epage%3D986%26doi%3D10.1021%2Fjm4016729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i38"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00210">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01861"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00210">10.1021/acs.jmedchem.7b00210</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Preparation and additional characterization for final compounds; effect of <b>33</b> and <b>32</b> in in vitro radioligand binding, enzyme and funtional assays (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_001.pdf">jm7b00210_si_001.pdf (586.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00210/suppl_file/jm7b00210_si_002.csv">jm7b00210_si_002.csv (1.8 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00210&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00210%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-7" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00210" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799397a0f933da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
